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SUMMARY
The recognition of Hepatitis B surface antigen (HB Ag) as as
marker of one of the causative agents of posttransfusion hepatitis
stimulated a demand for techniques applicable to mass donor
testing which would allow blood to be 'cleared' for use within
hours of donation. Counter-electrophoresis was the first technique
to be widely used for HB Ag testing within the blood transfusions
service but, with the advance of hepatitis testing technology, wa3
soon found to be of insufficient sensitivity. Commercial tests
employing the principles of haemagglutination and radioimmunoassay
became available, but at a price (particularly radioimmunoassay)
which proved prohibitive to maiy centres. This thesis describes
the development and application of a haeraagglutination-inhibition (HAl)
test for HB Ag designed specifically to meet the requirements of the3
blood transfusion service.
The optimum conditions under which fresh human erythrocytes
may be tanned and coated with partially purified HBgAg are
determined, and the procedure of testing established using u-bottomed
microtitre plates. Sensitivity and specificity are comparable to
that of commercial 'third generation' reagents.
CL.
To improve reagent eeonony the test has been 'miniaturised' using
Terasaki tissue culture trays. Reagent standardisation dtias improved
by the introduction of glutaraldeiyde-fixed spherocytes as HB3Ag
carriers, and 'bulk* preparation of reagents, which yielded sufficient
for one million tests if conduoted in Terasaki trays.
The use of antisera rendered monospecific by adsorption allowed
the HAI test to be applied to antigen subtyping, thereby providing
useful confirmatory evidence for the presence of HBflAg in a
V
positively reacting test serum. The results of a multicentre
evaluation of this HAI technique demonstrated that it was an acceptable
alternative to commercial third generation HB Ag tests for use in
o
large scale blood donor testing. Thus, with the appropriate
training, the technique can be introduced into most regional
transfusion centres, thereby keeping reagent costs to a minimum.
Re-investigation of more than one hundred donations implicated in
ten cases of posttransfusion hepatitis suggests that if HAI had
been used at the time of donation 40 percent of the cases may have
been avoided.
Results of an * on-going' evaluation of the efficacy of hepatitis
B immunoglobulin (HB-Ig&) in the prevention of hepatitis resulting
from accidental exposure to HB Ag suggest that fractionation ofs
HB Ab positive plasma provides a product which, by virtue of itss
high specific antibddy content, provides a significant degree of
protection against type B hepatitis, provided the 'challenge dose'
is small.
The pursuit of a specific theme invariably stimulates new ideas
aimed at fuxther improvement. This thesis concludes with a
consideration of those lines of research which are considered to be




VireX hepatitis ia the term used to describe acute
inflammation of the liver caused by an infectious &gent(s>
presumed to be a virus. The clinical spectrum of the disease
varies from asymptomatic inl'ection through prodromal symptoms of a
mild gastrointestinal nature with little or no overt hepato¬
cellular involvement, anicteric hepatitis, hepatitis with jaundice,
to acute fulminant hepatitis. Other symptoms such as urticaria,
arthritis and polya*teritia nodosa may occur as a result of
circulating immune complexes. Complications include chronic
hepatitis vshioh may progress to cirrhosis or hepatoma.
During arid shortly after the Second world i.ar, volunteer
studies indicated two forms of viral hepatitis:infectious hepatitis
(III,virus A) and sexum hepatitis (SH,virus b) (MacCailum,
rfcFarlan, Miles, Pollock and Wilson, 1951)» A number of
attributes ore now known to distinguish virus A Infection from
virus B infection and these are listed in table 1. The most
outstanding difference between 1H and SH oomes from the obsex-vation
that one does not o /ni'er immunity to the other, i.e. the causa cive
agents will not cro o-imffluwl— one against the other (itrugiuan,
(riles and Hammond, 1967; Krugman and Giles, 1970,1. .he
incubation period of 1H ia x-egularly 30-40 days irrespective of
oral or parenteral inoculation. On the other hand, that of SH Is
usually longer, particularly after infection by the oral route
(Giles, McCollum, erndtaon, jnr. and Krugman, 1969; Krugman
and Giles, 1970). dome patients with a short incubation period are
found to posse s Hepatitis B antigen (HB Ag) and it is likely that
TABLE I
Distinguishing Features of Hepatitis A and Hepatitis B
HEPATITIS A
PROTOTYPE STRAIN
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* In the South East Region of Scotland approximately 0.04 percent
of healthy blood donors carry HB Ag for up to 3 years and probably muchs
longer (Hopkins, Robertson, Ross, Turnbull and Das;1975).
+ Feinstone, Zapikian and Purcell (1973) described a possible hepatitis
A virus in the stool of acutely infected patients. Specific antibody v/as
detected in the convalescent sera of these and other hepatitis A patients.
** In countries where Hepatitis B infection is common (see page 19)»
the highest prevalence of HB Ag is found in children 4-8 years old.
s
*** Depending upon HB Ab content.
3.
the accelerated development of the illness is due to a high
concentration of virus in the challenge dose (dowser, London,
dutniok, Blumberg and Senior, 1970).
Infectious Hepatitis has been reoognised for many centuries,
but it has been suggested by Zuckerman (1970) that clinical SH may
have a relatively short history. He makes the point that even if
HB Ag has been enaemic in the population for many years, outbreaks
of SH only became apparent after the introduction of large 3oale
parenteral therapy and immunisation procedures and has paralleled
the increasing transfusion of blood ana use of blood produots.
It must be borne in mind, however, that it is only within the last
few years that we have been able to identify SH as a serologically
distinot entity. The origin of HB Ag is uncertain. Havens jnr.
(1961) suggested that it represented theemergenee of a new strain
derived from virus A. This seems unlikely as the causative agents
show no antigenic similarities and neither oonfers immunity against
the other (Krugman et al.« 19&7* hrugman and uiles, 1970). A more
acceptable theory is that HB Ag has been with us for a very long
time, being maintained in the population by sexual contact and
ritual operations involving scarification. Aith the advent of
parenteral therapy, it has emerged as a major complication
particularly with regard to the use of blood and blood products.
II. Association 01 HB Ag with Posttransfusion (Serum) Hepatitis
In 1961, Allison and Blumberg reported that some patients who
had received numerous blood transfusions developed precipitating
antibodies against serum beta-lipoproteins. During the course of
these investigations, an antigen was found in the serum of an
Australian Aborigine and was designated 'Australia Antigen' (Au Ag).
4.
It was not for some years that the association with viral hepatitis
was discovered (Bluraberg, Geratley, Hungerford, liondon arid Sutnick,
1967; Bluraberg, Butnick and London, 196B). In 1969, Giles et el.
presented data to suggest that the antigen was specifics ly vein tea
to long incubation (seruaj hepatitis. This discovery was the
result of work started a few years earlier at the willovrbr ok State
School in New Y rk (ijpugman et al., 1967)#
HI* 'Terminology
AS research efforts and publications rapidly increased, new
terms were introduced* Australia antigen (au kg or Au(i)J, serum
hepatitis antigen (Sh), hepatitis antigen (Ha) and hepatitis-
associated antigen (HA&) ail referred to one ana the same thing.
This welter of terms end symbols has often proved confusing to
clinicians, epidemiologists and laboratory workers* The priority
of the tens Australia Antigen is acknowledged, but if its
association with hepatitis is specific, then the name could be mis¬
leading, implying an unusual association with that country. The
alternative, hepatitis-associated antigen, could create confusion if
other antigen-antibody systems are discovered which prove to be
specific for other forms of hepatitis. The terms hepatitis A and
hepatitis B were introduced as long ago as 1947 (^actallum), and it
has recently been proposed that the antigen of hepatitis B be referred
to as hepatitis B antigen (HB Ag) (»*orld Health Organisation
Committee on Viral hepatitis, 1973)*
un the electron microscopy antigen positive 3era are frequently
characterised by the presence of three morphologic forms (see inside
page ), namely hOnm. spheres, rod-like structures also 20nra. in
diameter, and larger 4hnra .spheres known as lane particles, some of
5.
which possess an inner electron-dense core. The discovery and
subsequent confirmation of the existence of an additional antigenic
specificity associated with the Dane particle core (Almeida,
Rubenstein and Stott, 1971 J fraavik, Kjeldsberg and Siebke, 1973*
Brzosko, Madalinski, Krawczynski and Nowaslowski, 1973* Hoofnagle,
G-erety and Barker, 1973) an<* the 'e' system (Magnius and Espmark,
1972; described in detail later) necessitated the adoption of a
terminology capable of distinquishing those determinants present on
the surface of the antigens' lipoprotein coat and those found in
association with the Dane particle core. Hence the term hepatitis B
surface antigen (HB Ag) and hepatitis B core antigen (HB Ag) ares o
used in this thesis in reference to the surface and core antigens
respectively.
As the major portion of this thesis is concerned with the
serology of HB Ag, the physical and chemical properties of the






rEVIEw OF INFORMATION CUB1KHTLY AVAILABLE i-JS&AADiNG
HEPATITIS B SU&FACE ANTIGEN
CHAPim I
BIOCHEMICAL AND BIOPHYSICAL CHARACTERISTICS
1 • Morphology, stability and Chemical Composition
Bayer, Blumberg and Werner were first to observe the
pt^ysical appearance of HB^S the electron microsoope. Using
gradient-purified material, they were able to identify two types of
particle, 20-25>nm diameter spheres and rod-like structures 20-2Jjnra
diameter, but of v-rying length. Both types of particle were
aggregated by specific antiserum. These findings were soon
c nfirmed by Prince (1968). Almeida, Suckerman, Taylor and
waterson (1969) observed both types of particle in the serum of a
healthy carrier of *®QAg and in the acute phase sera of two patients
with viral hepatitis. In a later publication, cro;s striations of
the rod-like structures, showing a periodicity of ynm , were noted
together with an irregularity in the size of the spherical particles
t
whose diameter varied between 16-2^rm (Almeida, 1971)« Lane,
Cameron and Brings (1970) reported the presence cf large spherical
particles, k2xm in diameter (subsequently termed 'Dane Particles'),
in multiple serum specimens from three antigen positive patients.
These particles were also aggregated by specific antibody and appeared
to possess a complex internal structure. dust, Cross, Haider and
Ferris (1971) and Hirschmun, Vernace and Sohuffner (19/1) soon
confirmed the occurrence of Bane particles in antigen positive s< rum.
Almeida (19/1) escribed Dane particles as possessxng a double-aheiled
structure, the outer sherl having a diar;«ter of 45nm , and the inner
shell, released by the action of a non-ionic detergent, having a
diameter of 28m;. Similar particles were found in post-mortem liver
7.
homogenates from serum hepatitis patients (almeida, r.aterson, Trowell
and heale, 19/0), while inning (1^71) observed them in the nucleus
and occasionally in the cytoplasm of liver cells from renal transplant
patients who had developed antigen positive hepatitis.
Hirachraan, Schwartz. Vernuee, Schaffner and danz (1b72) studied
the structural polymorphism of HB Ag unaer aifferent experimental
conditions and concluded that the small round particles may be discs
of tightly wound helical protein that can stack to form tubes of
varying lengths. The interrelationship of the different morphologic
forms were investigated under varying conditions of pH, ionic strength
and expoaux^e to uigestive enzymes and organic denaturing agents.
In water and dilute buffer, tubular structures and small round
particles predominated. Lax-ge AO-BOron raulti-stranced structuxes with
up to four lamellae-like strands appeared in 0.12£M phosphate buffer
and when the antigen was digested with 0.1 percent ohymotrypsin at
acid pK, the tubular structures disappeared, leaving small round
particles. These findings indicate that the appearance of KB Ag in
serum may be due to equilibria cepenaent on ionic strength and the
concentration of certain polyvalent ions and peptides, including
ooraplement. The size distribution of HB Ag particles was founu to
alter in the presence of complement and specific antibody but ma not
affected by complement alone or by inactivated complement and antibody
(Hirschaan, Kochwa, kosenfiexd and Hchwarz, 1974).
Hollow particles measuring I5**20nm diameter have "been described
in one case of acute hepatitis by Ackertuan, therchel, Valet and Matte
(1^74), who believed them to be incomplete forms and possible
precursors of normal HB Ag. Muscate Llo, Bianchi and I'isi (1973)
have studied tte e.f< ot of specific antibody on antigen morphology and
8.
concluded that the cetaileu definition of the particles beeves
less, or is even obscured,in the presence of surface antibody at low
concentrations* iiigh antibody concentrations result in clumping
of the antigen* Suoh morphological changes may prove useful in
determining the presence of antibody, as non-specific clumping may
occur due to the negative staining procedure.
ilB Ag is remarkably stable* It is unchanged morphologically3
and immunologically, neither does it lose infectlvity, after heating
at 6o°C for one hour, at room temperature for six months, or at
minus 20°C for twenty years (liirachaan, bhulman, Barker and Smith,
1969, Barker, Smith, liehele and Shulman, 19&9}« Boiling for three
minutes does not completely remove antigenicity, since one of
thirteen ohildren inoculated with this preparation produced specific
antibodies (Krugaan and Giles, 1970)* him and Bissell (1971) found
HBgAg to be unaltered serologically after heat treatment, freeze-
thawing, putrofication, acid-alkali digestion end treatment with most
hydrolytic enzymes. They did fi.nd that subtilisin, subtilopeptidase A
and sodium dodecyl sulphate treatment was followed by reduced imouno-
reactivity. Hassur, toi-bett and Bluaberg (1973} found that anti¬
genicity vtas destroyed by a soluble, heat labile exoenzyme produced
during the growth of taeudamonas aeruginosa and fcschorlfcha c~li. This
phenomenon may have important epidemiological implications since it
is conceivable that HB Ag is released into the intestine with the
bile and immunologically altered by enayraea already there, 3uch that
faeces emerge carrying antigen which is no longer identifiable as
HB Ag* Both r* aeru/anosa^and d* coli are known bacterial inhabitants
& 111 " "u """
of the human gut and the enzymes they release may be equivalent to the
'faecal inhibitory factor' described by i iazza, Di Staaio and
Be Marco (1971) and iazze, Bi Stasio, Maio and Marzano (1973)«
* ?• aeruginosa is often present in soil and thus frequently infects
the human gut.
9.
Early biochemical investigations (Alter and Blumberg, 1966;
Barker et al*. 1969; Serin, Purcell, Koggan, Holland and Channock,
1969J suggested that the antigen was composed mainly of protein, but
possessed a minor lipid moiety. Boiyant density was found to be
< 31.06-1 «30gau/oa in potassium bromide, I*i6gm./cm. in sucrose,
1.19gm./cau^ in potassium tartrate, with a sedimentation coefficient
of 110S in sucrose. Millman, loeb, Bayer and Blumberg (1970) were
unable to detect nucleic acid by spectrophotometry, chemical and
radiochemical analysis* The following year, Joswiaok, Koacielak,
Madalinski, Brsosko and Nowaalowski (1971) reported the presence of
UNA in purified, concentrated iO^Ag. Hirschatan et al. (1971)
reported weak endogenous DNA-aynthesising activity which appeared to
be dependent on an BRA template, raising the possibility of an RNA-
dependent-MA-polymernae being present in concentrated tiB^Ag,
similar to the 'averse transcriptase' associated with some MA
oncogenic viruses (Bpiegelraan and Sohlom, 1972; Gallo, Yang, Smith,
iierrera, Ting and Fugioka, 1971)• The reaction was, however,
stimulated by the a dition of poly (di»T) and not by poly (rA)-
oligo (dT), as are the known fiNA-dependent DtiA polymerases
(Zuckerman and Howard, 197k)i furthermore, this interpretation has
not been confirmed by other workers in the hepatitis field.
In 1973, Kaplan, Greenman, frerin, Purcell and Robinson confirmed
the presence of a Dfl/t-palyiaerase in bane particle-rich preparations
of HB Ag. They showed that the reaction oould be inhibited by
actinoiiyoin-D, suggesting that it was associated with a DI*A template.
Peak activity appeared to be related to bane particle cores, no
DKA-polymeraso activity being found in association with the 20ma.
spherical particles. The following y ar, hobinson, Clayton and
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U-reenman (1y74j confirmed and extended these findings by extracting
radioactive DNA from labelled Dane particle cores* lectron
microscopic examination revealed circular ■double-strani.cd DNA
molecules approximately 0.7dnra in length. Identical circular
molecules were obtained when DNA was isolated by a similar
procedure from particles that had not undergone a LNA polymerase
reaction. The authors suggested that the circular molecules
probably serve as a template for the DNA-polymerase reaction carried
out by the Dane ..a tide cores. Huang, Mao, Ling i nd Overby (1975)
have reported the presence of 1 ree DNA in MB Ag positive plasma
which showed homology with radiolabeled Dane particle DNA by-
molecular hybridisation. Further work is required to establish
conclusively the nature of the DNA poly ;,er. se template and to identify
the enayi e a3 viral and not host specific.
Millman, Kutanen, Marino, Layer and Blumberg (1971) observed
that purified HB^Ag reacted with speoific antibody but not with
antibody to normal human serum components. Treatment of the
purified antigen wit the non-ionic oetergent TwSEN oG revealed
substances which reacted with antibody to human Ig&, beta iey'Ic
globulin, beta lipoprotein, transferrin and albumin. in the electron
microscope, the treated antigen particles appeared less cense and
unfolded, yet reta ned dimensions similar to those before extraction.
One interpretation of these findings is that the components
released by detergent extraction are either intricate parts of the
mscromolecule, or contaminants. Sutnick, Milloan, London and
Blumberg (1972) she ed that the ex meted substances differed
eleotrophoretically and i^iunologically from human serum proteins.
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A recent study by Hurre 1 (1975) has shown that purified I-
11.
labelled 20-25nrfs. particles produced low ai finity iuauno-
precipitetion reactions with antisera to several normal human
serum components, which ore immunologically distinct irom the
reaction due to the classical liii Ag determinants. Ho evidence
a
was found for the native material in norma1 serum or liver cells,
as an inte gral part of the structure of the 2Q-25nai particles#
Ultracentrlfugetion has ndioated particles of two molecular
(j 6
weights, 3*6 x 10 and 4.5 x 10 (Dr< esman, Bollinger, huriano,
Fujioka, runschwig and Melnick, 19?2)» Antigenic activity was
detected in particles having isoelectric points at pii 4 and pit 4.4#
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Purified 1-labelled antigen was found to contain six different
polypeptides of molecular weights 1U,0U0 to y9»0C0. ^he 2G-25n»«
particles contained increased levels of cysteine amino acid residues
(4.6 percent) compared with other animal viruses (0.5 percent to
2 percent), a figure which suggests that sulphydryl groups and/or
aisulphide bonds any play a major role in maintaining the trrtiary
structure of the antigenic determinants# Sukeno, Ohlrachi,
Yaaaguohi and Ishida (1972) also emphasised the role of oiaulphice
bonds in the structural integrity of HB Ag by showing that
reduction with dithiothreitoi caused irreversible loss of structux-e.
In 1975, Dreescaan, Hollinger, . cCombs and Melnick showed that
reduction and alfylation ue3troyed antigenicity, while reduction alone
caused loss of morphological integrity.
Vyas, v.illiams, Klaus and Bond (1972) obtained an optical
density of 5*726 at PbOnm us.ng an 0.1 percent solution of protein
l'rora purified 20na. particles. This protein appeared to consist
of two polypeptides which contained high propox-tions of proline,
leucine and serine, but only a small amount of tyrosine. Using
optical rotazy dispersion and circular dichroism, Sukeno,
Shirachi, Shiraishi sna Ishida (1972) showed that HB Ag containeds
a high concentration of alpha-helices (70 to 80 percent), thus
indicating a structural similarity to human lipoproteins. Burrell,
Praudfoot, Keen and liarmion (1973) have obtained evidence from
periodate treatment and chemical analysis of purified 20nai. particles
that significant amounts of carbohydrate are present and that intact
carbohydrate is necessary for serological activity. This finding
wa3 supported by the work of Howard and Zuckerman (1973) who found
that pure HBgAg, isolated by gel filtration and electrofocusing,
was aggregated by concanavalin A. The major phospholipids of
HB Ag have been characterised as phosphatidylcholine, sphingomyelin
and lypophosphatydylcholine. In addition, two carbohydrate-containing
lipids were observed, one of which appeared to be a non-sialic
acid-containing, water soluble glycosphingolipid (Steiner, Heulner
and Dreesman, 1974).
II. Antigenic Heterogeneity
Levene and Blumberg (1969) were among the first to discover
the existence of antigenic heterogeneity in KB Ag. They immuniseds
a rabbit with HB Ag-positive serum from a leukaeraic patient, whose
serum had given an unusual and inconsistent reaction with specific
antisera. The resultant rabbit antiserum, after absorption, had
at least one specificity in common with other HB Ab-containing sera
(anti-Au(l)) and one specificity not shared with these. This was
demonstrated by the production of a spur in Ouchterlony double
diffusion. The rabbit antiserum was designated anti-Au(2). Since
anti-Au(l) possessed at least two specificities which they called 'a'
and 'c', those of anti-Au(2) they called 'a' and *b'. In 1970,
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kaunio, London, Jutniek, iiillman and blumoerg reported the findings
of a study in which liB^Ag had been collected from different parts
of the world and compared in respect to speo-ficity against a number
of antisera. All the antigens appeared to have one specificity in
couaon, but by selection of appropriate reagents, differences could
be demonstrated. Kim and Tillea S>1971) obsei'ved three sub-
specificities in combinations 'a*, 'ab* and 'abc'. The latter
sho.ed electrophoretic mobility equivalent to that of oeta-globulin,
while 'a' and *ab* were intermediate between alpha- and oeta-k
globulin. The 'b* and *c* of Kim and Tiles (1 971) were not the
same as the 'b* and 'c' of Levene and blumberg U9b9;. Analysis
of the surface antiacne of HbaAg by Le nouvier (19/1) revealed one
common specificity 'a' and three additional determinants *d',
and 'y', which were not shared by all positive sera. It was possible
to diviue sera into three groups depending upon the possession of
'd' and *y', i.e. group A (ea+dyj| group D i=ud+y-)i group X
(ssay+d-). It is of interest to note that 'at* ano 'd' are equivalent
to 'b' ana 'c' of iLua and lilies (1971)» but are distinct from the
•b' and 'c' of Levene and bluiaberg (1969). It has been suggested
(Le Bouvier, 1972 J Le bouvier, .'.'cCollum, liierholaer, irwin,
Krugiaan and biles, 1972) that 'a*, 'd' and ,y* reflect the genotype
of the antigen, and teat 'x' may be a component of the host which
has become inte rated into the antigen or firmly bound to its surface.
Occasionally, the *d* ana 'y* specificities have beei. found on the
same particle (Nordmnfelt and Le Barrier, 1973/74)# the most likely
explanation for this being that a dual infection has occurred,
resulting in i-he combination of viral genomes with the formation of
a new genome representing both specificities. decent studies by
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Soulier and Gourouce- auty (1973) sur est a subdivision of group Y
1 2 3
into three categories (a y,ay,a y) and of group D into two categories
A C
(a d,a d) with a further group containing a genuine association of
D and Y (ady).
In 1972, Bancroft, Mundon and Aussell described three immuno-
diffuaion patterns of antigenic reactivity. Une showed identity
with Y and one with B, while one showed partial identity with both,
absorption with heterologous material showed that the third type of
reaction pattern was distinguishing two additional antigenic
determinants subsequently designated 'w' ana 'r'. 1'his study also
suggested that *e* was more common in the U.S.A., while *r* predominated
in sera from Thailand. ik-r-ohaiy-, Edwards, Moseley and Bancroft
(1973) confirmed ana extended these findings to show that 1 w*
occurred almost exclusively in the U.S.A., Europe, North Africa and
the Middle Bast. an investigation of antigen subtypes among
asymptomatic carriers in Ganaoa (lienman, Berris, Sinclair, robel,
Alter and Holland, 1973} showed that 1 and Y appeared to be related
to country of origin, implying infection at an early age. These
findings were confirmed by Kaxzur and Blumberg (1973)# *ho studied the
determinants *d', *y* and 'w* in 31 chronic carriers and concluded
that they represented good long term epidemiological markers.
A global pattern of subtype distribution appears to be emerging
with zones where -here is an excess of ore subtype and regions where
a mixture of subtypes is common. Maozur, Burgert and Blumberg (1974)
have suggested that a partial explanation of this distribution may
be that HB^Ag-positive mothers infect their children who then become
carriers of the same subtype. Laughters transmit the antigen to
their children and so on through many generations. This mechanism
could maintain the subtype brought into a new environment by an
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immigrant population. The introduced subtype would not
necessarily predominate sinoe there are other mechanisms which
produce carriers.
As previously described, treatment of the Dane particles with
Tween 80 released an inner 2lrm. diameter core (Almeida et al.,
197*1)• Specific antibody to this core (HB Ab) may be found in
patients convalescing from antigen positive viral hepatitis, some
possessing HB Ab in the absence of HB Ag. Such findings, which havec s
been confirmed by a number of other workers (Traavik et al.. 1971J
Brzo3ko et al.. 1973J Hoof'nagle et al.. 1973)* imply the presence
of a further antigenic specificity normally hidden by the stable
outer protein coat. Hoofnagle et al. (1973) found HBcAb in all
chronic HB Ag carriers studied and suggested that it may be a sensitive
s
marker of viral replication even when HB Ag is not detectable.s
Magnius and Espmark (1972) reported the existence of a
specificity *e', distinct from 'a1, 'd1, *y', *w', *r* and *x*, and
possibly related to contagiousness. This antigen was one of a group
of precipitating antigens found in HB Ag-positive sera. The 'e's
antigen was frequently present in sera from patients on haemodialysis,
and anti-'e* was found in serum specimens from healthy carriers. The
presence of 'e1 has been confirmed by Nielsen, Dietrichson and Juhl
(1974), who suggest that it may be a marker of continued viral
replication and abnormalliver function, and therefore of prognostic
value.
Neurath, Prince, Lippin and Chen (1973) used immunoab3orbants
coated with antibody to Apolipoprotein C to show that HB Ag particles
possess this protein moiety on their surface, and are therefore
immunologically related to LP«*&, an abnormal plasma lipoprotein
detected in the serum of patients with obstructive jaundice. In a
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letter to the Editor of Lancet, Goudeau, Houwen and Dankert (1974)
have suggested that these results may be due to non-specific adsorption
of HB Ag onto the antibody-coated gel.
s
There is increasing evidence (Holland, Pureell, Smith and
Alter, 1972, Iwarson, Magnius, Lindholm and Lundin, 1973), that in
the U.S.A. and Europe group Y is more likely to be associated with
clinical hepatitis, while group D is more frequently found in chronic
asymptomatic carriers of KBgAg. In a study of 63 asymptomatic
carriers of antigen in Toronto, Fienman et al. (1973) found elevated
serum glutamic pyruvic transaminase (SGPT) equally common in 'adr',
'adw* and 'ayw* specificities. Gold, Alter, Holland, Gerin and
Purcell (1974) used a modified haemagglutination test to subtype
HBgAb in terms of anti-d and anti-y activity. Blood donors from
the U.S.A. and Egypt showed frequencies of antibody that closely
parallel the frequency of antigen groups in each population. An
interesting x-esult of this study was that antibodies against both
*d' and *y' were not detected together in any patient, including
those who had been repeatedly transfused.
III. Mature of HB Ak
There seems little doubt that HB Ag is a viral product, while the
'full* Bane particle represents the infectious viiim. In the
electron microscope HB-Ag exhibits a morphology which is so character¬
istic a.3 to be of diagnostic value, and possesses the size,
pleomorphic symmetry and negative staining characteristics found among
other viruses. Furthermore, its close association with type B
hepatitis endows it with the epidemiological peculiarities of an
infectious agent. The work of Kaplan et al. (1973) and Robinson et al.
(1974) provides strong evidence for the association of a DNA-genome
with HBcAg. Early attempts to 'grov/* the virus in tissue and organ
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culture proved singularly •unsuccessful, possibly due to the use of the
surface antigen as marker. Subsequent studies suggest that it may
be possible to infect cultures with Dane particle-rich material and to
show an increase in the amount of core antigen (Panouse-Perrin, Rachman,
Courouce-Pauty and Dupuy, 1975). Despite the mounting evidence in favour
of the viral nature of the antigen, two features still distinguish it from
the majority of other viruses.
1, The amount of DNA associated with KB Ag ( 1.6 x 10^c
daltons) is unlikely to be sufficient to code for the DNA genome} the
core and e antigens; in addition to the complex lipoprotein coat that
surrounds and presumably protects the core proteins and associated enzymes.
2. The high alpha-helical content of HBgAg suggests analogy to





The incidence of HB.Ag in the blood of donors from several
countries is listed in table lM<Ll„of those studied, the highest
Incidence is found in countries near the equator, with the
exception of Greenland, The common feature of both polar and
tropical populations studied ia a poor socio-economic environment
with associated overcrowding and poor hygiene, suggesting that
this factor is of priatar^ 3.iaportance concerning the spxeaci of
HBflAg.
In 1969, Lewkooia and Finn reported an increased susceptibility
to serum hepatitis among group A blood donors, although subsequent
reports have shown there to be no significant relationship between
the antigen carrier state and the A, 1, 0 or Rhesus blood groups
(Hersch, (loyal, Grubb, Kerch and helnick, 1971 * bsuineaa, irince
and Cherubin, 1971# Hadayaiicia, IfcpaevangjeLou and Vi&solis, 1973#
Vale, Thomas, Hmwkes and Kelly, 1974), however, it is now
apparent that certain groups of bloou donox-s are associated with s
higher risk of HB.Ag transmission than others. These groups
include commercial blood donors (Kunin, 1999# Gr.'Gy and Cli&lmera,
I9b4» Cohen and Dougherty, 19b8| -..ulsh, iUrcell, borrow, ohanock
and Schmidt, 19/0j Cherubin and iririce, 1971)» institutionalised
blood donors such as prisoners or military personnel (Kliman, Leid,
Lilly and orrison, 1971 * Kelson and Cooke, 1971} and blood donors
from lower socio-economic communities where overcrowding, poor
hygiene, and occasionally drug addictiou may be found. homosexuals
table1(1)2.2.











Germany Holland Scotland Switzerland Austria
Volunteer Volunteer Volunteer Volunteer Volunteer
22,b00 10,900 73,boo 7,000 39,700
0.32 0.09 0.12 0.36 0.46
Fiedler,1971 Brujaaelhuis,1970 wailaceetal..1972 Frey-.ettstein,1972 <ewalksetal..1970
Spain Italy Yugoslavia Greece Turkey Israel
Paid
1 Volunteer Mixed 1 Mixed
000 1,800 14,400 5,100 1,600 10,000
1.0 1.5 3.3 3.0 0.9











Australia Japan Singapore PapuaNewGuine
Volunteer Paid ? ?
34,600 5,200 2,600 3,500
0.11 1.0 3.1 7.5












may also constitute a high risk group (Jeffries, James, Jefferias,
LiacCleod and tfilcox, 1S73)» Young adult males show the highest
incidence of antigen carriage (Bluraberg, Sutniok, London and
"Jelartin, 1972; butnick, iiondon, 0erstley, Cronlund and Bluaberg,
1968; London, Sufcniok and Bluaberg, \ 96s; 2Jason, Shaw, ilarding
and Jitney, 1972)• It could be argued that their greater social
mobility makes this group more likely to become infected and to
infect others, although it is difficult to see how this principle
could operate in all populations studied.
dost of the ouz'lj data relating to the incidence of HB Ag
obtained using the relatively insensitive techniques of counter-
electrophoresis (C#I»E»0»P«) and immunodiffusion (l.C.) It has
been estimated ^Chalmers and alter, 1971; Kliuxui et al.. 1971)
that those methods will detect only 20-40 percent of HB Ag carriers,
and evidence is beginning to accumulate which suggests that
haemagglutination and radioiiaiBunoassey are capable of detecting
circulating antigen at a concentration below the sensitivity of the
above techniques (Levy and Hawrisiak, 1972; beogini jar.,
Hoilinger, .>educ, Issarescu, beorge, blaokman, Thayer Jnr., 1972#
Shaffer, Vyas, .Jiahed, then and horkina, 1972; Ling, iruce,
Becker and Qveroy, 1973)*
Carrara, dryant and -eonard (1973) have reported lili^vb and
hB8Ag simultaneously in 26 of 10,470 blood donations, suggesting
that the presence of antibody may also identify potential antigen
carriers. JlilliaGti, -ondon, Sutnick and Ulurnberg (1970) 3ho»ed that
when some i£B Ab positive sera were pelleted, iiB Ag could be detected
in the pellet.
The incidence of in most volunteer blood donor
populations studied by I.B. or U.I.E.O.P. is similar to that for
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RB Ag; e.g., 0.28 percent in Copenhagen (Banke, Dybkjaer, Nordenfelt
s
and Reinicke, 1971)» 0.06 percent in the West of Scotland (Wallace,
Milne and Barr, 1972), the principal exception being an incidence of
(*./ percent among volunteer blood donors in New York (Szmuness, Prince,
Etling and Pick, 1973)* The use of haem&gglutination and/or radio¬
immunoassay techniques lead to an increase in detectable antibody to
between 1 percent and 20 percent (Ni, Shoff and Lama, 1972; Alter,
Lander and Purcell, 1971)• direct evidence has been presented to
implicate HB Ab—positive blood with KB Ag-positive jaundice (Gockes s
and Panick, 1972; Reinicke, Poulson, Banke and Bybkjaer, 1973; Aach,
n
Alter, Hollinger, Holland, Lander, Melnick and Weiler, 1974). However,
in a recent letter to Lancet, Renton and Vvadsworth (1975) have pointed
out that blood containing HBgAb appears to be four times as infectious
as blood negative for antigen and antibody, although this interpretation
may not reflect the true situation since their data derived from
an invalid reconstruction of population statistics.
II. Faeces
In 1970, Ferris, Kaldor, &ust and Cross reported a particulate
antigen similar in appearance to HB Ag yet serologically distinctb
from it, in faecal extracts from cases of HB Ag-negative hepatitis.s
These findings were confirmed by Cross, »>augh, Ferris, Gust and
Kaldor (l97l)i who went on to show that the larger particles (40-45 nm )
of faecal antigen appeared to possess an antigenic component in common
with the Dane particles observed in serum. It was suggested that the
faecai antigen represented serum antigen degraded as a result of passage
through the intestinal tract. Grob and Jemelka (1971) reported
HB_,Ag in faeces from eleven cases of sporadic acute hepatitis,
whose serum were all HB„Ag positive. Using two-dimensional I.D.,
Grob and Jemelka (1972) were able to show
22.
that i© Ag in faoces was immunologically and electrophoretically
similar to that an 3erum. Despite these findings, many workers
have been unable to identify KB Ag in faeoes of 3er'Uia-antigen-
positive patients, hoodie, btaiuiard and Xippa (1974) suggested
that this was due to the action of nycirolytio enzymes fauna in the
human gut, capable of degrading the aurfaoe lipoprotein of Mb Ag
and ©xpos-hig the inner core of Dane particles which Almeida et al.
<12/1) have shown to possess their own peculiar antigenicity,
III, Drute
Dluiney, arie, Flewett and wiliiaaa <12/1) were first to
concentrated
report the presence of ilDAg in/urine, .-.edition of jpeoific
antiserum resulted in the fom^ticn of characteristic immune
complexes when viewed by electron microscopy (I.M.j. These f-ridings
ware confir-aad by ..poatoiov, iiauer, Jelway, box, builey and
Dberlock (1271J and ,rapitais and horst (19/1)» who ;e onstrateel
immunological identity between i©_Ag in urine and in serum,
Heathcoto, Taiaaides and bherlook (1973) detected a substance in the
urine of soma antigen positive patients, which reacted arts hb Ab
by Complement fixation however, morphologioaify
oharaoteristio :©#;ig could not be seen in the urine by electron
mioroscopy.
IV, .Juliva and - tiior Body .'lurda
ward, Borehert, bright and Aline (1272) detected. i£B Ag in
saliva in 50 percent of mentally handicapped, institutionalised
patients. Antigen positive saliva has ween reported by ianno. Fay
and Aoncoroni (1272) in cases of aoute and chronic hepatitis and
postnecrotic cirrhosis, while histler, oonnabend and Krech (1273)
were able to detect I'll Ag by l.b. and E.M. in mixed saliva concentrates3
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from a similar group of patients which included two HB Ag positives
kidney transplant recipients# Antigen has been observed in the
saliva and semen of carriers with high serum antigen titres
(Heathcote, Cameron and Dane, 1974). Ogra (1973) employed L.I.E.O.P.
and imraunofluoresence (l.F.) to study patients with icteric and
asymptomatic infeotions. She found antigen in the naso-pharangeal
washings of some subjects over a short period. Other workers have
reported I© Ag in synovial fluid (Mc&enna, OfBrien, Scheinman,s
Delaney, Pelleoehia and Lepore, 1971)» amniotic fluid (Matsuda,
i'aaa, Shirachi and Ishida, 1972), gall bladder bile (Serpeau,
Mannoni, Dhumlack and Bertheldt, 1971i Bose, Bahu, Hammond and
Lubbat, 1971)» and sweat (Telatar, Kayhan, Kes and Aaracadaq, 1974).
It should be remembered, however, that any biological fluid
contaminated with infected blood will appear antigen positive if the
test is sufficiently sensitive.
V. Plasma fractions
The cold alcohol procedure of Cohn, Strong, Hughes, jnr.,
Mulford, A3hworth, Melin and Taylor (1946) has been most commonly
used for industrial scale fractionation of plasma. Several
investigators have fractionated HB Ag-rich plasma and looked fors
antigen in the resulting fractions (Andrassey, Ritz and Sanwald,
1970J Schroeder and Mozen, 1970» buckerman, Taylor, Bird and
Russell, 1971). HB Ag has been detected in all fractions excepts
immune serum globulin, a finding in accordance with the well-
recognised non-infectivity of this fraction. Such findings may re¬
flect removal of the antigen by fractionation or more likely,
antibody present in the fraction may have masked HB Ag by complexing
with it. In a recent report, Lewis, Maxwell and Brandon (1974)
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found concent,raten of factor IX to be associated with serum
hepatitis in haemophiliacs three times more frequently than
concentrates of factor VIII,
25.
CflAFTLR 3
lili Ag LIVEE DISEASE
3
I. Asymptomatic carriers; blinical Hepatitis
As early as 1971» Singleton, Mex'riil, Fitch, Kohler and
kettberg suggested, that the majority of iib8Ag positive blood donors
might be suffering from sume form of underlying liver disease.
Hov.ever, aeinecke, Dybkjaer, Poulsen, Banke, bylloff and
Nordenfelt (1972) reported that none of i'4 antigen positive Banish
bLood donors sho.ed histological evidence of hepatitis. Subsequent
studies have sho\?n that some HB Ag positive donors exhibit3
histological antV'or biochemical evidence of liver dysfunction
(basal and liobinet- -evy, 1972; vooife, Boyes, Bymock, ronton and
Stratton, 1972; Iapadopoulos, Traianoa, Thomakos and iiniakos, 19735
Anderson, Sun, Berg,and ohang, 1974), and it has been suggested that
the beat approach to apparently healthy lib Ag curriers is to observe
clinically, with regular biochemical tests of hepatic function as
long as no evidence of chronic liver disease occurs, reserving biopsy
for those patients with persistent hepatic dysfunction (Griffin,
1973)* An increased incidence of Bane particles in the serum of
patients with abnormal liver function tests has been reported
(Neilsen, Aeilsen and ivlling, 1973* houlias, touceru and boust,
1973).
r'he specificity of KB Ag for serum hepatitis has been confirmed
by the iillowbrook experiments of biles et al. (1969). initial
reports indicate a frequency of HB Ag in acute hepatitis of 12 percent
in Australia (bust and Lucas, 1971* Ferris, Kaldor and Lucas, 1570;
Hawke3, 1970), 53 percent in the U.S.A. (Prince, 1971)# 60 percent in
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Uganda (baynard, bacikali, Anthony and barker, \'-j70) and Ghana
(Morrow, Lai and barker, and 1j? pei-cent in Lonoon (Farrow,
Lamb, Coghill, Linden, 1-reece, ouckerman and ^tewart, 197k)•
From the data currently available, it appears that lib kg amy be
cetectable shortly before the onset of acute iilneaa. As the
antigen disappears, antibody to the lane particle core becomes
detectable and persists for a relatively short time. antibody to
the surface antigen specificities may not appear for many months,
and then possibly only as a result of subsequent challenge (see
figure barker, Peterson, . hulaan and Murray (1b73) have
described primary and secondary antibody responses in adults receiving
material known to transmit type B hepatitis. borne of those showing
secondary responses subsequently developed disease. It was con¬
cluded that primary responses were common after exposure to HB Ags
and that protective immunity frequently but not invariably follows
initial exposure.
n« fiteaato ialisOiigMfi.
ditnick, Gleich, bohoenfield, baggenstoos, outniok, blumberg,
London and boamtrskill (lp6y) studied 31 patients with chronic active
liver disease and found Ht>s» g in 3» all of wh'.»m had cirrhosis. These
findings led to the speculation that in some patients, a chronic
viral infection existed, even in the presence of cirrhosis. Maynard
et al. (1^70; found Hb Ag in 31 percent of patients in Uganda, as53
compared with 2 percent in normal controls, and suggested that
infection with MB Ag amy be of pathogenic importance in the develop-s
ment of cirrhosis. In 1972, ftowaslowskL, Krawezyniski, Brzosko and
Madalinski suggested a correlation between hepatocellular damage In



















Figure Serologic responses in a moderately severe case
of type B hepatitis. Antibocty to hepatitis B core
antigen measured by complement fixation (C,F.),
antibody to hepatitis B surface antigen measured by-
passive haemagglutination (PHA), hepatitis B antigen






Mikulaka, Biedrzycka, Roszkowska, Rudkowski, kabenda, Usiemska-
Losinska and I-ebaki (1973) iuentified liB Ag in 69 percent of
children with chronic hepatitis, and antibody to core antigen
(HBQAg) in ail of 50 cases studied. More recently, Van «aes,
Begers, Van .igrnond, Van liisnen, barbler, i&ieae and -emeuienaere
(1974) have reported on a long-terse follow-up of 45 patients with
chronic hepatitis and 41 patient3 with cirrhosis. Antigen was
present in 42 percent and 49 percent respectively. The clinical,
biochemical and histological findings were similar in antigen
positive and anti en negative patients. They concluded that when
no irreversible lesions existed, the disappearance of antigen was
taken as an indication that the disease would resolve.
III. Hepatoma
Reports from many laboratories indicate a higher incidence of
HBflAg in patients with hepatoma than among the general population
(Sherlook, Fox, Niazi and Hcheuer, 1970; Kadxiyunnis, Merikas
and Afroudakis, 1970; Vog^l, Anthony, N&tu, Mody and darker, 1970;
lennison, Peters and Reynolds, 1971; Specht and Noto, 1972),
suggesting that hepatoma could be the last stage in a process
initiated by acute hepatitis, leading to chronic hepatitis and post¬
necrotic oirrhosis. Simons (1972j presented evidence to suggest
that the use of sensitive techniques will result in a more
significant correlation between iilsAg and hepatoma. Using radio¬
immunoassay (RIA), Reed, Eudleston, Steen, Williams, Zuckerraan,
Bowes and Earl (1973) found 23 percent of 38 patients to be Hb#Ag
positive, the frequency being higher in those born outside
Great Britain (t>6 percent compared with 15 percent). In the
absence of conclusive proof of the onoogenio properties of HH Ag,
it JQ&y be that hepatitis B virus is merely a passenger.
Nowaslowski (fj?4) reported that the only cells supporting viral
replication within the region of a liver cancer were normal
hepatocytes, although this does not exclude the possibility of
transformation bp the HE Ag genome.
IV. Other Clin Icol -oaditiona
A number of nyiaptoms have been described which do not involve
the liver and are .oat probably due to circulating immune complexes,
dohenna etal. (1971 / have identified :U> .»g in synovial fluid,' '
O
while joint sympto.aa have occasionally been reported in acute and
chronic hepatitis \ .iperfc, Iaaeluacher and Bchur, 1971# Buckley,
Heiser, boldfinger and oaelbacher, 1970), and antigen has been
found in patients exhibiting polyarteritis nodosa (Baker, bit.el and
iCalan, 1971 )• Similar findings led MoCarty end ormiate (1973) to
suggest that an arthritic strain of KB ag may exist. The antigen
has also been associated with glomerulonephritis and nephrotic
syndrome (Coombes, bhory, Borrera, btastney, Bigenbrodt, Hull and
Carter, 1971) and various skin rashes (Alpert ct al.. 1971 )• frepo,
Zuckerraan, Bird and ■ rince (1974) have suggested that circulating
immune complexe::- may be responsible for vasculitis or polyarteritis,
but do not a pear to be pathogenic for the liver. Voa, brcbbelaer
and '.liner (1973)have presented evidence that the HB Ag carrier
state may predispose rone patients to cevelop renal disease, their
evidence being based on the observation that many carriers showed
aepressed C^-cos.»le..ent levels and that a relatively high percentage
of patients with renal disease carried HB Ag.
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V. HB Ag Subtypes and Liver Disease
O
One of the earliest reports implicating a particular antigenio
subtype with disease was a publication by .'.enzel, Le Bouvier and
Beam (1972) relating drug abuse and hepatitis in American marines.
All positive 3ez*a possessed antigenic specificity "ay". Subsequent
reports have shown a predominance of this subtype among drug
abusers (l»e Bouvier et al., 1972; Iwarson et al«, 1973) s^d in
association with serum hepatitis outbreaks in a number of renal
dialysis units, including the exceptionally severe outbreak in
Edinburgh (i«ariuion and Tonkin, 1972; Moseley, Edward, Meihaus,
Gordon and kedeoker, 1972). Gordon, Berberian and Stevenson (1972)
were unable to find a correlation between the forms of hepatic injury
and the antigenic subtype isolated from both acute and chronic
hepatitis patients, while Feinrnan et al. (.1973) found abnormalities
of liver function and histology to be equally common in asymptomatio
HB Ag carriers of both 'ad* and 'ay' subtypes in Canada. A numbers
of other studies, however, show that the 'y' specificity is
frequently associated with clinical illness, while 'd* speoificity
is often, associated with chronic asymptomatic oarriage (Schmidt,
Roberto and Lennette, 1972; Holland et al., 1972; Perry and
Chaudhaxy, 1973» Iwarson et al.. 1973; Cama, Krishnamurthy
and Gurdeep, 1974). In a study relating the degree of liver damage
in acute viral hepatitis to the HBflAg subtype, Nielsen and Le Bouvier
(1973) found the *y* speeificity in 79 percent of cases. However,
the acute disease was more severe in patients possessing the *d'
specificity as judged by histological and biochemical criteria.
A global pattern of subtype distribution seems to be emerging (see
chapter 1, II). In America and most Western European countries
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where the *d* specificity predominates among asymptomatic oarriers,
the *y* apeoificity is most frequently identified in clinically
apparent hepatitis. It remains to be seen whether the reverse is
true in those parts of the world where *y* is the common specificity
among asymptomatic (blood donor) carriers.
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CHAPTEE 4
HAH3MISSI0N UF HB_ Ag
lor many years, it was assumed that aerum hepatitis was only
transmitted by- parenteral routes (iropert, 193^; Beeson, 1343i
Turner, Gnaveiv, Grassxaon, Buehannan ana roster, 1 yn4; Meefe,
Stokes, aenhold and Luckene, 19h4» Grossman, Stuart and Stokes,
1545» MaoFarlane and Uhesney, 1944)# The discovery of HB Ag led
to renewed interest in the epidemiology of the disease.
I. Parenteral .ransalssion
In 19^7, kingertss and Getterberg reported a number of cases
among Swedish track-findera. It was suggested that spread of HB#Ag
was via bushes contaminated with blood and the communal wash basins
shared by competitors, since only eight secondary cases developed
from over six hundred index cases, suggesting that transmission was
by parenteral means rather than the faecal-oral transmission
associated with hepatitis a ^infectious hepatitis). The increasing
drug abuse among young adults, coupled with a tendency to 3hare
syringes, has led to a corresponding increase in the number of cases
of infection among such communities (Cherubin, Hargrove and Prince,
1969* aienicke and Nordenfelt, 1970; kelson et al», 1971; dzmuness
Bennett,
and Prince, 1971; Grady,/Gulhune, iorreat, Iber and the Boston
Inter-Hospital Liver Group, 1972), which provide a growing reservoir
of potential infection x.o the community at large. Tattooing has
been implicated as a parenteral route for transmission of HB Ags
(Robertson, 1951; terner, Agell, Gerzen and Berg, 1971; Goatling,
1971; Scutt, 19/2) as have dentists and barbers (, evsalka, onan,
Ki'aasnitaki ana I a3sendorfer, 1>70; Holm, 19/G; Levin, Handrey*
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mantis and Mendeloff, 1974; end menstrual bl^oc (Ma aur, 197$)•
Typing and control sera U3e& as standard laboratory reagents have
been shown to contain HB.Ag (Ginsberg and conrae, 1972; ..elti,s
Ileal and iale, 1973)*
Attention has oeon x'ooussed on the possible role of insect
vectors in the transmission of His Ag. The high prevalence in the
tropiC3 (Bluraberg, Uer3tley, nutniok, llillaan and London, 19/0) may
depend upon blood-sucking arthropods to ensure a high frequency
of exposure during the early years of life when the risk of
developing chronic i - Ag carriage is greatest (demoness. Pick and
Prince, 197G)» Prince, hetaelaar, kafuko, Bukwaya, ding and
Overby (1372) found HB Ag in 28 out of 187 pools of wild-caught
mosquitoes from denya and Uganda. In controlled experiments with
mosquitoes fed from a carrier, they were able to show that HB Ag
disappeared in parallel with blood meal digestion, being present
for at least 90 hours. They ooulu find no evidence of replication
inside the mosquito. These findings were subsequently confirmed
by Byrom, Davidson, Draper and Buokeraan (1373)« A recent report
from Greece provides further evidence that mosquitoes may act as
vectors for IiB Ag (i'apaevangelou and iiourea-Xrematinou, 1974).3
There is only one, as yet uneonfirmed, report that some species of
mosquito .nay serve as biological vectors for HB ng (Smith, ogunba
and Francis, 1372).
hebe, Bun;,aid and. lilts (1372) have reported that transmission of
HB Ag in a dialysis unit outbreak (Barker, Bhulman, Murray,
s
Hirschiaan, xustner, niefenboch and Geller, 1970) may.have occurred
via cockroaches. This possibility was tested experimentally by
infecting cockroaches with IIB Ag-poait^ve serum. Antigen remained
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detectable for long periods (1O-15 days) in both vocdtus and
haemolymph, suggesting a carrier state rather than just mechanical
contamination. It seeaa likely that other orders of blood¬
sucking 'anthro;.o(ticks, lice, sand-flies, tse-tse flies etc.)
may play a similar role, their relative importance depending upon
the frequency with which they bite man. This may explain the higher
incidence of IB ng in the lower socio-economic groups where over-
crowding is more likely to occur (Morrow at al., 1971).
II.. hon(inaimarent) arenterai transmission
It seems unlikely that a viral species should require modem
artificial mechanisms of transmission such as blood transfusion
and injections for its survival and propagation in natux-e. The
possibility of non-parenteral transmission of liB hg is at present
being studied in many laboratories. Krugraan et al. (1967) were the
first to demonstrate direct oral transmission of hB.Ag using the
itillowbx'ook IB2 agent, while other reports indicate that laboratory
technicians have become infected by swallowing blood or serum while
pipetting speciiaena from hh^Ag positive dialysis patients (weatwood,fit
Chnudhary and Peracy, 1973; • infection with serum by mcuth is,
however, not equivalent to faecal-oral transmission, and early work
with volunteers failed to show infection by the oral route with
extracts from the faeces of serum hepatitis patients (Ntefe, 1>46).
This finding may be explained in part by the presence of a "faecal
inhibitory factor' present in the human intestine (Fiasza et al.,
1971), capable of neutralising the antigenicity of Hli «g. This
faotor is neither an antibody nor intex-feron, and appears to be
species specific. In 19/0, Prince, Hargrove, bamuness, Cherubin,
lontana and Jeffries px*ecented epidemiologic evioence suggesting
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that the major proportion of UBflAg positive cases of acute hepatitis
among urban adults were transmitted non-parenteraily. Essentially
similar conclusions were drawn by Szmune3s and Prince (1971) on the
basis of epidemiological analysis of viral hepatitis in Eastern
Europe. Subsequently, a number of family studies have suggested
that non-paranteral transmission may be a major factor in the home
environment (Vaa, Spenc-e and G-ilmore, 1973; Garibaldi, Hatch,
Bisno, Hatch and Gregg, 1972; Bietzm&n, Madden, Seuer and Bunlop,
1973» Licci, le Boo and Caramia, 1973; Bruguera, Bosch and
Lodes,1973; Bruguera, Bosch, Lodes and Pedrcra, 197E-), although
parenteral transmission can never entirely be ruled out.
Harmion and Tonkin (1972) and Chalmers (i 973) have reviev.ed
possible routes of transmission specific for dialysis units. Borne
of these, e.g. blood transfusion, blood contaminated equipment,
"needle sticks"and other types of tissue penetration seem quite
obvious. Others such as contamination of conjunctiva or other
mucosa, spillage of blood over intact skin, aerosol formation and
exposure to contaminated linen have not yet been sufficiently
documented. However, the findings of a point prevalence study in
13 American haemodialyais centres indicate that although HB Ag can
be introduced into the dialysis centre by blood transfusion, the
role of transfusion in its perpetuation may have boen exaggerated
(Saiauiie33, Prince, Grady, Mann, Levine, Fraidiaan, Jacobs,
Josephson, Eigot, Shapiro, Stenael, Buki and Vyas, 1974). The
uniformity of antigenic subtypes detectable during outbreak.® of
dialysis-associated hepatitis would also aeeia to argue against the
predominant rolo of blood transfusion (Hcasley et al., 1972). It
appears that other, resumably aon-parenteral, routes must exist,
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and that they probably outweigh transfusions in relative importance.
Data from this study also suggeste thai the parenteral route is not
always responsible for clinical and asymptomatic hepatitis among
dialysis centre staff, since after the firat six months, the
prevalence of hepatitis did not appear to increase with increasing
length of employ-rut. Nor did the cumulative presence of H8 Ag
3
and HB Ab differ among physicians, nurses, technicians and
auxiliary personnel, suggesting that all personnel are heavily
exposed to infection from the very start of employisent. Non-
parenteral much ■ nisr.a of virus trans v ssion among both patients
and staff are supported by the results of an environmental surface
surveilance study using a swib-rinse assay in conjunction with
radioianiunoaasoy (Fav ro, Maynard, Petersen, feoyer, Bond, Berquiat
and Szmuneas, 1973). HB Ag was recovered from such surfaces as
u
gloved hands, needle-clippers, furniture find external parts of
dialysis equipment with end without traces of blood contamination,
although it is disputable whether such material is Infectious in
practice.
Venereal transmission of HB Ay would seen to be a distinct
s
possibility (Vanrmn, 197T; Jeffries et al., 1973)* Ue^rsfa at al.
(1971) found evidence of HB^Ag transit!ssion from antigen positive maless
to their intimate female contacts. Heathcote and Sherlock!1973) studied
the spread of srrun hepatitis in '.ondon, and concluded that sexual contact
with an KB Ag carrier emerged as the single most impoi-tant factor. In a
3
later publication, ,TB Ag was identified in semen (Heathcote et al.»
1974), a finding subsequently confirmed by tdnnoman and Goldberg
(1974). Heathcote, atecu and Sherlock (1974) presented evidence
that exposure to IV> Ag was mare common aaong sexual partners than
among blood relatives. They also found that contaots of carriers
with evidence of liver dysfunction fire at greater risk of presumed
non-parenteral exposure than are contacts of asymptomatic HB Ag8
carriers. Henigst (.1973) found a significantly higher incidence
of HB Ag (3 percent) among a group with frequently changing sexual
0
partners, a3 compared witn the normal population (0.4 percent) in
Munich. fulford, Dane, Catter&ll, Woolf and Denning C1973) have
suggested that HB Ag may be primarily a sexually transmitted agent,
and that such uell recognised means of transmission as transfusion,
the shared needles of drug users and tatooing, could be incidental
and may not contribute significantly to the maintenance of the virus
in the community. These parenteral routes may, however, carry a
greater risk of clinical illness. Conversely, in a study of 449
family contacts from 197 households containing IB Ag carriers,
0
Szrauness, Prince, Hirsoh and Brotman (1973) concluded that sexual
transmission does not appear to be of primary importance.
Data emerging from a number of laboratories suggest that non-
parenteral transmission may account for the spread of HB Ag
partic »larly in closed institutions (Kllman et al., 1971# Nelson
et al., 1971> ozmuaess, Prince, Etling and Piok, 1973# Biyon, Carr
and Gregg, 1973# Medhurat, Madhaven and yiinn, 1973)• Villarejos,
Visonu, Gutierrez and Rodriguez (1974) have reported HB Ag in the
saliva of 76 percent of antigen positive acute hepatitis patients
during the first three weeks after clinical onset, and in 8b percent
of chronic carriers intermittently. The incidence of KB Ag positive
"anesae samples" from antigenae.uio patients were found to be
33 percent. Antibody was found in saliva early in the clinical
disease, a feature which may limit infectiousness vis. this route.
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Ill, Transmission in Pregnancy
in 1934, Stakes, Berk, Malmmut, Drake, Barondess, Baahe,
ftolaan, Farquhar, Bevan, Lrummonti, Mayeock, Lappa and Bennett
postulated that hepatitis oould be transmitted from mother to foetus
through the placenta. At that time, however, thia concept could
not be evaluated due to the lack of a suitable test for hepatitis
virus identification, Vsith the discovery of lib Ag, techniques
became available with which to study transmission from mother to
neonate,
Does transmission occur before, during or after birth-' Krech
and donnabend (1970) reported a 6 percent incidence of hepatitis in
circumstances which suggested transmission during the foetal period
or shortly after uellvery. Prior to this, London, Li Figlia and
uodgers (1949) were unable to find evidence of transplacental
transmission in the case of a j oung woman who became HbaAg positive
six months before giving birth to an iih Ag negative baby, .methick
and fto tiy70) were also unable to f nd evidence of transplacental
transmission from a study of 2,223 cord sera. Keys, hobel, hitman,
Uh, ditnick ana Hewitt (19/1) suggested that transmission may also
occur during passage through the birth canal or by oi&ternal contact
in the external environment. More recently, buchhols, Frosner and
Ziegler (1974) found MB Ag in the cord blood of an infant delivered
by Caesarian section, thereby establishing that foetal infection can
occur, probably after infeotion of the placenta. In 1972, Cossart,
Hargreavea and March followed the pregnancies of 5 HBsAg-positive
hepatitis patients and three asymptomatic carriers. All babies
were HB Ag negative, suggesting that transplacental transmission did
3
not occur, but two became positive at a later cate. I'he mothers
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of both these children refined HBsAg positive after delivery,
while the other mothers had either becaac IfB Ag negative or had
not subsequently looked after their child. it is possible that
infection occurred as a result of breast feeding, but these workers
were unable to deteot HB Ag in ilk, a finding confirmed by
London et al. (19&9)* however, Linneman and Goldberg (1974) have
recently detected Lb Ag in the milk of an antigen positive mother.
Schwietser, wing, Mcreak and bpeara {19/2) found that of 26 women
who developed lib Ag-po»itive viral hepatitis during late pregnancy,
or up to six months after delivery, 19 had Hb AG positive cord blood,8
and 10 of their babies became iiB Ag positive. ihe antigen appearedis
to cross the placenta in three cases, and neonatal contamination at
birth probably occurred in one. The following year, Bchwietser,
Moaeley, Ashcavi, dvmrds and Overby (1973) published results of a
transmission study involving infeoted symptomatic mothers and their
offspring. It was conoluded that the developmental period when
exposure occurred, rather than the clinical status of the mother or
the HBgAg subtype, was the most important factor in determining
whether the infant become chronically infected. The highest risk
occurred when the antigen was present during the lust three months
before, or the first two months after delivery. Children of
asymptomatic carriers are less likely to became chronically infected
than those of mothers with clinical hepatitis. -transfer of some
maternal factor such as antibody or anti-viral proteins, in the early
gestational period, say lead to resolution of what otherwise could
become a persistent infection. These f.ndinga have recently been
confirmed in Britain by Dr. Vvonne Cossart (1974). Paulson,
Kotini and loraaro (1973) have reported transmission of fiiWig and
HB Ab from mother to neonate during the later stages of gestation,
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resulting in precipitating immune complexes es evidenced by a drop
in the immunoglobulin level of the neonate. This passive antibody
failed to protect* A follow-up study of 31 infants whose mothers
had lib Ag positive acute hepatitis, while pregnant or in the first3
two months post partus* revealed that the most common response of
the neonate was chronic HB Ag carriage coupled with histological
features of unresolved hepatitis. Occasionally* acute hepatitis
developed, but this was followed by rapid healing with removal of the
antigen and the appearance of antibody. in a recent study*
however* Dupuy, Froraael and alogi .ie (1975) have shown that fatal
1IB Ag hepatitis can result from maternal contamination.3
Transfer of HB Ag from mother to offspring appears to be co mon-
place and proviaes a means of perpetuating and expanding the
reservoir of infection. Post-natal rather than transplacental
(which may occur rarely via a transplacental lesion) or parenteral
transmission* would seera to represent the laajor hasard.
XV. ouaceptibilit;,
A genetic susceptibility to infection has been proposed by
Blumberg* Friealander, woodside* Sutnick and London (l9o9) in which
susceptibility to HB Ag is inherited as an autosomal recessive trait
(see chapter 3). ietrakis (1972) has pointed oUfc that in the above
report there is a critical mating between KB Ag-positive parents
which does not support the simple autosomal recessive hypothesis*
since only two of seven offspring are HBgAg positive. It may be
that the other five were not exposed. However, Vyas (1974) has
provided the first discrete evidence against blumberg'3 genetic
hypothesis. in a family where both parents were lib^vg carriers,
two of the three children were HB Ag and HB Ab negative, while the
a O
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remaining child possessed HB#Ab, indicating past exposure. If
the recessive hypothesis had been correct, thi3 child would have
become a chronic HB.Ag carrier. Results of a recent study in
Greenland (Skint'cNair and anoerson, 1y74) suggest that variation
in genetic susceptibility appears to be of secondary importance since
the prevalence of HB Ag was found to vary 10-fold between different
towns despite the existence of very uniform genetic, cultural and
climatic conditions. The incidence of 7.1 percent among the
normal population is similar to figures obtained from tropical
countries and institutions for the mentally retaraed (Prince et ai.,
1970* Bluraberg et al.. 1970). The common feature of both polar




when an individual la exposed to JiB^ag, a variety of responses
may occur• He may evelop antigen in his blood. which juay pei'sist
for a short or long time. Ke smy develop specific antibody or
immune complexes, These types of response may or may not be
accompanied by clinical evidence of hepatitis. The manner in
which a particular individual responds will be the result of an
interaction between the host and tl»e infecting agent. The nature
of the interaction will be largely determined by the genetic make¬
up of the host and that of the agent. Eluiaberg et al. (1967)
suggested that the HB Ag carrier state was the result of an
inadequate immune response. He later proposed the following genetic
hypothesis (Bluraberg et al.» 1969)} there is a gene which
when present in double dose confers susceptibility to persistence
of the antigen. That is. Individuals homozygous for this gene,
when exposed to become chronic carriers, /.hereus persons
with the alternative genotypes HB AgVfJB Ag° or HB Ag^/lIB Ag0, when& 8 3 3
exposed are infected only for a short time. Dudley, Fox and
Sherlock (1972) and Dudley, o'Shea and Sherlock 0973) put forward
the theory that the outcome of infection with lib Ag may be determined
by the competence of the cell-mediated (T-l^mphocyte dependent)
immune response. They used a leucocyte-migration-inhibition technique
to measure cellular immunity to !©8Ag in HB^Ag-poaitive patients,
patients with MB Ab, and normal controls (Dudley, Guistino ana
Mherlock, 1972). bell-mediated immunity, specific for i)£ Ag, ws-s
only found in patients with a previous history of Hb#Ag infection.
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These findings together with those of Laiwah (1971), Almeida and
Aaterson (1969) and Popper and MacKay (.1972) are consistent with
the view tnat liver ceil injusy is not a direct cytopathic effeot
of HB#Ag but rather a result of the interaction of virua-infected
liver cells and the products of the immune response, either
antibodies or sensitised lymphocytes. Luch a theory would seem
to be in conflict with the findings of xe<e3, Eddleston, Cuilens,
Williams, huckeriaan, Peters, Williams and Maycock (1973) who
infused high-titre antibody-containing plasma into chronic lkw>g
carriers, with no resultant liver function test abnormalities,
thus indicating that immune complexes do not, in thio instance at
least, play a part in hepatocellular damage. Butnick, Bugbee,
London, Loeb, Peyretti, Litwin and Blumberg (1973) showed there to
be no difference between the lymphocyte response to phyto-
haemagglutinin between KB Ag carriers and normal donor3. This
led them to suggest that a general immunodeficiency state is not a
prerequisite for developing persistent antigenaemia, and that I-
lymphocyte abnormality, when present, may be a result of the under¬
lying liver disease rather than a cause.
One obvious way that the virus may damage the liver cell i3 by
causing sufficient functional disturbances to kill it. Alternatively,
it might produce chronic hepatitis through some pathogenic immune
mechanism:
(1) Cellular material released as a result of viral infection
may be immunogenic*
(2) A virus which buds at the cell surface may incorporate
cell membrane components which may then become
immunogenic by virtue of their association with the
virus.
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(3) The cell membrane may be altered by incorporation of
viral components which might be recognised as
foreign.
(4) The continued release of virus particles from the ceil
surface might lead to a cell-mediated immune
reaction or an',lgen-antibody complexes at the cell
surface#
Albert!, Realdi, Treraolada and Cadrobi (,1979) have demonstrated
HBaAg on the ceil surface in acute but not in chronio hepatitis.
Chronic hepatitis is associated principally with lymphocyte
infiltration, and oa lymphocytes are mediators of the cellular type
of immune response, the outcome of infection with HB Ag may be
partially determined by the vigour of the cell-mediated response
to the infection. ihoae with a vigorous cell-mediated response
develop acute hepatitis. A few will be overwhelmed by the
infection, but the majority recover and clear the antigen, 6here
there is little or no cell-mediated response, cue either to antigen
overload or immunosuppression, the virus will continue to proliferate
causing little or no damage, and circulating antigen will persist,
in the intermediate situations a partial cell-mediated response
may occur which is sufficient to cause some liver damage but
insufficient to concrol the growth of the virus. continuous
cycles of virus growth and host response would result in chronic
aotlve hepatitis. It is possible that a combination of immune
pathogenic responses are in operation, providing an interesting
theory which requires further study. &udat, Bianchi, Sonnabend,
Thiel, Aenislmenslin and btalcer (1971)) have investigated the
appearance of HB cAg in liver cell nuclei, and 5IB Ag in cytoplasm
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in order to identify expression patterns which, together with
histologic parameters, could be integrated into four reaction types
of diagnostic and prognostic importance.
in 1^6^, Almeida et al. reported the presence of massive immune
complexes in the serum of a fatal o&se of fulminant hepatitis, and
suggested a similarity to serum sickness, a condition where severity
depends upon the balance between antigen and antibody. this theory
appeared to be supported by the finding of HB Ab or immunes
complexes in yO percent of cases of acute serum hepatitis and
100 percent of chronic serum hepatitis patients (brozoako,
Madalinski, Krawcsynski, Skwaraka and Kowaslov.ski, 1 971)• Keoently,
Madalinski, dztatehelaka-Budkowska and Brzosko (1974J dissociated
iitimune complexes from patients with acute and chronic hepatitis,
using DiSAE-celluIose chromatography, and showed that the antibodies
belonged to the three major classes of immunoglobulins: igb, lg>*
and IgA, i'he deposition of immune complexes in certain sites is
probably responsible for non-hepatic complications. drob, demelka
and iuiler i19/1 j found that HA Ag-poaitive patients with active
a
chronic hepatites had a uecreased component of 05 complement more
oiten t-nan iio ng negative patients. Hydegger, hambert, uerber and3
* 25
Miescher (l97dd used ~ i-labelled Oiq to detect the presence of
immune complexes in liB Ag carriers. Ho increased binding of label
was found among 18 asymptomatic carriers, but 20 percent to ou percent
of sera from acute transient and chronic persistent hepatitis
patients were found to bind biq, suggesting the presence of imivune
complexes. in a recent letter to uancet, hater, bohmits-du iioulin
and Borat-hilers (1974) presented evidence that igO deposited in the
sinusoids oi' Hii >ig-poaitive hepatitis patients was either '.hi Ab or9 S
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HBcAb, thereby adding support to the hypothesis that immune
complexes play a decisive role in the course of serum hepatitis.
However, Prince and Trepo (1971) found only a weak correlation
between the presence of immune complexes in the serum and liver
damage, while Moulias et al. (197.5) *ex-e unable to find any such
association, in the few instances where high titre HB Ab plasma
has been infused into HB#Ag-positive patients or carriers, there
has been no evidence of hepatocellular damage directly related to
the formation of i»s ne complexes (Lepore, iciienna, Martinez,





Control of serum hepatitis at present relies largely on the
observance of safety precautions by hospital and laboratory personnel,
screening of blood donations and the education of certain sections
of the public, particularly drug abusers. Following outbreaks of
severe liver disease among hospital and laboratory personnel,
stringent safety precautions have been set out (Sutnick, London,
Millman, (Jerstl y and Blumberg, 1971» Percy-Robb, Proffitt and
fthitby, 1970). The most important of these is the provision of
adequate facilities for the handling and disposal of potentially
infective material, the observance of strict hygiene among staff
members, with prohibition of mouth pipetting and the liberal use of
effective antiseptics. Renal dialysis units may be classified
according to whether they are HBaAg positive or negative, with
appropriate restrictions on patients and stalf.
II. Blood Donor Testing
There appears to be disagreement over the effectiveness of blood
donor testing in reducing the incidence of pcsttrursfusion hepatitis.
A significant reduction has been reported in the East of Scotland
(Cameron, 1973> personal communication) and North London (Cleghorn, 1973»
personal communication) Regional Transfusion Centres. The most dramatic
effcot was reported at the Philadelphia General Hospital (U.S.A.) (Senior,
Sutrick, Goeser, London, Dahlke and Blurcberg, 1974) where the
incidence was reduced from 17*9 percent to 5.6 percent by the use
of I.D. for testing donor blood. On the other hand, Rienicke,
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Banke and Dybkjaer (i 973) and Arnt-Ifanser slid Pyka (l 973) both
report that systematic removal of HB Ag-poaitive blood detected by
s
I.B. and C.l.B.u.P. failed to reduce the incidence of post¬
transfusion hepatitis. it may be that more sensitive techniques
are required before this complication is significantly reduced in
all recipient populations. Haema glutinatxon ^Ha) ana radio¬
immunoassay ^iLLA) are capable of deteoting HB„Ag below the
O
sensitivity of I.D, and C.x.E.U.P. (Shaffer et al.. 1572# Ginsberg,
Conrad, Bancroft, Ling and Qverby, 1972). Despite the improved
sensitivity, Hollinger, Aach, Gitnick, Koohe and Melniek (l973)
have suggested that the large scale use of tilA would not result in
a mjaor reduction in cases of posttransfusion hepatitis, a suggestion
which would seem to be borne out by the findings of Jennings,
De Pratti, Monroe, Pollock, Watson-Mlliams and Glaus (1973) who
compared RIA and C.I.E.O.P. for detection of HB Ag among biood donors
in California, and concluded that HIa would be of little value to
Blood Transfusion Ser-vices in reducing the incidence of clinical
hepatitis following transfusion.
III. Passive Immunisation
Normal gamma globulin (prepared by the fractionation of
pooled plasma) does not appear to be effective in the prevention of post¬
transfusion hepatitis, A field trial conducted in 1945 (Grossman,
et al.) and a second trial reported by Mirick, v.ard and
McGo.lum (1965) suggested that normal gamma globulin could
prevent or modify posttransfusion hepatitis. However, volunteer
studies (Drake, Baronaess, Bashe, iienle, Kenle, Stokes and enneil,
1955) and « small clinical study (Holland, hubinson, Morrow and
Sohmidt, 1966) did not support this conclusion. The results of a
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recent co-operative study (Grossman et al.. 1970) have indioated
that normal gamma globulin is entirely without value in preventing
or modifying posttransfusion hepatitis. Preliminaiy results
using gamma globulin prepared by fractionation of plasma known
to contain specific IIB^b demonstrated passive though not necessarily
proteotive immunity in man (Prince, Szmuness, Woods and Grady,
1971> Gocke, 1971# Conrad, Young, Park, Dinger, Gerling, Bickley,
Boykins, Tidwell, Petty and Knowlea, 1971» Krugman, Giles and
Hammond, 1971). Soulier, Blatix, Benamon, Courouce, Amouch and
Irouet (1972) at the National Transfusion Centre in Paris have
prepared hepatitis B immune globulin and. administered it to 27 subjects,
19 of whom had received a transfusion later found to oontain HB Ag,
s
and 8 of whom had been accidentally exposed (needle-sticks) to
antigen-containing blood. The hyper-immune globuiin was
administered between three hours and seven days after exposure.
None of the 27 recipients developed jaundice. Follow-up of 18
3ubjeots showed significant transaminase elevations in only 2 subjects
and HBsAg wa3 not detected in any of the 18 cases. It was concluded
that passive immunisation appeared to be both effective and
innocuous. Despite these encouraging reports, the use of hyper¬
immune HB Ab globulin, whether administered to the patient or to the
blood prior to transfusion (Katz, kodrigues and Ward, 19?1)» must
proceed with caution, since in theory it3 administration could
attenuate the disease and lead to an increased rusk of producing a
chronic carrier state with associated liver disease. Lepore et al.
(1972) infused high titre HB Ab plasma (220-350 mis. per day) for
three days into a woman who developed HB ^g-positive fulminants
hepatitis with ooma snortly after giving birth. A dramatic oiinical
5C.
response ensued durill£ which the patients blood became HB Ag
negative and she continued to isake a steady' and ultimately complete
recovery. The following year, need et al. investigated the
effect of infusing an immunoglobulin preparation with a high titre
of lib Ab. bix patients with active chronic hepatitis received
antibody intravenously. The infusions were well tolerated and
only two patients showed evidence of minor and transient immune
complex reactions. bne patient was lib Ag negative at the start ofs
the investigation and he wua the only one to show antibody,
detectable by i«. after infusion. where the Jnitial Hd Ag titres£»
were high, litcle change in titre 'was noticed, while in two patients
with initially low titres, liii.ng was cleared from the circulation
for up to y days, Ho patient, showed abnormal liver function test
results, suggesting that immune complexes play only a jainor role,
if any, in caus n; , hepatocellular damage.
TV-• <-.ctive Xu-iiuniSviiaon
Krugman ana Giles investigated the effect of active as
well as passive immunisation, and reported, that both were associated
with & protective effect, greater attenuation of the injecting agent
and a uecrease in the chronic earlier rate. as early as 19?1,
Krugaan, Giles and iiammoed produced relative protection by aetive
immunisation with o boiled ML-2 virus preparation. De Gast, nouwen
and Kieseg (1573) have shown specific lymphocyte stimulation by heat
inactivated HE Ag, suggesting that vaccination with such a preparation
8
might induce not only humoral but also ceil-mediatea immunity.
Lreesuan et al. (15/3) have isolated a small polypeptide by acid
treatment of reunceu nun-alky latea hi Ag. This polypeptiae retained
antigenic activity arxi may provide a source of material for cevelopaent
of a hepatitis B vaccine (see General Discussion). The preparation
of active 3ubunits of KB Ag has also been described by Rao and Vyas
(1973) using ultra-centrifugation and chromatography. Such lines
of research may lead to the preparation of a synthetic material
containing the immunogenic reagent, since there is little doubt that
polypeptides and other moieties such a3 lipoproteins can be attached
to a macro-molecular carrier and used for immunisation (Sela, 1966).
V. Transfer Factor
Vyas, Ibrahim, Rao and Likhite (1974) claim to have achieved
in vitro transfer of cell-mediated immunity to non-immune cells, as
measured by inhibition of leucocyte migration in the presence of
HB Ag, using RNA extracted from the lymphoid tissue of immune
guinea pigs. 3earing in mind the immui.e RM-mediated transfer of
delayed skin reactivity to tuberculin, varidase and monil ia antigens
(Han, 1973)» these findings hold promise for clinical application of
systemic transfer of immunity to KB Ag in man.3
VI. Miscellaneous
The work of I'ullis, Hinxaan, Sproul and Nickerson (1970) suggests
that the incidence of posttransfusion hepatitis can be greatly
reduced by the use of frozen blood. This work has been confirmed
by the results of Hayashi, Nakamura and Giorgi (1971) and Carr,
De Quesada and Shires (1973)» However, rterch, Grey, Kersh and
Melnick (l97l) found that HB Ag could still be detected in frozen
reconstituted cells if the donor had an unusually high HB Ag titre.
Lo Grippo (1969) has shown that biological products may be effectively
sterilised by treatment with betu-propiol&ctone, particularly if
this is combined with exposure to ultraviolet light.
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Clinical trials including both active and passive immunisation
are still in progress, and until such data hate been analysed,
prevention of aeruo hepatitis oust depend largely upon the observance
of aeasures that li.it the transfer of H3_Ag from one individual
to another by axy of the proven or implied. routes •
53.
CHAPTER 7
AHIMAL MODELS FOR VIRAL HEPATOSIS
*• Hepatitis B
A number of workers have found HB Ag and HB Ab among
£» o
apparently naturally infected chimpanzees and gibbons (Maynard,
Hartnell and Bex-quist, 1971* Lichtei', 19B9), and several
subsequent stuuies have demonstrated the 3usceptxbility of
chimpanzees to type B hepatitis (Maynard, Berquist and Krushak,
1572; Bai'ker, Ghisari, Modrath, Dalgard, Kirschstein, Almeida,
Edgingten, Sharpe and Peterson, 1973 > Desuyter, Liu, homer and
Mortelmans, 1973). Disease in these animals is generally mild,
accompanied by enjyrae elevations and with an absence of icterus or
significant clinical signs (Maynard et al., 1972\ Barker et al.«
1973), while serologic events ax-e remarkably similar to those seen
in .man (Barker, Maynard, Puroell, Hoof'nagle, Berquist, London,
Lerety and Krushak, 1975).
Areas in which the chimpanzee will prove a useful animal
model include preliminary evaluation of the safety and effectiveness
of HB-igd and vaccines, assessment of methods of eliminating HB Ag
from blood and blood products, and in the critical evaluation of
infectious material for subsequent animal challenge studies.
Barker, Almeida, Hoofnagle, Leretv, Jackson and Slcfrrath (1974) have
isolated and purified HBQAg from the liver of an immunosuppressed
chimpanzee which died of pneumonia following inoculation with HB Ag.
Chimpanzees may, therefore, become an important if somewhat




Although transmission of hepatitis A to Pains monkeys was
documented byBeazeroft in 1568 and 1565, the most convincing
evidence was obtained by Beirthardt, Holmes, Capp3 and Popper (1566)
who first reported the development of biochemically and histologically
typical hepatitis A in oa,,uinus fuscicollis. Snf:uinua nlgricollis
and daj-tuinua aealsua marmosets. In subsequent experiments Holmes,
..olfe, Jeinhardt and Conrad (l57l) were able to repeatedly produce
hepatitis in marmosets inoculated with acute phase serum from
volunteers infected with the MS-1 strain of hepatitis A, but not
with normal serum. ascoli, Ivtenaohn, Yilleijyyes, Arguedas,
Provost and Hilleman (1573) infected marmosets using specimens from
patients acutely ill with epideasi©logically proven hepatitis A in
Costa Pica. They were able to produce hepatitis and transmit the
agent serially. Convalescent serum (but not pre-ex^osure or
acute phase serum) from patients involved in the original outbreak was
found to be protective.
Puree11, beinstone and Kapikian (1574) used immune electron
.xdcro3copy to study hepatitis A. Btool extracts from patients
infected with the MS-1 strain were reacted with convalescent serum
from one of the volunteers. Small 2? n4h viru3-like particles
coated with antibody were visualised in acute phase specimens but




TECHNIQUES Cimmmx AVAILABLE FOR IB Ag TESTING
3
Introduction
The need fox- a simple but sensitive technique for testing large
numbers of blood donors on one hand, and a very sensitive yet specific
research tool on the other, has led to the development of a number
of teats that differ greatly in sensitivity, specificity, ais^lioity
and cost, each possessing its own characteristic advantages and
disadvantages, Jach of the techniques to be considered has been
shown to be sufficiently 3pecifio, provided appropriate controls are
included. It is proposed to group the Vicious techniques into
ohapters according to the type of reaotion involved.
%*
CHAPTSK. 1
FliECIF1IATIOK 21ACTIONS IN AfrAtOSX
I. Immunodiffusion (l.D.)
This is the technique by which HB Ag was first detected
(Blumberg, 1jbk)> end is still employed in many laboratories because
it is simple and specific and provides a useful means of
establishing identity. The reuotants diffuse through a medium of
approximately 1 percent agarose to produce visible precipitation
lines where HB Ag and KB Ab meet in optimal proportions. Eeagents
are dispensed, via capillaxy tubes, into wells cut in the medium,
wells may be replaced by filter paper discs soaked in reagent and
placed on the agarose surface (Dequeaney and Becker, 1970).
quantitation of HB.Ag is possible by allowing diffusion to occur
through a medium into which HBgAb is incorporated. The distance
from the centre of the antigen well to the ring of precipitation is
proportional to the antigen concentration. The sensitivity of I.D.
may be increased in a number of ways:
1. Pre-filling or topping-up wells (Kim and Tilles, 1971)•
2, Concentrating reagents e.g. with lyphogel (Ashcovlnand
Peters, 1971}«
3* Use of an enhancement or x*einforcoaent pattern (testing
eaoh serum adjacent to a positive serum) (bchraidt and
bonnette, 1972).
4. Use of a closed system of hexagonal wells in conjunction
with 8 percent polyethylene glycol has been claimed to
increase sensitivity by a factor of 8 to 16-fold
(Trasvik, oiebke and Kjeldsberg, 1972).
JV7,
5» Controlled evaporation from the reagent surface, a process
termed 'rhcophoresia* (Helper and Jambasian, 1972).
lueapite the many possible modifications, I.D. remains ® slow,
insensitive technique uneconomic in terms of reagents. However,
because of its ability to produce reactions of identity, it remains
a popular method of subtyping both MB Ag and JiB Ab, as indicated bys s
precipitation * spurs' (Govern etal., 1969; dust, 1>71» be Bouvier,
1971# noenisch ana hutz, 1971? Kaplan and Grady, 1971; Msesur,
Falker and. Bluaberg, 1972J 3»® Bouvier, 1972; he Bouvier at al.,
1972; Gordon et al., 1972; Magnius and Bspsark, 1972; nensel et_al.,
1972; Bancroft et ai.. 1972).
II. Counter-electrotihoresi.a (c,l ,F»0.P.)
This technique replaced l.P. as the nost widely used in large
scale testing for ?'B /g. Pairs of wells, usually 2 mm. in diameter&
and 3 mx. apart, are cut in agarose. Test serum (csthodic well) is
caused to migrate n an electric field through a suitable medium of
diffusion against a stream of Hi Ab ( anodic well) migrating in the3
opposite direction as a result of endosmotic flow. This technique
was first applied successfully to the detection of ffB Ag and HB lb by3 3
Bederida, Trinchcri and Cnrbonnra (1969)» Since then a number of
modifications have been described (Gocke and Howe, 1970;
Passendorfer, Kransnitaky end . ev.alka, 1970; Prince and Burke,
19/0; Vergeni, 1971)• The technique has also been modified for
simultaneous detection of KB A? and HB Ab by interposing the testil ©
sample between an HB/b-containing well on one side and an HB^Ag-
containing well on the other (..uckerraan and ay lor, 1970). However,
this may lead to the crossing-over of one of the reactants, resulting
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in the formation of a false positive. A discontinuous buffer
system in which buffer in the gel i3 at a lower ionic strength than
that in the electrode vessel is reputed to improve sensitivity
(Combridge and Shaw, 197$)» Sensitivity may also be improved by
diluting reagents in homologous speeie3 normal serum (Dree3man,
Hollinger and Melniok, 1972) and by 3taining plates after testing
with tannic acid (Hopkins and Das, 1972). Rearrangement of the
wells allows counter-eleetrophoresis to produce reactions of identity
and so be applicable to subtyping (Das, Hopkins, Cash and Gumming,
I97t)» The principle advantage of C.I.E.0.1'. over I.D. is speed,
since results are available within two hours. Both techniques
suffer from the disadvantage of requiring a fixed HB Ag-HB Ab ratio
o 8
and consequently do not take into account the possibility of false
negative reactions due to either HB Ag or IEB Ab in excess (Kohn,8 8
1970). This source of potential errors may be eliminated by using
an inhibition reaction, which is also claimed to increase sensitivity
(Milner, Dobie and (irobbelaar, 1972). False positive reactions may
occur due to the reaction of other antigen-antibody precipitating
systems such asanti-ruminant antibody (Alter, Polesty and Holland,
1972; Lama, Nl, Krakur, Greenwalt and Levin, 1974) and lipoprotein
isopreoipitins (Verrucei, Bluiaberg and Morganti, 1970; Blumberg,
Hann, London and Yin, 1974). All positive reactions should be
confirmed by tests of identify. Holland et al. (1972) have used






Latex agglutination is now an accepted teat for the presence of
rheumatoid arthritis faotor (Linger and Plot*, 1956) and is widely
used as a test for human chorionic gonedotrophin in the urine of
pregnant women (Graham and Kouah, 1967). In 19/1, Leach and auok
evaluated a corassercial latex agglutination teat developed by
Pfizer- Limited for the detection of HB.Ag. Antibody raised in
guinea pigs by istnunisation with purified HB^g Wf.a used to coat an
0.5 percent suspension of 0,8 ji , polystyrene latex spheres. The
latex was stabilised with bovine serum albumin and preserved with
0.1 percent sodium aside. The preparation appeared to remain
9
stable at 4 C for at least three months. Test procedure involved
25 ul of test serum being mixed with 25 fil of normal guinea pig
serum on a glass slide, before the addition of 25 yul of the antibody-
coated latex reagent. The slide was then rocked to and fro for
5 minutes, by which time an HB /ig-positive scrum showed definite
agglutination.
Hopkins and Das (1974) have evaluated latex reagents from two
commercial sources (Pfiaer Limited and Sioechat Limited (rabbit
HB Abj) and compared them with C.l.B.O.P. for sensitivity and
3
apeoifioity, using sera from blood donors, patients and plasma
fractions, G-ocx agreement was obtained when testing blood donations;
however, false reactions were observed with both latex preparations
among hepatitis patients* sera. The sraa.ll number of false negative
reaotiona encountered were probably due to the subtype of the
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antibody on the latox particles, rather than a lack of sensitivity
relative to C.I.H.G.P, False positive reactions were encountered
with both kits, but ?ere mors frequent with the Hoeehst reagent.
Such reactions my be caused by a number of factors, such 33
incomplete dotting of plaaaa or the presence of rheumatoid factor
(Burrell, Dickson, Gerbor, McCormick and Mansion, 1972? hiegenfuas,
jnr., 1972). floating the teat serum at 6C°C for 10 minutes ia
claimed to reduce the false positive rate to about 3 percent
(Perkins, Perkins and Vycs, 1974). The main advantage of latex
agglutination is speed. In their present state of development,
however, commercial Intex agglutination tests for HB i\g would seem
to be unsuitable for use on patient's sera due to lack of
specificity. This drawback may be partially overcome by use of a
'control* latox preparation coated with normal immunoglobulin,
although the simultcneoua presence of IE Ag and non-specific
agglutinins could not be ruled out,
Malin and Edwards (1972) claim to have improved specificity by
coating 0.9 u diameter Intex soheres with antibody of humeri origin.
These reagents retained sensitivity for up to eight weeks when
stored at 4°G. Stevens, Ziegler and Kelly (1972) described a
charcoal particle agglutination-inhibition technique in which antigen
was absorbed to particulate charcoal. As with latex agglutination,
the HB Ag-HB Ab complexes caused macroscopic agglutination. The
3 a
test appeared capable of detecting 1.5 /Jg® of HBgAg protein per ml.,
making it about 10 times more sensitive then C.I.F.O.P. False
positive reactions did occur.
Kachani and Gocke (1973) ascribed an aglutination-flocculation
teat (AFT) for detection of KB ag. This test involved the
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simultaneous agglutination and flosculation of HB A$ by HB Ab in
a a
the presence of 0,5 p diameter acrylic particles. Preparation of
reagents required the aensitisation of acrylic particles with
varying concentrations of hyperinrr. ne FIT' Ab gamms. globulin in
borate buffer. rmsltisation was carried out at r-om temperature
and ws.s followed, after 1 hour, by the addition of 5 percent bovine
serum albumin. The antibody-coated particles were not washed,
a3 the presence of excess antibody in the fluid phase produced
simultaneous flocculation, leading to improved sensitivity. last
0
sera were heate ! at 5c C for 10 minutes, :hen 25 pl» placed into
each cf six wells in : standard agglutination tray, ana 25 /il. of
foetal calf sarusi added to prevent weak non-specific reactions.
25 /»!. of bro lophenol blue was aided to each well before mixing
with an applicator stick. Finally, 25 yol. of each of the antibody-
coated partiolo preparations was added to the appropriate wella and
the plate mixed on a rotosfcat for 30 minutes befox^e being read.
The authors claimed the technique to be 3-fold more sensitive than
R IA and 1GOQ-fold ~oro sensitive than C.l.f.O.F. '.There are,
however, numerous disadvantages which make this test unsuitable for
blood donor testing:-
1. Each sample must be tested a number of times, against
different concentrations cf antibody, to overcome proaone
reactions,
2. High-titre rheumatoid sera are a source of false positive
reactions,
3. hyperimmune antibody of high specific activity is crucial
for co. ting the acrylic particles. This would necessitate
the immunisation of animals with pure 113 Ag, and require
fractionation of the resultant antibody.
4. Sera need to be he&ted prior to testing to remove a
thermolabile inhibitor of agglutination-floeculation
which is present in most normal sera.
II. Haero&gglutlnation* (Ha) and Haema^lutination-Inhibition (HAl).
In 1^69, Juji and Yokahi published details of &n Ha technique in
which formalinised erythrocytes were sensitised with purified HB Abs
and used to aetect HB Ag by airect imemagglutination*-. The purified
MB^Ab was prepared by a complex procedure involving the formation of
immune complexes, which were then dissociated and the KP.gAb isolated
by centrifugation and chromatography. Formslinised group *0* Eh.
positive humf 1 erythrocytes were tinned and coated with the purified
HB Ab. The sensitised cells were resuspended to 0.5 percent in
phosphate buffered saline (F.B.S.), pH 7.2, containing 1 percent
normal rabbit serum. Tests were eonduoted in disposable plates with
-bottomed weils, reagents being added in 25 pl» volumes. After
mixing the plates were left overnight at room temperature. This
teohnique was found to be more sensitive than I.D., but unfortunately
it was not evaluated for use in mass donor testing due to a hi^
incidence of false positive reactions among the negative controls.
It was also found that the sensitised cells ueteriorated rapidly if
stored at 4UC.
The following year, V^as and bhulman (197^) described an
HAI test in which jresh human erythrocytes were sensitised with
highly purified HB Ag. These cells were used for measuring HB Ab8 o
* sometimes called reverse passive haeraagglutination (EPHAj.
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by direct HA and MB Ag by an inhibition reaction. Plaaoe was
3
collected ftrom aayrnptomtic HB Ag carriers and the antigen isolated8
by ultra-centrifugatlon using density gradients. The purified
antigen gave c single braid in agarose and, when concentrated
10-fold, gave no precipitation reaction. Kith rabbit antiserum
against whole human pl&aca. Huaar. group *0' erythrocytes,
collected in anticoagulant end wasbod in saline, were uaue up to a
AO percent suspension and incubated with purified antigen and
chromic chloride, the latter acting ns a coupling reagent. A
factor affecting i-mnsitivity of the coated ceils -«as found to be
tha tamperstore ; t which sensitization occurred, this being optimum
Q O / \
between 22 C and 41 C ^'fa-vkea, 1973)* The sensitised cells were
made up to a 0.2 percent suspension in P33 pM 7.3 containing
0.5 percent bovine serum albumin, 0.0025 percent pciyvinylpyrolidlne
(PVP) and Tween BO at a concentration of 1 in 20,000, The testa
wero conducted in adorotitre plates with "Y'-bottoaaod walls, using
25 pi. volumes of reagents. The .inhibition reaction, used to teat
for MS Ag,u3ec 10 unit: of ::.S Xo activity. Sensitivity for Ab
detection was approximately 2000 times greater than I.E., while
sensitivity for IT' ig wa3 approximately 120 tinea that of C.X.4.0.P,4 8
?ho technique initially gained acceptance in uaiy laboratories once
its sensitivity oc>:\.areu favourably with C.l .S.O.f. vohadl'or ot ai.»
1972). To achieve reproducible results, Prince ot al. (1971} found
it necessary to store the uenaitiued cells in liquid nitrogen until
required. iioeslnk# Euiiool and Brujaaoihuia C197p} also found it
necessary to tao<!i£V' tho technique in order to obtain u cieg?ut» of
reproducibility. ...ty rcoorjuend that the following eonaiviuno should
be observed*
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1. Careful selection of donor cello, as only about 5 percent
of donor blood is suitable for eonaitisatlon,
2. I^xwn&aeat of tho chrosaic chloride coupling, allowing a
lose pure K5 Ag preparation to be used. Their proposed
aothod of antigen purification involved Freon extraction,
abaorptiun tukl olution from Aerosil, gel filtration end
extensive dialysis followed by concentration#
3. foe uflo of u apociul preserving fluid waioh allowed the
seiisitised cello to be stored at 4°G for up to six weeks.
K,.ak, Sturgeon end Gitniok (1973) have successfully automated
the toot using a sampling r« to of 60 tests per hours# results being
available within 30 minutes. Gold et al. (1974) h ve applied the
test to subtypin,: HB#Ab in t'-rras of anti-d ana anti-y specificity by
using a blocking antigen of known subtype.
In on attempt to c oumvent the need for cansity gradient
centrllUgation, !4©leoa, Fhipps, sntaor.# atts and Zwolenski (1973)
'wave extracted HB Ag flpr acrum with aercstl 200 and subsequently
purified it by column fraetiont.-.it, pepsin digestion and filtration
through © 0.« b p. oillipore filter. Irior to sensitisstion the
HB Ag v,as inactivated by heating at for one minute. The
8
sensitised cells were found to be unstable unless stored in liquid
nitrogen. A ceil suspension of 2.3 percent was used in a Teohnioon
autoanulyser, the agglutination pattern being recorded on absorbent
paper. Sensitivity for HB Ag detection was only 4 times greater
than C.I.S.C.P., while the sensitivity for IiB Ab detection was 32
times better.
Since publication of the work of Juji and Yokochi (1969), the
literature has, until recently, contained no reports concerning the
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use of HB Ab«costed cells for the detection of KB Ag. In 1573#3 S
however, Hirata, limerick and boley published details of such a
technique using purified guinea pig antibody coupled to double-
aldehyde-treated cells. Human type *0' erythrocytes were stabilised
by treatment with pyruvic aldehyde followed by formaldei^yde. The
stabilised cells were then incubated with a relatively low ionic
strength buffer (0.1M phosphate, pH 7.2) containing antibody.
Teat sera were diluted in phosphate buffer containing gelatin,
and tests conducted in *v*-bottomed microtitre plates. Sensitivity
was reported to be considerably greater than G.I.E.G.P. The teat
has been modified to subtype HBflAg by coating cells with monospecific
antibody prepared with the aid of an immunoab3orbant (.Hollinger,
Wabi, Dreesniaa and Melnick, 1573).
At the present time, three commercial companies are offering
HB Ag test kits based on this principle. Table 1(2)2.1. oompares
the characteristics of each of the products.
Addendum.
In 1969 Avrameas,Taudou and Chuilon (lmmunochemistry .6_, 67)
published data concerning different methods for coupling antigens to erythrocytes.
TABLE 1(2;.2.1.




Supplied by Wellcome Orpsnon Abbott
Cell sueciea used Turkey Sheep Human
HB Ab species used
s
Horse Sheep G.pig.
Test yehide u-plate u-tube v-plate
Test volume 25 pi. 25 /il. 25 fil.
Incubation time J5O-60 mins. 3 hours 3 hours
Final serum dilution 1 in 6 1 in 16 1 in 16
Approx. sensitivity
relative to i#D» 1000 £00 1000
Approx. coat per




A number o£ techniques have been described, most of wiuen use a
1?5
radioactive marker, usually .»b8*tg labelled wxtn ' Iodine, dd A|
xa purified uy uitra-ceutilfugation and gel chrocMibography before
being radioictoelxoJ by ins oJUoramiua-i aetnod of iiunter and
Greenwood vlifedj* ax'be* labelling, it ia necessary to separate
free label uriu laoelleu. serum prote.uas from laueiied Mn^ns# ibis
is usually achieved by column cjhruian tograply • lost radioimmunoassays
are based upon odtapebitian for antibody binding sites between
atanbaiu labelled antigen and any uni&oeiled antigen waxed may be
present in the aenua being tested, fas Major difference between
techniques is the manner in whion tne immune precipitate of antibody-
bound hd Ag is separated fro® tree w> ag after incuuatioa,
II, bougie afttiocgy ireoipitation ih.^.-hXA)
ine commonest assana of separation is tne uuuole antibody technique
(a&cn, orianaifl ana ■ arker, 1271 j toiler, dillman, naionerr and
blumberg, 1971» Uollin,,er» Vormiaui and oreesmun, 1£71» baauer.
Alter and thrceix, 1y/1)• ihe serum to be tested is incuoaied with
serum containing ha no and labelled iii» Ag, Ahis is followed by the3 S
addition of an aati—gaimiw-globuli* to co-precipitate the HA Ag bound
to the first antioouy, Alter incubation the co-precipitate is
isolated by centrifugetion and counted in an automatic g&tmaa counter.
If fixing is present in cue teat serum it will compete with the
labelled HtS^Ag for hiwVb combining sites, tnereoy reducing the amount
of radioactivity in the co-precipitate as compared to simultaneously
run negative sera, detection of circulating hh#ab involves
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incubating the test aerura with labelled HP Ag and then adding an
anti-huraan-IgG. Xranune complexes are isolated and counted as for
HBgAg detection. If MB Ab is present in the test sample, it binds
labelled HB ag causing a marked increase in radioactivity in the
co-precipitate in coiaparison to control sera. nlsh, Yalow and
Berson (1970) used paper chroaatoeleotrophoresis for the separation
of free and antibody bound This technique takes advantage
of the differences in nobility of free and bound HB Ag in an
electric field.
A major disadvantage of B.A.-LlA is the time taken to complete
the test, since the standard procedure for detection of the lib Ag
inquires 2 to 4 day3.
111' bolid Phase U. .-iiU)
Attempts to reduce the time factor have led to the development of
solid phase techniques \.Ling and Overby, 1972; Ginsberg, Bancroft
and Conrad, 1972), one such test ^.aarketted by Abbott Laboratories
Ltd., under the name J2IJA-1) involves placing 0,1 ml. of test
sample on the bottom of a polypropylene tube coated with purified
i\yperixaaune 185 hb (usually raised in guinea pigs). the tubes are
then capped and incubated for j$ to 16 houi's, depending on temperature.
The serum sample is aspirated and the bottom of the tube rinsed 5 times
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with tris-iCl buffer before the addition of 0.1 ml. of " 1-la.belled
HB^b. The tube is then capped end incubated for a further
SKI minutes, after v.uieh it is once again rinsed 5 tines and counted
in an automatic gaar.& counter for 1 minute. for e: oh group of tests
10 controi tubes containing nortasl human serum are induced and the
standard deviation of the counts ox the negative control tubes
oojopuxed. HB Ag present in the test serum should complex with the
specific HB^Ab in the tube snd not be removed during washing. The
labelled antibody should then complex with another site on the
bound HB^Ag particle and remain in the tube during subsequent washing,
thus raising the radioactivity count above that of the negative
control tubes. In theory this technique sho .Id be capable of
detecting KB Ag having only two KB Ab-binding sites available. This
3 &
my be somewhat optimistic, although in practice the teat has proved
to be considerably more sensitive than C.I.E.O.P. (Hansson and
Johnsson, 1974). Count rates for the negative control tubes are
generally leas than 0,3 percent of the radioactivity used. A factor
of 5 standard deviations from the negative control mean is used to
determine whether a serum is positive or negative, i.e. sera having
count rates higher than the mean of the negative controls plus
5 standard deviations are considered positive. *U£i.iA-1 has recently
been superseded by an improved kit (AUBRIA-2) in which the unlabelled
HE Ab is absorbed on to polystyrene beads resulting in an increased
9
surface area and a theoretically improved sensitivity. the solid
phase system oan be employed fox the detection of HB Ab by using
KE_Ag-coated bead a in conjunction with labelled \T-J\g (Ginsberg et el.
s s ———
1972). Puree 1, .ong, alter and Holland (1973) adapted the S.P.-HIA
for use with microtivre serological equipment. Polyviryrl 'V*-
bottomed microtitre plates serve as the salid pheae into each sell of
which 75 pi. of an appropriate dilution of Ab was added and the
plate incubated for 4 hours at 4°G. healduel HB Ab was aspirated
O
by washing twice with saline and 0.2 mi, of bovine serum albumin added
Alter a further overnight incubation at 4 c the plates ».ore ©gain
washed with saline and the residual fluid aspirated from the wells.
The test was performed by adding 23 yul. of sample to the bottom of
each well, followed by an overnight incubation at 4 t. The following
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day the wells were washed 5 times with saline, and 50 yul. of
labelled HBsAb added. The plate was then incubated by rocking
gently at 37°C for 4 hours. The wells were once again washed with
saline before being cut out and placed in the tube of an automatic
gamma counter and counted for 4 to 20 minutes eaoh. Results were
expressed as the ratio of residual counts in the sample well to the
mean residual count of wells that received a sample known to be
HB Ag negative. Radio-labelled HB Ab was prepared from both
s s
human and guinea pig sera. The most sensitive system was obtained
using HB Ab of guinea pig origin, although this system also
exhibited mar\y false positive results. When human HBaAb was used
speoifioity improved but at the expense of sensitivity.
Figensohau and Ulstrup (1974) have desoribed a teohnique in
whioh Protein-A-carrying Staphylococcus aureus is used as a solid
phase anti-gamma globulin reagent. The test is easy to perform,
being complete in two hours. The competition principle is used in




Simons (1973) described a simple, sensitive, rapid and relatively
inexpensive radioelectrocomplexing teohnique which involved
oomplexing radio-labelled HB Ag or HB Ab with unlabelled HB Ag or3 3 3
HBsAb as a result of counter-directional movement produced during
electrophoresis. Microscope slides were covered with 4 ml. of
1 percent agar in 0.05H barbital buffer pH U.6, and two wells 3 mm.
diameter and 4 mm. apart were punched as 4 parallel pairs in the
central area of eaoh slide. To detect HBfiAb, 5 ^1* °** undiluted
test serum and labelled HB Ag were pipetted into the anodio and
3
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cathodic wells respectively. After electrophoresis (10 m&,
200 volts per slide for 50 minutes), the agar was out into three
zones well aone, inter-well zone and HB^Ab well zone) and
transferred to garataa spectrometer tubes. The percentage
distribution of label in the three zones was calculated from these
values and the radloelectrocomplexing index determined. In the
absence of i IB flAb, labelled fiBaAg moved through the inter-well zone
and into the fB^b well zone. *hen HBsAb was present, the labelled
HB Ag was confined to the inter-well zone and the iiBgAg well zone.
CHAPTER 4
MICROSCOPY
!• Sleotron Eicroacopy (S.K.)
The technique of negative staining has been used by aat\y workers
to 3tudy the fine structure of HB#Ag (Bayer et al.. i960; Dane et al..
1970), Direct examination of negatively stained preparations is
particularly useful for the demonstration of naturally occurring
iaaaune complexes that imj prove difficult to identify by rountine
serological procedures. The addition of HB^Ab (immune Electron
Microscopy, I.B.M.) is,however, preferable for diagnostic identi¬
fication of samples in whioh the three characteristic morphological
forma of the HB Ag are not readily visible. A technique described
by Kelen, Hathaway and MoCleod (1971) offers a rapid and relatively
simple procedure for this purpose. Specimens were diluted 1 in 2
or 1 in 4 and incubated with an equal volume of HB8Ab, then plaoed
on an agar surface. A formvar grid was floated on the surface of
the drop. The fluid phase diffused into the agar causing any
immune complexes present to be concentrated onto the surface of the
grid, which was subsequently stained and viewed. Mayerick and
Smith (1973) have described a similar technique using agarose and
polyethylene glycol to concentrate the test serum. They claim a
sensitivity similar to complement fixation.
while E.M. is essential for studying the morphological
characteristics of HB Ag, it has certain disadvantage*, being an
elaborate technique requiring specialised personnel and expensive
equipment. It has limited application and is time consuming sine#
each sample should be scanned for at least 13 minutes before being
recorded as negative. A recent publication by Snma, Bens, Aaoh,
Jj-
Hacker and Kaplan (197>) reported 8 false positive samples among
patients suffering froia primary biliary cirrhosis, and implied that
E.M. alone is an unreliable test for KB Ag.
s
II. Immunofluorescence (I.P. ;
The technique of immunofluorescence has been used to identify
HB Ag in cells from liver, spleen, bone marrow, testis ands
mesentery (fiillmen, Zavatonc, Gerstley and Blumberg, 19&9) from
patients with HB^.g-positive hepatitis. bells were stained directly
with specifio HBgAb conjugated with fluorescine i3othiocyar.ata and
the specificity determined by blocking with unconjugated KB Jib.s
Similar methods nave been used to detect HB Ag in sections of liver
s •
from patients with circulating HBaAg (Noweslowski, Brsosko,
Madalinski end Krawczynaki, 1970) and in cultured human liver ceils
inoculated with HB Ag-positive sercm (Brighton, Taylor and Suckerman,
197l/» The technique is difficult to master, particularly when
looking for HBgAg in mammalian haemopoietic tissues due to their
'sticky1 nature. It ha3 the advantage of being able to detect cell-
localised HB Ag, which would be otherwise undetectable exoept by thin
section 15.". or autoradiography. Immunofluorescence is a complex
technique involving ouch washing and is not readily applicable to
testing large numbers within a short space of time. Brighton et al.
(1971) used the technique to demonstrate HB Ag in cultured hepatoeytes
following inoculation, and wt^able to demonstrate progressive changes
spreading from cytoplasm to nucleoli.
CHAPTER 5
MEASUIMKKT OF CELL-MEDIA'iXD IMMUNE RESPONSE
I • Lymphocyte Trtinaformation
This test provides a sensitive taeans of detecting previous
infection when specific antibodies are not detectable in the
circulation by such sensitive tests as HA and AIA. Lymphocyte
transformation was first applied to HB Ag by Laiwah (1971) using
phytohaemagglutinin (FHA), purified protein derivative (PPD), and
serum rioh in HB Ag, as transforming agents. Partially purified3
lymphocytes from 20 ml. of venous blood were resuspended in Eagles
medium containing 20 percent normal human serum to give an a^proxi-
6
mate cell concentration of 6 x 10 cells per ml. All lymphocyte
cultures were set up in duplicate, each tube containing lymphocyte
suspension, Eagles medium,penicillin and streptomycin. Nothing
further was added to the control cultures. Each test was stimulated
with (a) PHA, (b) PI), (e) HBgAg. Ail tubes were incubated for
o
120 hours at 37 0. Assessment of transformation was measured by
14
uptake of C-labelled thymidine, added 18 hours before harvesting
(i.e. after 102 hours incubation), determined n a scintillation
counter. In a recent publication, Laiwah, Chaudhari and
Anderson (1573)have shown that purified HB Ag is equally as good a
stimulant as KB Ag-rieh serum in both lymphocyte transformation and
leucocyte migration inhibition. Pettigrew, froudie, aussell and
Chaudhari (1972) were able to confirm the findings of Laiw&h (1971)>
but noted that all KB Ag-rich sera were not equally effeotive in
stimulating the transformation of sensitised lymphocytes. They
found evidence of cell-mediated immunity in all eleven cases of
chronic alcoholic liver disease studied; this leans them to
suggest that HB Ag may be an aetiologieal factor in the development
of alcoholio cirrhosis.
7
n« ^eucoc^te Migration Inhibition
This technique my, in cotnscn with lymphocyte transformation,
be used to assay the ot&te of cell-mediated immune responsiveness
of an individual to KB Ag. The test cesoribed by Laiwah et al.
(1973) la t Modification of that reported earlier by Sorborg and
Bendixen (1 967) • Leueocytea at a concentration of approximately
8
1*2 x 10 cells per ml. were mixed with either normal (control)
serum or HB#Ag-rieh serum and incubated at 37°b for 90 minutes.
Capillary tubes of 50 pi. capacity .ore then filled with the
incubated cell suspension and one end sealed. They were spun at
900 g. for 5 minutes and the packed cell layers separated by
breaking the capillary tubes just below the oell-fluid interphase.
The stubs containing the cells were immediately laid on the floor of
migration chambers containing Bugles medium. Alter incubation at
o
37 C for 15 hours the area of cell migration was magnified by a
projection microeoope and measured by planimetry • The effect of the
stimulating agent on cell migration was expressed as the Migration
Index (M.I.), where
m I a t.i«sn iai/ration area of stimulated cultures* * **
•. eon migration area of control cultures
Ibrahim, Vyas and • erkins (1975) have used this technique in
conjunction with HA and MA to study the immune response to JIB#Ag in
normal persons, HB Ag carriers, acute HB Ag-positive hepatitis
s s
patients and convalescent hepatitis B patients. Their findings
suggest that HB Ag is eliminated rapidly by a cell-mediated immune£$
response, detectable for a limited period, followed by an i£BsAb
response in relatively few patients more than 3 months after the




I. Complement Fixation (C,F.)
The 3eruns to be tested is mixed with complement and HB^Ab
(or HB Ag), If an antigen-antibody reaction occurs complement
will be 'fixed* as demonstrated by testing for residual complement,
A number of procedures are available, although the micro-technique
has been most widely used for HB^Ag testing (Purcell, Holland, nalsh,
fiong, Morrow and Chanook, ' $691 Shulraan and Barker, 1969; Taylor,
1970)• Overnight incubation at 4°C provides a more sensitive but
often less specific test, while incubation at 37°C for only 60
minutes results in a less sensitive but more specific reaction.
The tost for HB Ag has been automated (Sturgeon, Kwek, and Gitnick,
1971; Kwak, Gdtnick and Sturgeon, 1973)* Sera containing high
concentrations of HB Ag may not react at low dilutions due to a
prozone phenomenon, therefore test sera should be assayed over a
range of dilutions, HB^Ag and HB^Ab may be present in the same
specimen as immune complexes (Almeida et al., 1969), a situation
which may result in anti-complementary activity (Shulman and Barker,
1969), Roes and Pringle (1971) have found that heating the test
serum at 85°C for 1 hour may liberate HB#Ag, HB^Ab being destroyed at
this temperature. C,F, is slightly more sensitive than C,I,S,G.P.
for detection of HB Ag, but approximately equivalent for the
detection of HB Ab,
11 • Taamie Adherence Hae-aa :/ilutin£tion U.A,i:.,)
The phenoraenon of immune adherence was first described by
bavoran and Aesnic (1901) and was baaed on the observation that
complexes of antigen, antibody and complement adhere to primate
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erythrocytes. An I.A.A, assay for l!B Ag has been described by
Mayumi, Okochi and -ishioka (15?1)# &«d is reputed to be 100 times
niore 3en3itive than C. ,, but only 10 times more sensitive for the
detection of KB Ab ("iahioka, 1572}. The major disadvantage of
this technique is that large proacnes are observed when the KB Afi
titre is high, and for tliis reason it is necessary to test sera over
a wide range of dilutions. Conversely, if the KB Ag concentration
is low the presence of normal serum complement C"* inactivator amy
inhibit the reaction, causing a false negative result.
III. Platelet ,-y^;st.lop
The interaction of KB Ag»H&gAb immune complexes on the surface
of blood platelets results in their aggregation under certain
conditions, with a consequent change in their settling patterns
(Melertin, Myllyla ;nd enttinen, 1570). Unfortunately, individual
batches of platelets vary in their sensitivity to immune cor^lexea,
thus application of this principle for large scale Ht- Ag testing
is not recommended. False retctions cue to non-immunological





fthile *third generation' assay techniques, such as R.P.H.A.,
HAI and RIA, are beginning to be seriously evaluated by some
Blood Transfusion Centres, many still rely on C.I.E.Q.P. to deteet
HB Ag carriers among their populations. The short-comings ofs
C.I.E.O.P. have already been mentioned (Part One, Seotion Two,
Chapter 1, II), and the advantages and disadvantages of &.P.H.A., HAI
and RIA are discussed in Part One (Section Two, Chapter })» It is
hoped that thi3 project will provide a simple, sensitive, rapid and
economic test for HB Ag suitable for adoption by any Blood Transfusions
Centre.
II. General Aim
To improve HB Ag testing facilities within the Blood Transfusions
Service, and at the same time avoid the necessity of purchasing large
quantities of expensive commercial reagents.
III. Specific Aims
1. Development of a simple, sensitive and economic HBAg teatS
suitable for assaying large numbers of blood donations in a
relatively short time, thereby causing the minimum of delay to fresh
blood required for transfusion and/or processing.
2. Evaluation of the above test in terms of sensitivity and
specificity by (a) comparison with R.P.H.A. and RIA using established
HB Ag panels, and (b) comparison with C.I.E.O.P. in determining the
incidence of HB Ag and HB Ab in the blood donor population of the
3 3
South-East Region of Scotland.
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3. Application of the test to HB Ag subtyping, therebys
providing essential confirmatory and useful epidemiological
information.
4. Modification of the test for detection of Hepatitis £
core antibody (HB^Ab).
5. .tie-investigation of C.I.E.O.P.-negative donations
implicated in posttransfusion hepatitis.
6. Follow—up of recipients of hyperimmune HB Ab gamma
9
globulin given as a preventative measure in cases of accidental





The association of HBgAg with posttransfusion hepatitis
stimulated demand for a rapid means of testing blood donations prior
to U3e. At one time, C.I.E.O.P, fulfilled the requirement admirably
3ince it used inexpensive equipment, was eas> to perform and allowed
fresh blood to be used within hours of donation, an important
consideration concerning the availability of labile products such as
cryopreoipitate and platelets. As the technology of HB Ag testing
9
became more sophisticated and sensitive, the inadequacies of C.I.E.Q.P.
became apparent. Commercial A.P.H.A. and AIA tests are available
but at a price which may prove prohibitive to some centres. Direot
haemagglutination tests suffer nonspecific false positive reactions,
while B1A introduces the additional hazard of isotope handling, is
time-consuming and requires expensive counting equipment
The ueOi3ion to undertake the development of a haemegglutination
test designed specifically for the requirements of the Blood Transfusion
Service was guided by the following considerations:
1. Haemagglutination (HA) and haeraa.:glutination-inhibition
(HAI) are sensitive techniques which have been in use in one form or
another for many years within the Blood Transfusion Service, They
are, on the whole, simple to perform and easy to read, requiring no
sophisticated or expensive equipment.
2. Basic reagents (erythrocytes, HB Ag, HB Ab, normal serum)S S
are in abundant supply at most centres as a result of current
C.I.E.O.P. testing.
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3. The 3table nature of 'fixed* erythrocytes could lead to
standardisation of testing within and between centres if reagents
are prepared in bulk. Thi3 would be much more difficult with a
test such as SIA where labelling and standardisation must be performed
at relatively short intervals.
4» There is every possibility of eventual automation, since
maiy Blood Transfusion Centres are gaining experience in the use of
autoanalysers for various routine blood bank assays.
A basic concept for tanning and sensitisation of erythrocytes
will be outlined end followed by a series of experiments designed to
determine the optimal conditions of a number of variables. The
resultant modified procedure will then be described in detail and
compared for sensitivity and specificity with current techniques.
II* Brief Background to Erythrocyte Sensitisation
.Red blood cells are convenient, passive carriers of antigen
(Hirata and Stashak, 1965* Sindo and ».akakura, 1932), acting as
markers whieh allow agglutination by specific antibody to be observed
with the naked eye. If the cells are tanned before being sensitised
with antigen they are more readily agglutinated by specific antibody
(Shiari, 1964)* Treatment with tannic acid increases the instability
of the cells causing a normally non-agglutinating reaction to result
in agglutination (Pirofslty, Cordova and Imel, 1962). Once treated
with tannic acid at the right concentration the cells will exhibit
agglutination settling patterns. The tendency to agglutinate may
be balanced by adding a stabilising agent such as normal serum so
that autoagglutination is just cancelled out. The cells are thus
in a veiy sensitive state, ready to agglutinate in the presence of a
very small amount of specific antibody. This form of passive
82.
haemagglutination is quite distinct from the active haemagglutination
seen with Influensa Virua (Francis, 1947)# where the virus alone is
responsible for causing certain types of erythrocytes to agglutinate,
since it actively absorbs onto receptor sites on the erythrocyte
surface*
Felton, Francis and Scott (1961) used passive haemagglutination
to study Herpes ;.'implex Virus* They showed that pH and tannic acid
concentration were critical, while the age of the antigen and the
temperature and time of sensitisation were more flexible, allowing
some diversity of performance anu application, A few years earlier,
Scott, Felton and amey (1957) had shown that the concentration of
antigen used for sensitiaation had a direct effect upon the HA titre
of specific antibody, the titre being reduced when lesser concentrations
of antigen were used.
Ill* Initial (Starting) Procedure for Preparation pf HB^/V-coated
Human Erythrocytes
1. HB Ag (C,I,E,0„P.-positive) serum was treated with beta-
3
propiolactone and ultra-violet light in an attempt at inactivation.
2, The antigen was pelleted by centrifugation (120,000 g, av.
for 5 hours at 20 Cj, washed and resuspended in l/2Qth of the
o o
original volume, heated at 60 C for 3° minutes and stored at -20 C
until required*
3* Ten mis* of human group 0 rhesus negative blood was
Q
collected in anticoagulant and allowed to stand overnight at 4 C,
4. The blood '.was washed three tines in hyslologics.1 saline
and made up to a 6.6 percent suspension in phosphite buffered saline
(i'.B.S,) pH 7*2 and an equal volume of 1 in 10,000 tannic aoid was
added before incubating et 37°C for 15 minutes.
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5» The tarrncu ceils were vjashed in P.B.S. pH 6.4 and re-
suspended to a 4 percent suspension in the sane buffer prior to
adding HB Ag in r- ratio of 4s 1 (v/v; ceils; HB Ag). The mixturea S
was then incubated at room temperature (approx. 20°C) for 60 minutes.
6. The coated cells were washed three times in stabilising
buffer (P.B.O. pH 7*2 containing 2 percent normal human serum) and
allowed to stand overnight at 4°C as a 1 percent cell suspension.
IV. Initial Tost Procedures
HB^Ab was tested by direct haeraagglutination of antigen coated
cells, while HB Ag was tested by an inhibition reaction. Both
reactions were perforrsed in disposable u-bottomed aicr©litre platea
using 25 jal« volumes of reagent. Positive reactions suggestive of
HB Ab were confirmed by (a) retesting with pooled-plcsaa-coated cells
and (b) demonstrating that activity could be inhibited by HB Ag but
o
not normal serum. Positive reactions suggestive of HB Ag were
confirmed by testing the inhibitory effect of specific antibody
compared with normal serum.
V, Sxperlaents to l'cter;:ine the Optimum Conditions for Tanning.
lenaitisation ana Performance of the Test
1. Affect of tannic acid concentration on sensitivity
Different concentrations of freshly prepared tannio acid
(M & B batch no. 06743) In P.B.b. (Appendix A ) pH 7«2 were used to
tan erythrocytes in a 37°0 water bath for 15 minutes. The effect
upon sensitivity c:.* the IL. test is shown in table 2.7.1. At a 1 in
5,000 concentration cell lyais occurred, while a 1 in 50,,00
concentration proved too weak as evidenced by a decline in the ability
to dateot HBgAb. Tannic acid at a concentration of 1 in 10,000
proved optimal. It is suggested that this type of experiment be
84.
repeated for different brands of tannic acid, and indeed each batch,
since experience haa shown that considerable variation exists (the
B.D.II. product was satisfactory at 1 in £,000, while U&RC tannic
acid appeared to bo unsatisfactory at concentration).













2. Effect of ; /,f- concentration (for cell coatinr) on
i;«.. nuruu _t: t. rinr jpa
sensitivity
Partially purified KB Ag was prepared as previouslys
described. The final pellet was resuspended in i/20th its original
volume and serially diluted in PBS pli 6.4. Each dilution was
titrated using latex agglutination (.Pfizer batch no. L13/3) and
C.I.E.O.P, (using antiserum T2160C supplied by Hoechst Ltd.) Each
KB Ag dilution served to sensitise an aliquot of cells, the results
s
of which are given in table 2..V..2. Optimal sensitivity was observed
using the dilution of partially purified antigen containing
128-2i>6 latex units (4-8 O.l.E.Q.P. units} of iii^Ag activity. If
more IS Ag was coated onto the cells autoagglutination ensued, while
3
reduction of KB Ag on the cell surface reduced sensitivity#
a
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1 512 16 auto-
agglutination
2 256 8 20,480 good
4 126 4 20,480 good
8 64 2 5.120 good
16 32 me 1,280 good
32 10 - 40 good
64 8 - - good
128 4 - - good
3. effect of temperature and time of senaitisatlon on
sensitivity
Aliquots of tanned cells were incubated with optimal
concentrations of HB Ag at four different temperatures each for a3
period of one hour. Further aliquots of cells were then sensitised
for Trying times at optimum temperature* fables 2,7oa end ;_.V.3b
present data indicating that sensitisation is most efficient over
o o
the temperature range 20 t~37 0, wiiile at that temperature maximum
lid Ag coating of the cells was obtained after only 60 minutes,s
Longer sensitis&tioa times did not improve sensitivity.
86.























4. Aa&s&j&JBaj&g: otm^ mSL£S£JB&k P.y.lilfl&JBB
aenaltivtty
Four b2 quota of HB^Ag were prepared and adjusted to
contain optimal concentrations of antigen.
(a) HB Ag in normal serum.3
(b) Partially purified HB Ag prepared as just escribed,
(o) Partially purified Hp Ag prepared by polyethylene glycol3
extraction and filtration through Sephadex 0200 (Appendix B )•
(d) Purified KB hg prepared by density gradient centrifugetions
(Appendix C } and normally used for radiolabelling.
KB^Ag from each preparation was used to coat tanned cells.
Coating unpurified HBgAg resulted in autoagglutination of the
sensitised cells (table 2.V.4)possibly due to the excess of protein
resulting from the presence of normal serum. Preparations (b) and
(c) showed optimal sensitisation, while the highly purified HB^Ag
exhibited a much reduced sensitivity. An interesting observation
was that within a few days of aensitisation, cells coated with (c)
and (d) had lost most of their activity, presumably as a result of
KBgAg eluting from the cell surface* suggesting that over-purification
is to be avoided. It may be that a certain amount of non-specific
protein is required to allow a stable attachment between antigen and
cell* exoess leading to autoagglutination.
TabJtft_&*Y.Jn of U3ed for oeL3- senaitisation on
sensitivity











5* Mfect of sensjtiaeo cell concentration on sensitivity
Jensifcised cells were mad© up to different concentretions
in stabilising buffer and used to titrate an JtW^b-positive serum. Table
2.V.5. shows that the 0.75 percent cell suspension combined good
sensitivity with esse of reading. Increasing the cell concentration
reduced sensitivity, while using fewer ceils resulted in poor
readability.












6. Effect of -galrig serum or plasma as teat sample
Two blood samples were taken from each of five accredited
donors (i.e. donors of long standing, where previous donat ons have
not been implicated in posttransfusion hepatitis). One sample
was allowed to clot In order to obtain natural serum, while the
second sample was collected in anticoagulant in order to obtain
plasma. Each serum and plasma sample was then serially diluted
and tested against ooated cells. The results in table 2.V.6 indicate
that even in the absence of HB^Ab the use of plasma could lead to
non-specific false positive reactions. Such reactions were not




iteeipJFOoal of seruVplas"^ dilution




































7. jkffect of jattMlteft ^ygfife-bl^ ^ different anti-
£glffl*3£gfeL5» the suitability ^ **9f senalt^aation
.reah , ;roup *0* rhesus negative blood from the some donor
o
sas collected in lour different anticoagulants, stored at 4 C
overnight, tanned and sensitised with HE Ag« Only blood collected
in lithiuai-heparin ma found to be unsuitable as evidenced by
autoagglutination of the sensitised cells (table 2.V.7).
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blood, In different.aKtl-
of cells for sensitls&tion











A.C.P. a acid citrate dextrose
E.D,r.A» » ethylene diamine tetra acetic acid
&• Variation tunon,; different batches of g^lfi sensitised oella
Serum from 10 different HB Ag carriers (8 adw, 2 ays)
were prepared for cell sensitisation and each preparation used to
sensitise an aliquot of cells from each of three cell donors. The
data in table 2.V.8 suggests that the techniques for HB
S
preparation, cell tanning and sensitisation are sufiiolently
reproducible to be able to produce a standardised reagent. The
prosone type of phenomenon observed with preparation f? remains
unexplained. However, this could be overcome by mixing with ax\y
of the other preparations.
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1 Patient 9gm a + ♦ ¥ + + + + ¥
b ♦ + ♦ ♦ ¥ ♦ + ¥ - -
c ♦ + + + ¥ + + ¥ — «• mm
2 Donor a&w a + + 4- + * ¥ + • -
b + * ♦ + + + ♦ ♦ - mm mm
c ♦ 4- + + ♦ ¥ ♦ 4- «• mm mm
3 Donor a&tv a + + + 4- ♦ *»• ¥ + ¥ -
b ♦ ¥ + ♦ + ♦ ¥ ♦ ♦ ¥
c + + + ♦ + ¥ + ¥ ¥ -
4 Donor edw a + ¥ ¥ ¥ + ¥ + ¥ + "
b ♦ + ■f + + + ¥ ¥ + + -
0 + + + ¥ + + ¥ ¥ + + •»
5 Donor adv a — - — + ♦ + + ¥ + + -
b Wft - t ♦ ¥ + ♦ ¥ 4- ♦ »
c - Mi — + ¥ + + ¥ ¥ ♦ -
6 Donor &dn a *■ 4- + + + + 4- 4- ¥ ¥ -
b ¥ ♦ ♦ ♦ + + ♦ + ¥ + •»'
c + 4> + ♦ ♦ + + + ♦ -
7 Donor ads? a + ¥ + + + ¥ 4- + + *
b + ¥ + ¥ ♦ + ♦ ♦ + -
c 4- + + + + + + ¥ ♦ +
8 Donor adn a + + ♦ ♦ + + + ¥ ¥ ♦ -
b + ♦ ♦ ♦ ♦ ♦ ¥ ¥ ■f- -
c + *• + + ♦ + ♦ ¥ ¥ + -
9 Donor adr; a + ♦ ♦ + ♦ ♦ ¥ ¥ ¥ -
b + ♦ ♦ ♦ ♦ ¥ ¥ ¥ ¥ mm iM
c 4 ♦ + + + ¥ ¥ ¥ ¥ «m mm
10 Donor ads; a + ¥ + + +• ¥ ¥ ¥ ¥ -
b ♦ ¥ ♦ + + ¥ ¥ — —
c +
I
¥ + + + ¥ ¥ ¥ ± ±
♦ s positive agglutination




9. Effect f concentration on ,IAI sensitivity
An HB Ab-positive serum was titrated and the last dilution
to show complete agglutination was considered, to represent 1 HA
unit of H3#Ab activity (i.e. a doubling dilution back would contain
2 HA units of activity etc.) The endpoint of an HB Ag titrations
was etermined us Erg 2, 4, 8 and 16 units of HA activity. Table 2.V.9
indicates that the sensitivity of the inhibition reaction is increased
as the amount of HB^Ab decreases. However, there comes a point
at which the dilution effect of adding test serum and cells results
in premature collapsing of the agglutination pattern leading to
false FflWig positive results.










10. Effect of preincubation time on HAI sensitivity
HB#Ag positive serum was titrated by pre-inoubating with
4 HA units of HBgAb activity at 37°C for varying time intervals
prior to the addition of sensitised cells.Table 2.V.10shows thet
maximum inhibition of ®aAb under these conditions occurs after
30 minutes. Further preincubation did not enhance sensitivity.
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overnight (4 0) 2,000
£#T# « room temperature
11# bffeot of storage (at on sensitivity
Freshly prepared sensitised oells were kept at 4°0 until
oell lysis was apparent (approximately 7#5 weeks)# At intervals
during storage the ceils were titrated against an HB Ab-poaitive
serum. Some cells were brosen in liquid nitrogen in the presence
of dimethyloulpkcxide (BMIQ) to prevent the formation of disruptive
ice crystals# At 4°U the cells retained sensitivity for approxi¬
mately 6 weeks after which rapid deterioration was observed due to
cell lysis caused by ageing (Fig.VLV. «i). Storage in liquid nitrogen
proved unsuitable as approximately 80 percent of the cells showed
lysis during subsequent washing to remove BMSO.
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6 7 8 9 To
VI* yioaX (Detailed) Procedure for Preparation of llB^'.r-sensitiaftd
Human irythrocvtoa
In the light of data obtained from the preoeding experiments,
the following procedure was adopted for preparation of HB Ag, tanning
and sensitisation of cells.
1. Preparation of
HBgAg waa obtained by bleeding a oarrier into a dxy bottle
and allowing the blood to clot. HB Ag-positive aerum was
•tr 0
recovered and treated withbetapropiolactoneand ultra-violet light
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(Appendix D ) according to the method of ho Grippo and Hartmen
(1958) end ho Grippe (", 973). The treated serum was then spun at
120,000 g. (av) far 5 hours on an H.3.B, iuperapeed 75 centrifuge
using an 8 x 25 al« titanium angle head rotor. The resultant
pellet was reauspended overnight in 2 als. physiological saline
followed by gentle mixing with a pasteur pipette before being
transferred to a new centrifuge tube and mace up to 16 mis. with
saline. The suspension vras then re-pelleted as before and the
seoond pellet resuapended in 0.5 mis. HSB pli 6.4. The concentration
of HB#Ag was then adjusted to 128-256 latex units by addition of
PBS pH 6.4, whereupon the preparation was heated to 60°C for
0
JO minutes, then divided into 0.5 ml. aliquota and stored at -20 C
until required.
2. Tannin." - nd semitisatlon
Human group 0 rhesus negative venous blood was collected in
A.C.D. and allowed to stand overnight at 4°C. The fallowing day
3 mis. were washed three times in 12 mis. of sterile physiological
saline (M.S.I. :'inor bench centrifuge no. 3 for 5 minutes.) 0.08 mis.
of packed, washed cells were rssuspended in 1.25 mla, PBS pH 7.2
( 6.6 percent cell suspension) and incubated with an equal volume of
freshly prepared 1 in 10,000 tannic acid (M efe B batch no, 06743)
0
prepared in the sasse buffer, The mixture was incubated in a 37 C
waterbath for 15 minutes, shaking gently every few minutes to ensure
thorough mixing. The tanned cells were (M.S.K. Minor
bench centrifuge no. 3 for 1 minute) and washed once in 2.5 als. PBS
pH 6.4 before being reauspended in 2 ids. IBS pH 6.4 (i.e. 4 percent
cell suspension). C.3 nla. prepared HDflAg was added to the tanned
cells (i.e. 4 volurr.es cells: 1 volume HB#Ag) and the sensitising
mixture incubated for 60 minutes at room temperature (approximately
o x
22 t) using either a Luckham rotostat or a Mattturn mixer to ensure
thorough mixing. The sensitised cells were washed three times in
3 mis. of cell diluent (PBS pli 7.2 containing 2 percent normal
human serum), made up to a 1 percent cell suspension and left at
o
4 C overnight. Next morning, the supernatant was replaced with
fresh oell diluent nd the cells stored at 4°C until required.
Photograph 2..*'lib Ag absorbed onto the surface of a red cell.
'■> •
Cells from the same source were sensitised with a 1 in 123 dilution
of pooled human plasma and used as 'control' reagents.
VII. Pinal Test rocedure
Tests were performed in disposable u-bottoraed mlcrofcitre
plates (Flow Laboratories) into which reagents wei'e added in 23 ul.
volumes using a pasteur pipette. Serum specimens were diluted to
1 in 10 in 33 pH 7.2 prior to testing.
(a) hireat haanwwrlntlimtion fat for MB Ab
25 jtfl. of test serum dilution (1 in 10) was pipetted into
a well end 25 jul. of 0.75 percent HBgAg-sensitiaed cells added.
Each plate contained a positive control (antiserum + sensitised cells)
and a negative oontrol (normal serum + sensitised cells). The plate
was gently shaken to ensure thorough mixing and incubated for
#0 minutes in a 37°C incubator. The presence of detectable HB^Ab
was characterised by a smooth matt of agglutinated cells covering
the bottom of the oell, while a compact button of oells indicated
that no KB Ab coul be detected (photograph 2.-^h4). i ositive
3
reactions were confirmed by reteating with pla3ma-sensitisec 'control*
cells, and by showing that uctivity could be inhibited by hBgAg





Photograph 2.VI.1. HB Ag adsorbed onto the surface of tanned3
human erythrocyte. Mag. »s5£,Ooe>
Photograph 2.VII.V Haoeagglutination settling patterns in
u-bottamed wells.
5>a.
( b) Haeina,<glutination-inhibition test for HB Ag
0
An HBsAb~positive serum was serially diluted in PBS
pH 7.2 containing 10 percent normal human serum and the end-point
(i.e. the lowest concentration producing oomplete agglutination)
determined. This was defined as one haemagglutinating unit
(1 HA unit). To test for HB Ag, 25 ul.of test serum dilutionS '
were mixed with 25 pi. of HBaAb containing 4 HA units of activity
for 30 minutes at 37°C. 25 pi. of HBgAg-sensitised cells were
then added and after gentle mixing, the plate was re-incubated for
a further 60 minutes. HB Ag in the test sample would neutralise the
3
4 HA units of antibody activity and cause the sensitised cells to
fall as a negative button. Absence of HB Ag in the test serums
would leave the agglutinating ability of the 4 HA units intact,
leading to a positive agglutination pattern. A positive control
(antiserum + HB Ag + sensitised cells) and a negative control
(antiserum + normal serum + sensitised cells) were included in each
plate. Positive reactions were confirmed by demonstrating the
ability of the sample to reduce the titre of HB Ab as compared with£»
normal serum.
VIII. Sensitivity of iiA and HAI
The ability of the inhibition reaction to detect HB Ag (pools
of subtypes adw/ayw) was compared with I.D., C.I.E.O.P. (Hopkins
and Das, 1972), latex agglutination (Leach and Buck, 1971)» using
two commercial reagents (Pfizer Limited: Hoechst Limited), l.E.M.
(Kelen et al.» l97l)» BIA-SP (Ausria-l) using reagents from
Abbott Laboratories Limited (Kent) and EIA-DA based on the test
described by Lander et al. (1971) and performed by the Virus
Diagnostic Laboratory at Edinburgh University Medioal School.
The sensitivity of the direot haemagglutination test for
HB Ab was assessed by conqparing the *end-point titre' of a knownS
positive serum as determined by HA and C.I.E.Q.P.
Figure 2.VUI.a indicates that HAI exhibits a degree of
sensitivity similar to both H1A techniques, being more sensitive
than I.D., C.I,E,Q.?„ latex agglutination and I.E.M. The direot
HA test is capable of deteoting very low levels of HB3Ab oonpared
with C.I.E.Q.P. (figure 2,VIII.b).
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DIRECT HAEMAGGLUTI NAT I ON
IX. Specificity of iiAl and HA
The specificity of HAl was tested by coding HB Ag-poaitives
and HB Ag-negative sera and distributing them randomly among the test
sera.
Figure 2.IX.a shows the results obtained when HB^ g-positive
sera were coded, mixed with HBQAg-negative sera and tested by a
variety of techniques. HAl detected all positive samples as did
G.laE,0«P. and BlAt and gave no false positive reactions, while one
batch of latex, I.D# and 1«E.H* failed to detect several of the
positive sera, and latex reagents from both commercial sources gave
false positive reaotions.
10*..
Table 2.1£.b confirna the specificity of HA and HAI by shoeing
complete agreement with C.I.E.Q.P# when sera from selected blood
donors and dialysis patients were tested for antigen and antibody.
In two patients, low levels of antibody capable of agglutinating
HB^Ag-sensitised cells were in fact due to reactions against serum
protein(a) as dernonatrated by the agglutination of plasma-sensitised
cells. This antibody did not inhibit the reactivity of HB#Ag,
Figure 2.IX,a. Results obtained when HB Ag-posltive and HBo/>g-negative
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The agglutination of particulate antigen by ita specific
antibody ia probably the simplest way of estimating the quantity of
that antibody in serum. Some soluble antigens can be coated onto
inert materials whioh then react as if they themselves possessed
the specificity of the antigen. &ed blood cells are convenient
passive carriers of antigens since it is possible to coat almost aiy
antigen onto their complex surface, thus providing a sensitive
indicator of speoific antibody aotivity. Correctly sensitised
cells lend themselves to the observation of settling patterns, e.g.
in the wells of perspex trays or in glass tubes.
Many antigens may be effectively coated onto red cells merely
by exposing the cells to antigen for a period of time, but
sensitivity of the resultant cell is greatly improved if their
agglutinability has been increased by previous tanning (Boyden,
1951)• To avoid difficulties due to the presence in the test sera
of heterophile agglutinins, it is sensible to use homologous species
cells wherever possible. The haemagglutination test described in this
thesis was designed to test human serum for KB Ab and H3 Ag, and3 3
therefore uses human group 0 rhesus negative erythrocytes, partly
beoause they are easily obtainable, but mainly because there is
little chance of a test serum possessing antibocty to either the blood
group or rhesus determinants.
There is, of course, the possibility that if antigen coated
cells are kell positive, the presence of anti-kell in the test serum
could lead to haemagglutination in the absence of an HB Ag-HBAbs s
reaction. This possibility is, however, remote 3ince a saline-
reacting anti-kell is uncommon and tannic acid treatment would tend
to reduce such activity by altering the cell surface. The use of
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fixed cells would further reduce the likelihood of suoh misleading
reactions. It is also unlikely that antibodies to the HL-A system
would lead to misinterpretation in hepatitis B testing since suoh
antibodies, even if present are not haemagglutinating.
It i3 generally assumed that tannic acid acts upon ceils in
such a way as to cause them to take up protein antigens. However,
this may not be its main function since cells will adsorb antigen
and become agglutinablo without the aid of tannic aoid (Hirata and
Stashak, 1965, Sindo and Wakakura, 1952) though the sensitivity of
such preparations is usually low. The quantity of protein antigen
attached to the cell increases after tannic acid treatment (Shioiri,
1964) but its chief function appears to be to increase the instability
of the cells so making a normally non-agglutinating reaction reault in
agglutination. In this respect, the role of tannic acid may be
analogous to that of some enzymes, for it has been observed that the
red blood cells of some cold-blooded animals may absorb bacterial
antigens but are not agglutinated by the homologous antibody unless they
have been altered in some way by the action of proteolytic enzymes
(heter, Cohen, westphal and LUaerita, 1959) • Unce treated with tannic
acid at the right concentration, red cells will show agglutination
settling patterns. This tendency to a6glutinate may be balanced by
adding normal serum as a stabiliser (Atkin, 1909) so that it is just
cancelled out. The coated cells are thus in a very sensitive state
ready to agglutinate in the presence of a very small amount of antibody,
hence the great sensitivity of the test. The greater the concentration
of tannic aoid used, the greater the agglutinability of the cells.
However, they must not be made so agglutinable that they cannot be
stabilised. Some batches of cells may be abnormally sensitive to the
action of tannic acid, and to avoid uutoagglutination or cell lysis,
105.
it is advisable to cariy out tests using different concentrations of
tannic acid for each 'source' of cells. Tanning is usually carried
out at 37°C (&eorge and Vaughan, ; Stavitsky, 1954) but appears
to be effective in the cold (Shioiri, 1964) or at room temperature
(hoyden and Sorkin, 1555). -A period of approximately 15 minutes is
considered sufficient for the reaction. There is evidence that it
is completed very rapidly, increased time of exposure having little
effect on the sensitivity of the cells produced (Herbert, 19&7).
After tanning a single wash was found sifficient to remove excess
reagent.
In order to successfully ooat HB Ag onto tanned human red cells,
it was necessary to adhere closely to predetermined criteria relating
to antigen concentration and degree of purity. Of particular interest
was the finding that optimal coating required partially purified
(pelleted, washed) KB Ag. The autoagglutination observed when neat
KB Ag-containing 3erum was used probably reflects the influence of
excess non-speoific protein. At the other extreme, the poor
sensitivity and rapid deterioration in activity of cells coated with
highly purified HB Ag suggests that a certain amount of noxi-specifios
protein is required to facilitate and stabilise the adsorption of
HB Ag onto the tanned red cell surface,
s
The apparent absence of marked variation among different
sensitised ceil batches avoids dependence upon a select group of
red cell donors and reflects the inherent stability of the technique.
As is the case with mai.y haemagglutinution tests, serum as opposed
to plasjaa is the preferred test material. In this particular
teohnique, blood collected in anticoagulent may be converted to a
useable serum by the addition of commercial bovine thrombin, while
serum prepared by recalcification invariably leads to autoagglutination
of the HBgAg-coated cells.
The relatively high sensitivity of the HA and HaI tests should
improve efficiency of lib Ab and HB Ag uetectability and lead to a3 3
greater economy of specifio antiserum for antigen testing. Despite
the inherent specificity of an inhibition reaction, experience in a
variety of other biological systems, including hormone estimation
where the tanned cell haemagglutination system has been used
extensively, has shown that non-specific inhibition can occur despite
the use of speoifio antibody (otavit3ky ana ingrtham, 1964). However,
the speoificity of the present HAI test seems to be acceptable
It is probable that a proportion of the normal, apparently
healti^r population may show positive reactions with HB Ag-coateds
cells due to low levels of antibody directed against or cross-reacting
with plasma proteins. Brumelhuis (1971» personal communication) found
13 suoh reactions in 30,000 samples tested by the Netherlands aed Cross
Transfusion Service U3ing I.D# Multi-transfused patients are likely
to produce such reactions due to the development of iso-precipitins
(Blumberg, 1964* Bangenhyysen, 1971). The use of highly purified
JiB Ag for ceil coating may overcome this problem, but as has alreadys
been shown, this i3 not practicable. Therefore, sere, showing
agglutination with HBQAg-coated cells should be retested against 'control'
cells coated with pooled human plasma, when a specific HB Ab will shows
no agglutination.
Antigen may also be attached to red cells by means of a chemical
bond. Jandl and Bimmons (.1937) reported a method of coupling protein*
to red ceils by the use of metallic cations. Thqy found the most
useful of them to be chromium. Vya3 and Shulman (1976) adopted this
principle to couple HB Ag to red cells using chromic chloride. Thes
logisti03 of application of this teehnique for large scale testing
are not practicable due to the high degree of purity of HB Ag required
(Vyas et ai.. 1972) and the great variability observed between different
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batches of cells (feesink and Buimiel, 1^/3). Furthermore, it is
aesirable to use treated ^inactivated V) for coating cells
which will subsequently be used as a routine test reagent. In our
experience, the outcome of coupling betaprone-ultra-violet light-
irradiated lib Ag to human erythrocytes by chromic chloride has proved
s
unreliable.
It is hoped that the tanned cell iiVHAX teohnique described
will be a step toward fulfilling the current HB Ag/HB Ab testing
3 S
requirements of the Blood Transfusion Service.
PART T H it L Is
RQEIPlCAi'IuKS ui* BASIC TEST
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SUBTYPJNG 'Y Ml
I. Introduction
'he foregoing h- 3 resulted in n simple, efficient and economic
teat for H3 tg and IIB Ab, 'capita the apparent specificity of theQ &
inhibition principle, it is of utmost importance to obtain
confirmatory data on any sample giving n HB Ag positive result.
One could recommend thst a sample be shown to be positive by at least
one other techni .ue. duch a principle raa., have beer acceptable when
the co monly used tests ..ere 1.0. and C.I.1,0,?. where it was a
relatively simple matter to show identity with known positive
controls (Das at nl., vith 'third generation' methodology,
however, a situation my arise whore a sample is positive only by
HAI, JiFHA or RIA, the latter two being particularly prone to false
positive reactions. In such circumstances, the ability to identify a
positively reacting aample as belonging to one of the established
subtypes would provide valuable confirmatory information.
11• Preparation of Monospecific Antiaera
A number of IDs Ab positive sera were tested by C.l.A.O.P. against
3
HB Ag previously subtyped by Dr. (r.L. be Bouvier (Yale University,
s
U.B.A.) One antiserum reacted only with HbsAg possessing the *d*
antigenic determinant, suggesting the presence of anti-d (and
presumably anti-aj in the antibody positive senna. nti-a and anti-w
were neutralised by concentrating the antiserum five times with
lyphogel (GelmanJ and incubating, with different concentrations of
Q
HB Ag (ay; at room temperature lor one hour followed by 1 C ovemi ht.s $
»iost of the resulting im une complex was removed by centrifugation at
2U,00U r.p.m. (Sorval lit 2h) for one hour. The supernatant was tested
< noI V-V *
for the presence of anti-ci by direct haetaagglutination using H3 Ag
(ad) coated cells (figure 3»1*U.a). The absence of anti-ay activity
was demonstrated by the absence of agglutination of KB Ag (ay)
coated cells (table 3»1«Il,b).
A'lgure 3.1 .JU.*. . fligation of (anti-d) following adsprgtion
.gpn^Rtotiftfts sLM1££~jJ&Li
.• bonfinaatlon of monospecific KB/b (aaU-d) following








+ agglutination - no agglutination
Anti-y was prepared in the sam way by adsorbing KB ab (anti-ay;
with Hi Ag (ad).
3
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,„ftr typing Hb/fi ^Determinants d and y
rionospeeiflc antibody was used in conjunction with cells coated
with the appropriate H2j Ag subtype. For example, anti-d was used
in conjunction with iLWig (ad) coated cells. Absence oi
a gglutination we.3 indicative of 'a' in the test sample, while the
presence of agglutination suggested that the unti-d had not been
neutralised and the teat sample did not, therefore, possess the d
determinant. as d and y are mutually exclusive, oonfiraation was
obtained by using anti-y and HB Ag (ay) coated cells to test for the
y determinant, which if present, neutralised ohe anti-y and caused
the HB Ag (ay) coated colls not to b© agglutinated*
The reliability of sub typing by IIAI was investigated by typing
HBgAg positive sera from the following different sources; (i)
National Institutes of Health, Bethesda, 'J.2.A., (ii) American ..ed
Cross and (iii) hoc .1 (bluou donor) carriers, and putients involved
in the dialyais-asaooiatod hepatitis outbreak in Edinburgh in
1369. Sera from (i) and (ii) hud been subtyped at source by I.D.,
while sera from (ill) had seen subtyped by Dr. d.L. Le Heavier
(Yale JaiversiV* Connecticut, U.C.a.), also using I.D, All sera
were double-cocod aid interspersed with negative sera prior to
subtyping.
IV. kesultg
Complete agreement was found between the subtyping data
obtamed by HAl and l.D. (t ible3.1.XV").
111.
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At the time of writing, most HB Ag subtyping is perfoz-raed by
l.b. or C.i.E.O,P. Unfortunately, both techniques are wasteful of
precious monospecific typing antiaera and are relatively insensitive,
being unable to subtype sera found positive onxy by the more sensitive
tests such as HFHA, IUA and HAI,
application of ISitl to HB Ag subtyping permits rapid (within
o
2 hours) identification of the d and y determinants, with a
sensitivity similar to that of other 'third generation' tests, and
therefore provides essential conlirraatozy information relatively
quickly.
11£«
The discovery of at least two mutually exclusive but relatively
common determinants of the HB Ag system clearly implies thats
techniques and reagents used for blood donor testing should be
capable of detecting both subtypes with more or less equal sensitivity,
bubtyping of HB Ag and HB ab provides an important epi-8 8
demeological tool to probe the relationship between subtype and
disease*
By adopting the same approach used for d/y subtyping, the
Hal test has been applied successfully to the w/r system. Further¬
more, the Hal test may be used to subtype HB Ab by using HB Agio S
positive sera of known subtype*
CHAPTER 2
PfiEPAr-ATCOH OF HB Ag-COATED, (rLUlH&ALtEHYDI-FIXED3
SFHEROCYTBS
1. Introduction
Since the shelf life of fresh HB Ag-coated erythrocytes is
only four to six weeks routine bloou donor testing (for example, ^00
tests per day) would necessitate reagent preparation at least once
per month. The interval between preparation of subsequent batches
of reagent could be increased if fixed erythrocytes were used,
furthermore, if large scale production were possible, reagent
standardisation would also be Improved.
Fixation of erythrocytes renders them mechanically more robust
as evidenced by the absence of lysis in distilled water, and by an
increased shell life. has (1y/Q) reported that the storage xife of
fibrino;-en-coated sheep erythrocytes was extended from one month to
more than five months as a result of prior fixation in formaldehyde,
in the same year, Hoc and Das (1970) published details of a study
concerning the preparation of human erythrocytes for the assay of
human serum fibrinogen degradation products. Part of this study
involved a comparison of formaldehyde, pyruvic aldehyde and gluter-
aldehyde as ceil fixatives. Results indicated a high incidence of
autoagglutination a:xong formaldehyde and pyruvic aldehyce-iixed cell
batches, while none of seventeen batches of glutersldehyde-fixed
cells were so affected.
It seemed logical, therefore, to investigate the use of gluter-
aldehyde for the fixation of human group 0 rhesus negative erythrocytes
prior to tannin/: nnd coating with HB Ag. Uniortunately, three out
of five cell batches fixed in gluteraldehyue according to the method
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of Hoq and Ea3 C1970) and subsequently tanned end sensitised with
HB#Ag resulted in autoagglutination. Such a high incidence of
unusable reagent was clearly unacceptable. Tanning and sensitisation
of 'fresh' cell batches seldom resulted in autoagglutination, so it
was decided to modify the method of glutftralaeixyde fixation oy
using only as much ilxative as would provide an acceptably robust
cell.
as stendaruisation of reagents should theoretically be enhanoed
by a high degree oi cell uniformity it was also decided to introduce
a form of 'selection1 oy weaning the fresh arythrocytes in a
controlled qypstonic medium to 'select' the more roouat among then.
!!(«)• Reparation g| Spherocvtea
One unit (approximately 450 ml.) of human group 0 rhesua
negative blood not more than three weeks old and collected in anti¬
coagulant (citrate phosphate dextrose) was obtained from the blood
bank.
The molarity of phosphate buffer pH 7.2(Appendix E ) required
for selection of the appropriate cells was determined by aerially
diluting isotonic (0.2M) buffer In deionised water. 0.1 ml. of fresh,
well-mixed blood was added to 2 ml. of each dilution of buffer in a
test tube. The cells were evenly suspended and allowed to stand at
room temperature for 60 minutes. The suspension showing at least
50 percent haemolysis was arbitrarily considered optimum. This
usually occurred within the range 0.045^ to O.OjSOM but was determined
for each unit of blood being spherocyted. The remainder of the
blood unit was then nixed with the optimum hypotonic concentration of
buffer in the ratio one volume of blood to four volumes of hypotonic
buffer. The bulk volume was divided into 2cG ml. aliquots for ease
of handling. Al ter 60 rainutea at room temperature the aliauota
were centrifuged at 1500 r.p.m, for 15 minutes at 10°C on an M.S.!.. 6L
centrifuge and the supernatant (showing considerable haemalysls)
was replaced with -resh buffer. This prooedure was repeated until
onlp a minimum of i-.^eaoClysis could be observed. At this point the
remaining ceils accounted for approximately half of those originally
present. These erythrocytes were considered to be uniform since
they represented the most robust of the original cell population,
bet film micro.soupy showed them to have lost their characteristic
biconcave appearance aid become r .unded or 'apherocyted*. They
were thus subsc .outly referred to as spherocytes.
11(b). fixation of Soherocvtes
One aliquot of spherocytes was oivided into smaller quantities
(approximately 25 nil,) to each of which glutqroldehyde (Koch-bight ,
25 percent) was aoded to give the following gluteraldebyde
concentrations: 1 in 100, 1 in 200, 1 in 400, t in 000, 1 in 1600,
1 in 3200 and 1 in 6qG0. After thorough mixing the spherocyte
aliquots containing fixative were left at room temperature overnight.
The following morning spherocytea from each aliquot were examined
microscopically and subjected to a 'water resistance* test which
involved adding 25 Jul. of 'settled' gluteraluehyue-treated spherocytes
to 2 ml. deionised water, when properly fixed spherocytes resisted
haemolysis. illations of glutoraldehyde up to 1 in 1600 produced
acceptable fixation, although dilutions up to 1 in 400 tended to
distort the shape of the apherocytes, causing them to revert to
biconcave discs.
The remaining aliquots of fresh spherocytes were fixed in the
appropriate concentration of giutoruldehyde (approximately 0.02 per cent)
no.
O
as above and stox-ed at 4 C in a total volume of 200 ml. in deionised
water containing 0,1 percent sodium aside.
III. Tanning and densitisation of G-lutcraldelivde-fixed Suheruc.vtea
The procedure was exactly that used for fre3h cells, except
that the concentration of tannic acid was halved.
IV. Performance and Storage of HB^Ag-coated. Gluteraldehyde-fixed
Spherocvtes
Two batches of gluturaldehyde-fixea spherocytes were each
divided into five aliquois and coated with HBAg ^adyw) as previouslys
described. After stabilisation, the sensitivity of the sensitised
fixed spherocytes was oeterrained by titration of a standard KB Ab
positive control. 'This titration was repeated at approximately
one month intervals for one year, during which time eaoh of the ten
o
aliquots was stored at 4 C.
Table 3.2.IV.a shows that spherocyting and subsequent fixation
in weak gluteraldehyde solution has no adverse effect on HB^Ag coating.
Furthermore, table 3»2.IV.b shows that glutcraldehyde-fixed HB Ag~s
o
coated spherocytes may be stored at 4 C for up to one year without
appreciable loss of sensitivity.
Table 3.2. Coi.r-r.rg4J.ve sensitivl t/.r ;f coated fresh human
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Table 5.2.IV.b. storage life (at, 4°Uy of coated fresh
nu,~<. ^r-Vthruatea and ooatea KiutAraidehi, ue fixed
sphcro^ytes
tic ag coated
3oells Time (in months)
fresh erythrocytes
fixed spherocyfces
012 } 4 5 M M 10 11 12
+ + - (lysis)
+ + * + ♦ ♦ + + + + ♦ + +
+ denotes acceptable sensitivity
V. Discussion
Gluteraldelyde-fixed spherocytes prepared from reasonably
uniform human group 0 rhesus negative erythrocytes appear to be
stable carriers of Hb Ag that proviae a sensitive indicator of'
specific antibody. Osmosis provides a useful means of selecting
those ceLla most suited to fixation and subsequent HP Ag coating.
The desired level of osmotic effect will vary somewhat according to
the particular sample of erythrocytes being treated, out a medium
having an osmolality between 100 anmol. and 200 m.uoi, should be
suitable. Thus is conveniently proauced in an aqueous solution of
sodium and potassium phosphate with a molarity between G.O/d and
G.1£i*. Under such conditions, the less physically rooust eexls will
undergo haemolysis while the more physically robust are conversed
to spherocytes. t.iiile considerable variation is possible, a
recovery of spherocytos of she order of 20 percent to pO percent of
the original erythrocyte population is preferable. A plurality of
treatments may be required to obtain a suitable level of spherocyte
conversion, the numuer of treatments depending to some exteiit upon
the ratio of erythrocytes to medium. Using the 1 to a ratio
previously descrxoed, it is usual to perform at least four treatments.
Fixation of spherocytes may oe posaiole with afcenta such as
alcohol or acetic acid. However, the class of fixatives
comprising tne aluelyuoa were of general interest un this project,
and in particular t.ioso derived irou uiourboxy lie ueios \£oi- example,
glutoralueiyue). a suitable aonoentration of giutbialdelyue,
luouxng to fixation -si 1- to 71 noura, was between t.ob percent to
o.ob percent of „ac ysock. solution (kooh bight , portent). The
o
resultant fixed spherocytes were conveniently stored at g. u in
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deionised water containing an antibacterial agent (0.1 percent
sodiua aside) until required for coating with HB Ag.
The finding that glutnraldetyde-fixed s-heroqytea may be stably
coated with opened the way for large acule preparation of a
highly standardised HBaAg "Cea'b reagent, particularly as the teat




MIKLTURISATIOK OF TEST PR0CKDU6E
I* Introduction
In its present form the HAI test for HB Ag is simple to set
up and to read. Its reliability is such that it may he used with
confidence for large scale blood donor testing. The South-East of
Scotland uegional Transfusion Centre (at Edinburgh Royal Infirmary)
currently testa about 5»COO blood donations per month for HRgAb and
HB Ag. This is equivalent in terns of reagent usage to 10,000 tests
per month. The monthly requirement of HB Ag-coated, glutqraldehyde-s
fixed spherocytes equals 10,000 x 23 J»l. = 230,000 pi. or 250 mla.
of working suspension (0.75 percent). If 50 mis. of neat HB Af
positive serum yields approximately 3 ml. of Ha Ag suitable for
spherooyte coating, and 0,5 mis. of such an HB Ag preparation results£
in sufficient coated spherocytes for 400 tests (therefore 50 mis.
neat HB Ag positive serum provides 2,400 tests), then 10,000 tests
3
would require x 50 = 200 ml. HB Ag positive serum to be
i , 4Uv 3
processed. For the purpose of reagent standardisation, It is
advisaole to prepare larger quantities of reagent, say sufficient
for one million tests, and correspondingly more HB Ag positive
plasma would require to be processed. One million tests would
1.000,000
necessitate the processing of *,f, * 200 = 20 litres of
strongly HB Ag positive serum, clearly a mammoth undertaking for any
Regional Blood Transfusion laboratory quite apart from the hasards
involved in the handling of so much potentially dangerous material.
Clearly, there is a case for investigating the possibility of a
more economic usage of reagents. It is the purpose of this chapter
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to investigate the possibility of reducing the volume and concentration
of reagents required for lib Ag testing by HaI.5
II. Materials. Methods and results
lerasaki microteat tissue culture traya ^bio-cult) are
admirably suited for use in a miniturised version of the liAX test.
Each tray i&eaaures 52 rata, by !j7 ma. and contains 60 x 1£> jsl. wells
which have a bevelled side and a flat base. Diagram j>,II.a shows
the cross-sectional view of a leraseki tray as compared to a 'IT* bottomed
miorolitre plate.
Dia-raa j.j.11.a. lie,tramatio comparison of ^erasaxi tray well and
microlitre plate (u-bottomed) well
Terasaki Tray well.
U-bottomed Microtitre plate well
1,2
Test procedure is essentially the same as previously described
for the 'u' bottomed rsicrolitre plate except that 5 )*1. volumes of
reagents are added using an Eppendorf 5 ul. pipette with disposable
tip. durang incubation minutes at i7°t) the cells settle to
form a continuous circle around the periphery of the base of the
well, at whu.ch poixxt ositive and negative agglutination patterns are
indistinguishable. ihe tray is tilted, carefully to avoid undue
vibration, to an angle of 40 and left for approximately 1£» minutes,
in those wells where no agglutination has occurred, the cells
gradually slide down the sides of the bottom of the well, while in
those wells where agglutination is present, they remain as a complete
circle of agglutination around the base of the well I,diagram
Diagram j«>.il.b. Qe-1 settlixxg oatUrns in uerasaki tray a
I I
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The distinction between positive and negative may be enhanced
by centrifuging the plates (Griffin George bench centrifuge with
serological head, 60 seconds at No# 2 setting) prior to placing them
at an angle.
Further economies are possible if the concentration of
sensitised cells is reduced. The optimum cell concentration for
use in the miniturised (Terasaki trap) system was found by titrating
an HBgAb positive serum using different concentrations of sensitised
cells. The results shown in table 3.3»ll«c. indicate that a
0.25 percent cell suspension provides the moat acceptable results
in terms of sensitivity and ease of reading.
Table 3.5.11.c. Effect of itbpng coated spherocjte concentration, on


























As a test vehicle the Terasaki tray allows a reduction in the
volume of each x-eagent from 25 ul to 5 ul. This is an important
eoonooy not only in terms of HB Ag-coatea gluteralaehyde-fixeds
spherocytes out also of test serum which may not be readily available
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in the quantities necessary for confirmatory ana/or subtyping teats
using other techniques. deduction in volume combined with the use
of only a 0*25 percent spherocyte suspension leads to an overall
aoonomy of the order of fifteen-fold. In practical terms, this
means that if, as has already been stated, 20 litres of neat Hb Ags
positive serum requires processing to provide sufficient reagents for
one million tests by the raiorolitre plate method, the same number of
tests could be performed by the miniturised (ferasoki tray) method
as a result of processing only ~ =1,3 litres of neat serum.
Logistics such as these place bulk reagent preparation easily within
the capability at many Blood Transfusion Laboratories.
Economics of this magnitude cure seldom achieved without
eacrifioe, and in this instance the robustness of the test appears to
suffer. The miniturised method is particularly vulnerable to
/ o
rough handling and/or vibration once it has been plaoed at the 40
angle. Fortunately, this problem is easily overcome by using
an angled shelf bracketed to a solid vibration-free wall (diagr. 3.3.ill).
This arrangement also has the advantage of introducing a degree of
uniformity to each test since the angle is kept constant. If the
angle is much greater than 40° agglutinated oelle will oollapse
prematurely, while a smaller angle will cause slower cell settling.
It was also found that a 1 in 5 dilution of test serum could
be used.
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Mafiraa Jr'u ;.,l~aoqntyi shelf tytyy y?t9§





(cells remain as circle)
Solid wall
Negative agglutination
(cells slide to lower




BULK PREPARATION OF KBfiAg-COATEB, 0LUTfiB/Li EHYRE-FIAED
SPHEROCraSS
I. Introduction
Large-scale preparation and storage of a reagent used for
serological testing is very important for standardisation and eoonosy,
particularly if that reagent is sufficiently stable to survive
transportation to and subsequent storage in other laboratories.
Unfortunately, the highly sensitive *third generation' HBgAg test
reagents are only available to the majority of Blood Transfusion
Centres on a commercial basis, the oost ranging from 10 nee pence per
test (Hepatest- R.P.H.A., Wellcome Reagents, if bought in bulk) to
50 new penoe per test or more, apparently depending upon geographical
looation (Ausria-i1, R1A Abbott Laboratories). Experimental data
suggest that HBsAg-coated, glutaralaehyde-fixed spherocytes are a
stable, sensitive and specific reagent well suited to testing large
numbers of blood donors.
This chapter describes the bulk preparation of HBgAg-coated,
gluteraldehyde-flxed spherocytes in a quantity sufficient for approxi¬
mately one million tests (if the mlnl&urlsed test system is employed).
II. Tannine. 3enaitiaatlon and Stabilisation of Sufficient Reagent
for una Million Tests
Sixteen mis. of paoked glutamldehyde-fixed spherooytes were
washed twioe with 500 ml. volumes of physiological saline (MRC bottle
spun at 1,000 r.p.m. for 5 minutes on MSE 6L centrifuge at room
temperature). The cells were reauspended in 500 ml. of tannio acid
(M. & B., 1 in 60,000 dilution in PBS pH 7.2 previously heated to 37°C)
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and left in a 37°C waterbath for 15 minutes with occasional mixing.
The tanned cells were spun down as before, washed twice with 500 ml.
PBS pH 6.4 and finally reauspended in 400 ml. of the same buffer.
Twenty ml. KB Ag, prepared as previously described and containing
both the 'd' and *y* determinants, was added and the spherocyte-
antigen suspension mixed continuously at room temperature (see
discussion). After 20 hours, a 1 ml. aliquot was removed, stabilised
(as previously described) and used to titrate a known standard
HB^/b-containing serum. Sampling was repeated at approximately
20 hour intervals until a satisfactory sensitivity was achieved,
when the bulk of the reagent was removed from the mixer and the
spheroeytes recovered by centrifugation as before. The sensitised
spherocytcs were then stabilised by resuspension and mixing for
4 hours at room temperature in 500 ml. PBS pH 7.2 containing 2 percent
normal human serum to give a cell suspension of approximately
3.0 percent (or ten times working concentration). Storage of these
o
cells overnight at 4 0 was followed by a repitition of the stabilising
procedure. Thereafter, the 3.0 percent suspension was dispersed
o
into 50 ml. aliquot3 and stored at 4 C until required, when each
aliquot (or part thereof) could be diluted ten-fold with BBS pH 7*2
containing 2 percent normal human serum to achieve working
concentration.
fiiacussioa
The ability to prepare a large batch of stable KB^Ag test
reagents in a Blood Transfusion Centre provides the basis for
uniformity of donor KB Ag testing and represents a considerable
saving in both cash (one million Hepatests = £60,000, while one
million AUSkIA - II ■ £500,000) and time, and allows third generation
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testing efficiency to be made available at a fraction of the cost of
purchasing commercial reagents.
Bulk preparation seems to result in reagents which are ©very
bit as sensitive and stable as those produced in much smaller
'experimental* quantities, since transportation over thousands of
miles via air freight appears to have no adverse effect even when
oells are maintained in the liquid state.
If sampling of the sensitising mixture suggests that a
satisfactory sensitivity is not being aohieved, it is possible to
add more H3#Ag. However, care must be taken in this respect sinoe
an exoess of antigen will lead to autoagglutination, presumably
resulting from overcoating of the fixed spheroeytes. It is well
to bear In mind that stabilisation of 'samples* requires overnight
at 4°C, during which time the bulk reagent is still sensitising.
Experience of bulk reagent preparation suggests that sensitivity
plateaus after about 48 hours if no further HB#Ag is added.
An interesting observation was that cell sensitisation proved
successful when mixing with a mechanical turntable, but unsuccessful
when mixing with a magnetic stirrer and plastic-coated follower.
Adsorbtion of HBgAg onto the follower has been eliminated, but the
eleotroohemioal or eleotrophysioal possibilities for such a failure
have yet to be investigated.
Addefid^a
The work reported in this chapter and in chapter 2 (lla and
lib) was undertaken in collaboration with hr. A.D. Watt (Chief
Technician, Microbiology Unit, Blood Transfusion Service, Royal
Infirmary, Edinburgh) and has been included in this thesis to





Reagents used routinely should be made as safe as possible
for the proteotlon of staff members who are in daily contact with
them. This is particularly important when a known pathogen, such
as HB Ag, is involved. General viral inactivating procedures, such
as treatment with betapropiolactone and ultra-violet irradiation
(La Grippo, Hoys.shi and Saeed, I97i), are necessary precautionary
measures, but until a valid test of infeetivity becomes
available, the effectiveness of such measures for the inactivation of
HB Ag raist remain questionable.
Gamma irradiation from a cobalt source is a recognised method
of virus inactivation for which some data is available (Ginosa,
19^8). Unfortunately, the reagent to be irradiated should be in
the lyophilised state to prevent the generation of excess heat.
Pasteurisation (60 C for 10 hours) is considered by some to be
an effective means of inactivating HB Ag (Mosen, Schroeder and
Cabasso, 1972) based upon the hepatitis-free history of human
albumin prepared by Cohn fractionation.
II. 9f iS^Ag-coated, Glutoraldetyde-fixed Safaerooytes
A 3 percent suspension of HBsAg-ooated glutaraldehyde-fixed
apherocytea was divided into 8x1 ml. aliquota which were allowed
✓ 0
to stand in a 60 C v?at©rbath for periods ranging from 0 to 2k hours*
o
At the appropriate times, an aliquot was removed and. stored at 4 C.
After removal of the final aliquot (24 hours), each was diluted ten
130
times (with PES ph 7,2 containing 2 percent normal human serum) to
a working concentration of percent and used to titrate a
standard Jill ah-positive aerua.^able'3.5.II indicates that this
9
. o
reagent may be maintained at a temperature of oQ 0 fur at least
16 hours before significant reduction in sensitivity occurs.
A.5a-.a«
o













III. SL Ift^Aff-ooatcfr,, QluVfraldeiyde-
fl»d SDherocvtea
HE Ag—coated, glutaraldetyde-fixed spherocytes were adjusted to
a 3 percent suspension in PBS pH 7.2 and divided into 1 ml. ali^uots
In clean glass screw cap tubes (Flow Laboratories). The contents
of each tube was 'shell frozen' in liquid nitrogen and lyophiliaed
on a Virtis dryer. The lyophiliaed reagent was stored at room
temperature. Twelve tubes containing lyophilised reagent were
exposed to 2.3 megarads of gamma irradiation from a cobalt source
(by kind permission of Ethleon Limited).
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tyophiliaed and lyophilised-irradiated reagent* were reconstituted
by adding 1 ml. PBS pH 7,2 containing 2 percent normal human serum
to the tube, allowing to stand for 5 minutes and adding r further
9 mis., resulting in 10 sis. of working concentration. Titration
of a standard HB Ab positive serum showed the sensitivity of both
lyophilised end lyophillced-irradiated reagents had been reduced by
one or two doubling dilutions.
IV. Diaouasion
BPHA tests for HB Ag bare to sooe extent allayed fears
9
concerning reagent infectivity by using oells coated with speoifio
antibody oresumed to be free of HB^Ag. Unfortunately, such reagents
are expensive to produce, unstable once reconstituted and subject to
non-specific agglutination due to the presence of impurities or
unwanted specificities among the immunoglobulins used for coating.
The HaI test, on the other hand, exhibits a high degree of specificity
end is oapable of equal or greater sensitivity than BPHA. Reagents
are relatively inexpensive to produce in large quantities end are
extremely stable, as further evidenced by their ability to withstand
pasteurisation, !yophilination and gamma irradiation. HB8Ag-c©ated
reagents do, however, carry an increased infectivity risk and for
this reason reagents were submitted to the procedures detailed above.
Pasteurisation of *bulk* reagents presented no additional
problems and appeared to leave sensitivity as unaffected as in the
pflot experiments. The reduced titre obtained after 24 hours at
60°C eould have resulted from elution of Hl^Ag f'roat the spherccyte
surface or deterioration of *iB0Ag antigenic sites. These
possibilities were not investigated further. subsequent batches
of reagents were treated at 60°C for 16-18 hours (conveniently
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overnight). experience has mown that their stability remains
uniiqpaixed over the following jaontha of storage at 4°C. «iailar2y,
gamma irradiation appears to have little effect upon subsequent
reagent stability whether stored xu the lyophiliaed or liquid state,
ihe slight loss of sensitivity following reconatitution is dis¬
appointing, more so sxnoe the neat settling patterns were obtained
using a 1 in 10 dilation of test serum vpre-lyophiliaation reagents
could be used with a 1 in 5 dilution of test serum). lyophllisation
appears to be responsiule as the sensitivity of pre- and post-
irradiated lyophiliaed reagents was identical. It may be that
the forces aoting upon the 'frozen' reagents during 'drying' caused




CCBP1-2XB& smsm B&SSJVX HAEMA&G-LUTINATION (C.&.P.H»A.)
I• Introduction
In n recent publication (Technical Report ne.r5.03 No. 570,
1975), the World Health Organisation here recommended that RFHA
he used for routine "blood donor (fB Ag) testing. Three suoh testefl>
are commercially available and were briefly oonpand in Part One
(aeotlon 2, ohapfcer 2) of this thesis. SPBA has the advantage of
being a sisplo one-step test, with a sensitivity between G.I.B.O.P.
and BIA, which mj be road within 1 to 3 hours. Unfortunately,
the commercial product Is expensive and unstable once reconstituted,
and the purified animal hyperimmune globulin used leads to
occasional false positive reactions. The long and complex procedure
of raising antisera in aniacls, purifying It and finally adsorbing
it onto & suitable carrier places kFIlA reagent preparation beyond
the scope of most Blood Transfusion Service laboratories.
The addition of one simple step to the procedure for preparation
of HBgAg-ecated, glutareldehyhe-fixed apherocytes enables these
reagents to be used in a one-stop BF'dA test for KBfAg.
1*. Anti,^94y , ^uter&ldeiad^xed
An aliquot (5 «1». of 3 percent suspension) of HBgAg (adyw)-
ooated gluteraldehyde-fixed, stabilised spherooytes was spun gently
on a benoh centrifuge and the supernatant removed. The packed
cells were resuspended in 20 els. of neat human serum known to
contain a high (HA titre > level of HBgAb (it is preferable
that the antiserum be active against all the HB#ng determinants
coated opto the spheropyte surface, end it may be receeaery to mix
antiaera in order to achieve such broad-spectrum activity), and an
equal volume of FBS pH 7,2 added. The oontainer was then attaohed
to a mechanical (Mattburn mixer) mixer and the HBftAg-coated
apherooyte-antiserum suspension mixed at room temperature for
approximately 72 hours. (it is essential that the mixing be
continuous in order to prevent the formation of iimune aggregates).
The antigen-antibody coated spheroaytes were then weshed three times
in PBS pH 7,2, adjusted to working strength (approximately 0,3 peroent),
and allowed to stand at k°C for e period of 4 to 5 days, after which
thsy were ready for use, The presence of HB Ag-HB Ab Immune3 3
complexes on the spherocyte surface led to the adoption of the term
complexed reverse passive haeaagglutination (C.R.P.H.A.)
in. ftr tyn
Test sera were diluted 1 in 5 in PBS pH 7*2 as for HAI,
10 jui, of thy test serum dilution was placed into the well of a
Terasaki tray and 5 Ul» of C.k.P.H.A. reagent (0,3 percent suspension)
added. The tray was gently shaken to enhance mixing, and floated
on the surface of a 37 C wsterbath for 1 hour, by which time the
epherocytes had 'sattied' to form a circle round the base of the well,
0
The tray was then gently placed at an angle of 40 to 50 as for HAI
and read after 5 to 15 minutes or when the negative controls (iQ ul,
1 in 5 normal serum ♦ 5 Jul, C.E.P.K.A, reagent) were down. The
presence of deteotable HB Ag in the test sera was evidenced by a
O
oomplete cirole of agglutination, while in the absence of en Antigen-
antibody reaction, the spherecytes slide down to the lower part of
the base of the well.
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IV. Comparison of C.R.P.H.A. Sensitivity with other Third
&Miration Tsffts for K^Afi
(a) Titration aensitiritv
Doubling dilutions of two HB#Ag positive sera (one
adw and one syw) tested by C.R.P.H.A., HAI, HPHA (Eepateat), and
RIA (Ausria-2).
(b) Panel atudiea
C.R.P.H.A., HAI and RIA were used to test two well
documented panels (B and C) supplied by the Central Public Health
Laboratory (C.P.H.L.) and two lesser known panels provided by the
ftest of Scotland Regional Transfusion Centre (Law Hospital) and the
Natal Blood Transfusion Centre (Durban* South Afrioa).
V- Results
Titration study result*(table3.iV".a)indioate that C.R.P.H.A.
performed as described is as sensitive as the oommeroial BPHA
(Hepatest), but less sensitive than HAI or RIA (Ausria-2).









SPHA (Hepatest 2,000 4,000
RIA (Ausria-2) 16,00G 8,000
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Results obtained from G.P.H.L. panels B and C (tables 3.6.V.b and
3.6.V.o) suggest that the sensitivity of C.R.P.H.A. implied by the
titration studies is borne out when 3era oontaining various
concentrations of HB Ag are tested under code. Results obtained
s
from testing the Natal B.T.8. panel (table 3.6.V.d) and the iest of
Scotland B.T.S. panel (table 3*6.V.e) further confirm that the
sensitivity of C.&.P.H.A. is comparable with established 'third
generation' test3, although results obtained with samples No. 20 and
27 in the Natal panel and samples No. 21 and 26 in the west of Scotland
panel suggest that the C.It.P.M.A. reagents are vulnerable to
occasional false positive as well as false negative (sample 13#
table 3*6.V»e) reactions as is the ca3e with commercial JRi'HA
reagents. i'his aspect of their performance requires further
investigation.
VI. li-iscusaion
Continuous mechanical mixing of HD Ag-coated, gluttons!dehyue-s
fixed, stabilised spherocytes m an environment of neat serum
containing an excess of specific antibody results, after 2 to 4 days,
in a suspension of HB Ag-coatea spheroeytes which are 'overcoated*2
with specific antibody but are not agglutinated (presumably because
no hB antigenic sites remain exposed to react with antibody over-
2
coated onto other antigen-coated spherocytes). however, these
antibody overcoated sellerocytes will agglutinate if introduced into
a test medium possessing fAee antigen.
Preliminary obsexvation3 suggest that C.k.P.H.A. reagents are
extremely stable, presumably because they utilise the KB Ag-coated
spherocyte as a carrier to which antibody is linked by a stable
antigen-antibody interaction, a feature which removes the necessity
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of preparing and passively coating purified hB#Ab which results in
a rather unstable cell-antibody bond.
Frovioed a reasonable balance of anti-o and anti-y is
maintained in the overcoating procedure, aenaitivity of G.A.P.H.A.
ia equivalent to any of the commercial k&Ak tests, while pilot
experiments suggest that certain modifications of test procedure
may further increase sensitivity.
The simplicity and economy inherent ia the preparation of
HAI reagents applies equally to G.&.P.H.A., since antibody over¬
coating requires only one simple additional step. If after the
first overcoating, free antigenic sites remain, the overcoating
procedure may be repeated as often as ia necessary (provided the
apeoifioity of HBgAb and HB^Ag correspond).
C.R.P.H.A. reagents also possess the potential for HB#Ag and
KB0Ab subtyping, although this has not been investigated in eny
detail. For example, if ady coated apherooytes are overooated
with anti-ad, then they will be agglutinated by a and d antigenic
determinants in test serum, but will also be agglutinated if antl-y
is present, and vice versa.
13S.






1 ♦ ♦ ♦
2 ♦ ♦ ♦
3 ♦ *
4 ♦ ♦ ♦
5 ♦ ♦ ♦
6 ♦ 4 +
7 4 4 ♦
8 4 ♦ ♦
5 ♦ ♦ ♦
10 ♦ 4 ♦
11 ♦ 4 ♦
12 4 4 ♦
13 + 4 +
14 + 4 ♦
15 ♦ 4 ♦
16 ♦ 4 ♦
17 4 4 4
18 4 4 4

















4 ♦ ♦ ♦
5 ♦ ♦ ♦
6
7 ♦ ♦ ♦
8 ♦ ♦ ♦
9 ♦ ♦ ♦
10 ♦ ♦ ♦
11 ♦ ♦ +
12 ♦ ♦ ♦
13 - - -
14 mm - -
15 ♦ ♦
16 ♦ ♦ ♦
17 * ♦ ♦
18 + ♦ ♦
19 ♦ ♦ ♦
20 • "• **
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Xable ^.u.v.u. tteyilts of testing panel provided by the Nfrta^ Bl09d








3 - mm -
4 ♦ ♦ ♦
5 ♦ + *
6 - - ***
7 • -
8 ♦ + ♦
9 + ♦
10 ♦ ♦ ♦
11 - - -
12 - mm -
13 ♦ * +
14 ♦ + +
15 - - -
16 ■f ♦ +
17 mm mm -
18 V + ♦
19 mm - -
20 * mm •
21 *■ ♦ ♦
22 + ♦ ♦
23 mm - -
24 * + *
25 - - -
26 - - -
27 ♦ mm -
28 » » -
29 ♦ ♦ ♦
30 ♦ ♦ +
31 • - mm
32 + ♦ ♦
33 ♦ ♦ ♦
34 ♦ * ♦
35 • - -
36 - mm mm
37 • mm -
38
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iable >b.Vtg. E»»ult» of testis panel provided by the v.eat of Scotland





2 + + ♦
3 ♦ ♦ ♦
4 - - mm
5 ♦ ♦ *
6 + + ♦
7 ♦ ♦ ♦
8 - - mm
9 ♦ ♦ ♦
10 ♦ + +
11 - - mm
12 ♦ + *
13 ♦ + +
14 - + -
15 + ♦ ♦
16 .. - -
17 ♦ ♦
18 ♦ *
13 ♦ ♦ +
20 + +
21 - -
22 + + v
23 - mm -
24 ♦ ♦ ♦
25 - - -
26 ♦ - -
27 - - -
28 - - -
29 ■i"
30 - - -
31 + + +
32 * ♦ +
33 - « mm
34 + + ♦
35 «M - -
36 ♦ mm








Despite the rejection of blood donations found to possess
HB Ag by C.I.E.O.P., hepatitis oontinues to complicate tiie3
therapeutic use of blood and blood products (Aeinicke et al,» 1573)'
More sensitive serological tests for HI kg may further reduce the3
incidence of posttransfusion hepatitis but are unliKeiy to
elimxnate it completely because of the possible inf'ectivity of
blood containing antibody to the Dane particle core in the absence
of detectable KB kg (lioofnagle, G-erety, Li and barker, 1>74) arm
the possible existence of a hepatitis G virus (Prince, brotman,
Grady, Kuixna, Hazzi, Levine and Millman, 1?74) ~ quite apart from
other possible causes such as hepatitis A virus and other microbial
agents (Zuokennan, 1970),
*Third generation' testa for ixb using the principles of3
haemagglutination and radioimmunoassay are now commercially available
and reports suggest that these kits can detect carriers of Kb Ag
too weak to be positive by G.I.E.u.P. (Ling and Overby, 1y72»
Cayzer, Dane, Gameron and Denning, 1S>74), Unf ortunately, the
effective use of sucn commercial reagents in the blood transfusion
service will prove expensive and only time will tell whether such
expense is justified.
Data reported in ihrt Two (Vill and IA) or this thesis
suggests that the Hal test possesses the chaructez-istics of
accepted "third generation" technology, fhe potential of HAi for
U3e in mas3 blood donor testing was investigated by conducting a
multi-centre evaluation involving over 70,000 donations.
I4i.
XI• Materials and Methods
Three Scottish --egional Transfusion Centres were involved in
the evaluation study: the South-East of Scotland regional
Transfusion Centre, Edinburgh, the East of Scotland .-egional
Transfusion Centre, Dundee, and the North of Scotland regional
Transfusion Centre, Inverness. The initial part of the study
involved the use of fresh huinun erythrocytes coated with HB Ag.
Antigen was prepared centrally at Edinburgh, but cell sensitisation
and subsequent reagent standardisation were performed at each
centre independently. however, with the iaplisentation of bulk
production of fixed spherocytes, it became possible to supply each
centre with reagents from the same batch, thereby Improving
standardisation considerably. The rainiturised (Terasaki tray)
version of HAI was performed at each centre in parallel with
C.I.E.G.P. 4ud6 of the 44,0^,5 donations tested at Edinburgh were
also tested with the 'hepateat' ^»>eilcoiue keagents) &..P.H.A. kit.
Positive HAI reccfciona were confirmed by subtyping.
HI. kesuits
The overall incidence of lib Ag among donors at the three
3
centres taking part was 0.04 peroent. HAI detected seven HBgAg
carriers missed by C.I.E.O.P. (table 4.1.ill). Five of these were
'new' donors and two were donors whose previous donation had been
implicated, among others, in posttransfusion hepatitis. Each centre
found at least one additional positive by HAI. Among the 4,086
donations tested using 'Hepatest', three HE Ag carriers were found,
but these were positive by HAI and C.I.E.O.r. in addition, the
commercial kPHA tests gave 20 positive reactions which were
subsequently shown to be nonspecific.
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No.HAl pos. No.CISOP pos.
Edinburgh 44,053 18 14
Inverness 16,371 4 2
Dundee 9,800 4 3
Total
4
70,224 26 (0.04$) 19 (0.03$)
IV. Plaouaa^on
Recent reports hare highlighted the inadequacies of C.I.E.Q.P.
for deteoting KB Ag in blood donations (Reinioke at al., 1973, Ring3 —————
and Overlay, 1972J Cayser at al., 1974)• The Amerioan Red Cross
seam to have opted for SIA, while Regional Transfusion Centres in the
U.K. appear to favour RPHA, Three commercial RFHA assays are
currently available and have been reviewed in Part One (section two,
chapter 2) of this thesis. The cheapest of those retails at
approximately 10 pence per teat if bought In bulk. All three tests
are susoeptible to a email number of false positive reactions, these
being resolved by abaorption-titration experiments.
HAI has a sensitivity for HBflAg deteotion conparable with other
third generation techniques and, being an inhibition reaotion, haa
an inherent specificity not found in RPKA tests. The use of
monospecific antibody (prepared by absorption) allows HAI to be
used to subtype antigen-positive sera, providing an essential
oonfiraatoxy step.
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The cost of HAl is negligible due to the availability of raw
material, the considerable expertise in haem&gglutin&tion technology
within the blood transfusion service and the simplicity of reagent
preparation combined with the small quantities (5 Jul.) needed for
testing.
The prime criterion in evaluating a new screening test such es
this must be the number of additional antigen carriers detected
in comparison with current techniques. The results indicate that
HAl is capable of deteoting donations containing HB#Ag in
concentrations below the sensitivity of C.I.E.G.P.*
HAl may prove an acceptable alternative to commercial third
generation HE^Ag tests for use in large scale blood donor testing.
It seems that with appropriate training, the technique may be readily
introduced into most regional transfusion centres, thereby keeping
reagent costs to a minlbik.
*
HAl detects 50-100 ngm HB Ag protein**.---5
CIEOP detects approximat&y 5000 ngm HB Ag proteinpe-3
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CHAPTER 2
PREVALENCE OF HB^Ag SUBTYPES AHOJSJ (BLOOD DONOR)
CAilRURS IN SOUTH-EAST SCOTLAND AND TKEIfi, ASSOCIATION
WITH ABKOBKAL LIVER FUNCTION
I. Introduction
The *d* determinant of HB#Ag appears to predominate among
apparently healthy blood donors In Western Europe and the U.S.A.
(Mazaur etal.» 1974), while the *y® determinant is frequently
associated with clinical evidence of HB^Ag positive hepatitis in
these re&gion* (Wenzel et al», 1972; Le Bouvier et al.t 1972;
Koseley et al. , 1972)* Sons workers have been unable to find such
a distinct association between the HBflAg subtype and liver daaage
(Cordon et_al., 1972; Feinaan et al.t 1973)« On the basis of
subtype distribution among acute and chionic cases of type B hepatitis,
it has been suggested that infection with the d detgrain&nfc is more
likely to result in mild illness progressing to the chronic HB#Ag
carrier state, whereas infection with the y determinant seems likely
to result in a savers, aouto, bit self-limiting illness (Holland et &1.,
1972; Dodd et al., 1573* Suckerman, Hacker and Aach, 1974) •
HB#Ag (blood donor) carriers were subtyped for determinants s,
d, y, w and r by Hal and liver function data (serum glutamic pyruvic
transaminase, 3GPT; serum glutamic oxaloacetic transaminase, SCOT)
was obtained, where possible, in an attempt to correlate H& Af
subtype with abnormal liver funotion in the South-East of Scotland.
Materials and Methods
HAI subtyping was performed as described in Part Three(chapter 1)
of this thesis* Liver funotion tests (S&PT and SOOT) were performed
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in the Department of Clinical Chemistry at the Edinburgh Hoyal
Infirmary. Eighty apparently healthy blood donors found to carry
HB Ag were 3ubtyped. Thirty gave regular (three-monthly) blood
a
samples for HB Ag and liver function determination,s
HI. icesults
As expected, the 'a* determinant was found to predominate
among ilB Ag (blood donor} carriers in the bouth-Kaat of Scotland
(table 1m2.HI.a). All samples possessed both the 'a' and •«'
determinants in addition to either 'd' or 'y'.
MaSLhtZf.'U-j&f subt,Ypej^onfii apparently hcnltlg
• B Ag carriers in South-Feat Scotland
No. 3ubtyped No.adw No.ayw Ko.aar No.ayr
ao 64 im>) 16 0 0
Of the thirty carriers who presented regularly for follow-up
study, only four exhibited persistent abnormal liver function, while
two more showed occasional slight SGFf and b&OX elevations (table
4.2.III.b). Of these 6, one carried HbAg of subtype ayw.
0
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Table 4,b, Incidence of abnormal liver function among apparently
healthy HB^Ag carriers in South-East Scotland
Liver Function
Normal Abnormal
adw (2b) 21 5
ayw ( 4) 3 1
Total (30) 24 6
IV, Statistical Analysis
In order to test the (Null) hypothesis that there is no significant
difference between the adw and ayw groups in relation to liver
function other than would be expected to occur by chance, Fisher's
exact test was applied as follows (nomenclature according to Leigy
Scientific Tables)?
Normal Abnormal
adw X1 1 1 "1
ayw *2 W2 " x2 H2
X N - X N
From significance limits for four-fold tables; the firs t table was
rearranged so that If and x^ ^ ~ that is:
Abnormal Normal
adw 1 3 4
ayw 5 21 26
6 24 30
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N *1 2o*Q«20 2«=G.10 2*=G.0J> 2a.=0.02 2*«G.G1 2«#*G.G02
30 4 1 . - 20 • - 22 . - 24 . - 25 . - 26 . - 27
Therefore the Null hypothesis cannot be rejected, that is, there
is no significant relationship between adw and ayw subtypes and
liver function.
Fisher's exact test was applied because the figures xn certain
2
boxes were too saall to a ply "X_ unalv sis.
Y. Discussion
The predominance of the adw configuration of iib Ag8
determinants (tiG percent) among apparently healthy blood donors in
the South-hast of oootland is in agreement with previous studies
covering western furope and the U.S.A. {dazzax- et al., 1974). If
the thirty lib Ag carriers followed for liver function studies are
representative of other apparently iwealthy Kb Ag carriers in this
region, it would appear that approxiaately one in five of such
carriers are experiencing a mild chronic liver disorder. statistical
evaluation of the present study suggests that among apparently healthy
carriers of ho Ag persistent liver dysfunction is not significantly
associated with either Use d or y antigenic determinant. This is
in conflict with the frequent association of the y determinant in
more severe 'clinical' eases of HB Ag positive hepatitis t*enael
s
et al.. 1972# be bouvier et al.. 1972# itooeley c-t al.. 1972).
following the discovery of the 'e' antigen system of HB Ag by
Magnius ana hspaark (19/2) and its possible association with chronic
liver dysfunction (.einoaa, berris, dinclair# «robel# 14urpty ana
Uaynard# 1973)# the incidence of e arm unti-e among apparently
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healthy HB#Ag (blood donor) carriers in this region was investigated
using the I.E. technique. At the time of writing, 22 HB#Ag carriers
have been tested. Three were e-antigen positive, 16 possessed
e-antibody, whilo neither a-antigen nor a-antibody oould be found
in 6. The three e-antigen positive carriers were the only ones to
exhibit persistent elevations of SSOT and S&PT, suggesting that in
apparently health;'' UB^Ag carriers, the e antigen reay provide a
batter marker of possible chronic heoatitis than the BB^Ag subtype.
There wa3 no correlation between presence of e-antigen and the
d or y determinant*
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CKAPTOR 3
EZ-BWrAirl&ATIQN OP BLOOD DONATIONS IMPLICATED
IN POSTTRANSFUSION HEPATITIS
1• Introduction, Materials and Methods
Data presented in Chapter 1 of this part of the thesis clearly
indicates that HAI is capable of detecting HQ#Ag carriers who would
be missed by C.I.I.O.P. Since not all recipients of HB^Ag positive
blood develop antigenaeaia and/or hepatitis (Cooke and Xavay, 1969),
it is important to establish whether or not those carriers found to
be HAI positive bat C.I,E.G.P. negative are likely to be infective.
From mid-1973 the South-last of Sootland Regional Blood Tranafusion
Servioe has stored 0,5 nl. allquota of serum at -20°C fro® all
donations for a period of six months. Since that time eight patients
with suspected posttransfusion (viral) hepatitis have been reported
to the Blood Transfusion Centre, and it has been possible to
investigate each case by retesting the original C.I.E.G.P. negative
donations using HAI, RIA (Auaria I) and 1PHA (Hep&test). In
addition, two suspected posttransfusion hepetitis cases were referred
from Manchester Blood Transfusion Centre for similar investigation,
although in this ease the donations actually tested were obtained at
a return visit of the donors and were not therefore truly representative
of the original donations.
II. Results and Comments
The retesting of more than 100 donations implicated in eight
cases of posttransfusion hepatitis in Edinburgh showed that in two
oases an HB#Ag positive unit of blood had been transfused whioh was
not ceteoted during initial testing by C.I.E.O.P. (table 4.3.11).
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Auaria 1 KHA1 Turkeyoelle
„ . EVei. ♦ 8 All neg. All n*ge All ueg. All neg.
E
Mo£• + 14 H »
tt •«
MOO.''- 18 tt 1 rot* 1 Poa. 1 Pos.
nil. + 18 H All nag. All neg. All neg.
E
Kaw. + 52 rt
tf »t
Lid.\ 14 ti 1 Pos. 1 Pos. 1 Pos.
frow. - 5 •I All neg. All neg. All neg.
Pea. ~- 10 M It It 91
_ U
Par. ♦ 4 M 1 Pos. 1 Pos.
It
Ali.^n.t. 17 W All neg. 1 Po.S.... 1 Pos.
E c Edinburgh
M a Aancnester
♦ a hb Ag Positive
» doing negative
n.t. = not tested
Me-investigation of the two oases from Manensater revealed a positive
HAl result from each though, interestingly, one was Biased by
MrHA and the other lay AiA. The positive unit transfused in case 'far.'
was subtyped by n.4l as adw» while that transfused in case 'All' was
found to be ayw, suggesting that the ooBuaei'oiai MIA test used may
be more sensitive for the detection of adn than nyw. A similar
MIA-bias has been described by Vanderwald, Mahaood, Golfin, Porter
Megson and Cosaart
11>3.
It appears that HAI is capable of detecting C.I.E.O.P.-negative
HB Ag carriers which can produce hepatitis if transfused into a
3
susceptible recipient. Had HAI been used at the time of donation,
it is probable that 40 percent of the posttransfusion hepatitis
cases investigated here would have been avoided. Whether the four
remaining cases in which all donations were nagative by Mil, EPHA
and EIA and the recipient was HBgAg negative were in fact due to
HB Ag is unclear, particularly in the fa^e of circumstantial
evidence of a hepatitis G virus(es) (Prince et al., 1974).
Unfortunately, convalescent sera were not available to test for
the appearance of HB Ab#
154.
UiiAi'Ilii 4
877BCTiVKi&SS OS HKViTIflS l> I^'UHQGLGBdLIft HI m ilUiVEiTflOH
0? HSPATI'IIS BSSULTXIS; TAU. ACCIBhNXuL SXPOSUSS TO HBgAg
I. Introduction
Normal iajsaunoglobulia (N-IgG) prepared iroa the pooled plasma
of unseleoteu blood donors may prevent or modify infectious (type A)
hepatitis. There are. however, conflicting reports regarding its
efficaoy in relation to serum (type B) hepatitis (Crossia&n et al.,
1945» McCalluia, 196$j Brake et al.« 1953 ^ Holland et &!., 1266).
During the recent virulent outbreak of dialysis-associated type B
hepatitis in Edinburgh (Mansion and Tonkin, 1972) H-Ig£ exhibited no
apparent protective effect. On the other hand, the use of hyper-
iaaaune hepatitis B globulin (HB-igd) in France and tho U.S.A. was
associated sith a definite protective effect 7/hich was particularly
evident if administered aoon after exposure to infective material
(Krugman et al., 1971J Soulier et si., 1972). Soulier et al. (1972)
followed 18 recipients of HE-Ig£ who had been exposed to I3J Ag bys
transfusion of antigen positive blood or by accidental parenteral
exposure. A rise in transaminase levels occurred in two patients,
but none developed Lb antigcauemia, neither did passive xmuunisatlon
appear to favour the development of an KB ng carrier state as had
been feared by some workers (Prince et al., 1971).
Large clinical trials are currently being conductsc. in the U.K.
and U.S.A. to provide- farther data regarding the safety o«3 efficacy
of H£-Ig&, Meanwhile this chapter is designed to provide an insight
into the use of HL-igu by considering the initial findings of an
'on-going* stud^- ui the South-Bash of Scotland Iiegional Blood
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Transfusion Centre, ulnourgh. The Hi-IgC used la this study was
prepared at the Lieerfccn Protein i'ruetienation Centre nearly.
Its serologics (IB Ah) status was colored with similar preparations
from o titer centres.
II. hateriala and Methods
(*) EE-2tf pi-ep^atloruj
Sines 1971 three batches el' HB-IgG have been prepared
from pooled donations known to possess specific KB Ab by G.I.E.O.P,s
In each preparation the starting poel and the final product were
exhaustively investigated for the presence of L2 Jig or ia&une
complexes. HB~IgG- »as supplied aa a 10 percent solution of gun
or 0.5 gm. doses for Intramuscular use. Siailar preparations were
obtained tram Paris, Amsterdam and the Auctrali&n Coasionr-sslth
Serum Laborstcay (C.S.L.) for coop&rison of serologic activity
with our local product.
(b) Laboratory testa
Teats for HE Ag were by HAI and EIA (Ausrla-2). The
amount of UBftAb activity was estimated by direct HA titration, while
P.M. was usee to look for IiB.Ag-KB.Ah iaasune complexes. Eollcw-up9 3
liver functions tests consisted of measuring serum bilirubin and
transaminase (3&0T and SCPT) levels.
(c) Sxocriiaental crctccol
0.5 - 1.C ga. HB-Igl was given within 3 to 5 days
following accidental exposure (needle-stick or non-parenteral
exposure) to H2 *.g. Prior to treatment the accident victim was
tested for LBj&J* ®*& HS^Ag to (i) avoid administering HB-Igi to an
individual already currying Idgk concentrations cf PS At or KB#Af and
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thereby avoid wasting by unneoeeeary innoculation, and
(2) determine base level of HB#Ab (if any) injvictim prior to
treatment. Serum samples mere obtained 3 to 4 days after HB-Ig&
administration and, whore possible, at fortnightly intervals for
the first three months, theny monthly intervale for the next three
months, Hach soeidsnt was categorised as *high* or 'low* risk
depending upon the relevant oircumataneea. Twenty-two high risk
oases of direct parenteral innoeulatlcn with HB#Ag poai.tive hlood
resulted from either * needle sticks1 or cuts with broken glass. A
further twenty*three low risk cases occurred as o result of eocident
situations in which infected hlood was splashed onto large areas
of unprotected skin, swallowed as a result of mouth to mouth
resuscitation, or parenteral innovulation with blood from a patient
who had previously been HB A t positive but who was KB Ag negativeSI •£
at the time of the accident. During the follow-up, a record
kept of any other treatment the HB-Ig& recipient received,
in. Vesults
(a) Assesflu.^nt of HS-IkS- preparations
123-Igii prepared in Amsterdam* Edinburgh* Faria and the
Commonwealth Serum Laboratory (Australia) were compared for EB#Ab
aotivity by HA. All preparations exhibited a high concentration of
HB#Ab with slight variations within and between centres (table 4.4.III.a).
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Table 4.4.III.a. Titration of different preparations of KB-I«&














(b) Assessment ox' response to Kb-IgO
Of the 45 recipients of iiB-IgO only 22 were available for
comprehensive follov/-up (Table 4.4.iil.bj. None developed 1IB -anti-
genaemia and serum bilirubin levels remained normal. Pour HB-igG
recipients (BL, Svlci), VU- and J&) exhibited abnormal transaminase levels.
BB had chronic hepatitis with persistently abnormal liver function
prior to inclusion in the hB-IgO stuc^y, suggesting that the elevated
transaminase values were unrelated to recent HB Ag exposure. Patients
s
McB and JA were receiving auti-tuberculosis therapy and. suffering from

























































































































































































LR=lowrisk;i&*high*chronicepatitisreceivinganti-T.S.drugs; -=nodatavail ble;*•*«HE-IgjGpreparedtListerInsti ut(P tr ); ***»pre-existingHB^Afr.
1W
relating to patient EG- (figure 4.4.iII»c) may be related to his
accidental exposure to HR Ag. EG is a medical laboratory
technician who cut his hand on a broken centx'ifuge tube containing
HEgAg (ayw) positive blood from a renal unit patient Implicated in
two fatalities during the 1969-1970 dialysis-associated epidemic
in Edinburgh. There was little doubt, therefore, regarding the
infectivity and virulence of the innoculum. EG received 20 ml.
immediately after the accident, the following day and five
weeks later. He also received 1 gm. of HB-IgG (supplied by Lister
Institute, Elstree) three days after the accident. An influenza-like
Figure 4.4.III«c« Post-HB-IgG follow-up of patient EG.
- = HBsAb(HA) titre
64 n
= Influenza- like illness
= Elevated SGPT
= Epigastric discomfort
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illness followed by abdominal pain developed nine weeks later with
epigastric discomfort 20 weeks post innoculation, the latter being
preceded by a moderate but persistent SG-PT elevation lasting eleven
weeks. The circulating HB Ab titre rose prior to the prodromal
symptoms but no HB Ag was detected throughout the follow-up period.
EG has remained well since then.
In all but one of the patients followed the HB-IgG administered
contained sufficient activity for HB Ab to be detectable (suggesting
that antibody was in excess) for an average of 11 weeks. The
highest passive HB Ab titre usually occurred between 1 to 4 weeks
post HB-IgG administration, a feature which may refleot the
cumulative effect of the slow release of antibody from the site of
intramuscular innoculation into the circulation. Those receiving
1 gm. of GHB 2 usually exhibited higher circulating HB8Ab levels
than those reoeiving 0.5 gm. of GHB 3. Although one would expect
this to be the case, the data cannot be compared directly since
initial quality control studies on the HB-IgG preparations suggest
that the activity of GKB 2 was greater than that of GHB 3*
As anticipated, the recipients of HB-IgG were all medioal,
nursing or technical staff, and as such it was interesting to note
that among this high exposure risk group, 9 percent showed evidence
of previous exposure to HB.Ag, representing ten times the incidenoe
of KBflAb than among healthy blood donors in the same region.
IV. Discussion
The distinction between 'high risk' and 'low risk' exposures
to HB Ag is difficult if not impossible to make (not all the six
3
staff members who died in the 1969-1970 dialysis-associated outbreak
in Edinburgh were obviously parenterally exposed). The type of
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acoidenfcal involvement aad the source of the Irmoculum should be
carefully analysed in eaoh case. Some of the subjects in the
present study did not report actual parenteral innoeulation, but
were given HB-IgG because of the circumstances surrounding their
exposure (e.g. mouth to mouth resuscitation of a neonate immediately
after delivery of on antigen positive mother)* In such oases
assessiaent of the prophylactic value of HB-IgG may prove difficult.
None of the HB-IgG recipients showed evidence of immediate or
delayed reaction to the injection. Most had detectable circulating
KBgAb for an average of eleven weeks after innoculation. confirming
the findings of S&muness, Prince. Goodman, Enrich, Pick and Ansari
(1974). Xhe reason for the rapid disappearance of antibody in
BL, B, TH and FQ is not clear. None had pre-existing, anti¬
globulin (GM, Xnv) to the administered HB-IgG. BL had chronic
hepatitis possibly of autoimmune origin which icay have accelerated
HB#Ab removal by virtue of abnormal protein metabolism, but the other
three were clinically and biochemically normal. Since immuno¬
globulins are suicidal proteins, being catabollsed in the performance
of their function, it could be argued that accelerated clearance
of HB-IgG may reflect the presence of HBaAg in or on the tissues.
Millman et_al. (1969) reported the occurrence of HBgAg in the
hepatocytea of serum negative patients and demonstrated cellular
hypersensitivity to HB0Ag in nearly 60 percent of a group of Hb^Ag
negative chronic hepatitis patients. Further investigations regarding
the occasional rapid clearance of HB-IgG are dearly merited.
Several batches of N-IgG, Rhesus anti-D and vaccinia immuno¬
globulin wear* tested for HBflAb. No eotivity was found in the few
anti-P or anti-Vaccinia preparations tested, and only one of the
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21 N-Igfr preparations exhibited an H2 Ab titre of greater than
1/500 by HA, most ahowing a litre of leas than 1/10. It would
seem, therefore, that the fractionation of KB Ab positive plasma
produces a product Ahich, by virtue of ita high KB#Ab content,
provides a significant degree of protection against type B hepatitis
as a result of accidental exposure involving a relatively small
challenge dose. l*he presence of detectable circulating HBgAb for
some weeks after iiB-igG administration suggests antibody excess and
infers that any circulating KBsAg has been complexes £uid5hopefU13y,
neutralised. It seems logical that HB-lgG- should be administered
as soon as possible after exposure (except where HB#Ab is already
present la high concentration or where the victim is already found to
be an HB#Ag carrier) for maximum efficacy before the virus gains the
protection of the (hepatic) cells in which it replicates.
The HB-lg& preparations used in this study possessed specific
antibody to both the d and y determinants of KB_Ag. It seems
logical that the protective value of the product will be dependent
in part upon the presence of antibody to all the HBaAg determinants
associated with the infecting virus. i'he HB Ab activity of GHB 2
and GHB 5 was similar to that of HB-Igb prepared at other centres.
Variation between batches is a feature requiring further assessment.
HB~Igd Is currently prescribed by volume or weight, whereas it say
prove more beneficial to the rsoipient if doses were to be standardised
in terms of biological activity. The feasibility of expressing the
antibody activity .irectly is supported by Ginsberg et al. (1972)
who observed a correlation between antibody titre and apparent
protection. It is felt that the present study demonstrates the
prophylactic value of HB-IgG which in turn emphasises the need to
standardise such preparations on a world-wide basis.
PART F I V I
FINAL DISCISSION AND CONSIDERATION OF
F8TURS f-TMfra OF nag**PAW
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fikal discussion
I. Identification of HB^Ag
Recognition of the aignifio&ncs of the presence of H&gAg in
blood has led to & proliferetion of laborfttoxy teohnioues over the
past five years, many of which have been reviewed in Pert One
(beotion Two) of this thesis. It is now established beyond doubt
that 'third generation* teats (RIA, RPKA, HAl) ore superior to
C.I.E.O.P. for the deteotion of HBflAg among blood doners and patients,
increasing the number of detectable carriers (blood donor) by up to
50 percent (Korets, Klaha, Ritnan, ramus and Gitnick, 1973J
Vandervelde et al», 197'V; Hopkins, Robertson, Rocs, Tumbull and
Das, 1975J Wallace, Barr and Milne, 1975; Polesky and Taawell,
1975; Dodd, Ni, Maiin end Greenwalt, 1975). Data presented in
Part Four (chapters 1 and 3) suggests that the higher sensitivity
of HAl, BPliA and SIA could result in a worthwhile reduction of the
number of oases of posttransfusion type B hepatitis.
As one with some experience in the use of .moat of the never
HB Ag assays, X find the most endearing quality of RIA to be its
objectivity. Unfortunately, this is offset by the high cost of
reagents and counting equipment, quite apart from the has&rds of
handling radioactive isotopes. Kaqy laboratories, particularly
those responsible for blood donor testing, are reluctant to uao filA
because of cost and the tine required for ooropletion of the teat.
Among those who have evaluated some fora of RIA a popular ©boioe has
been the sandwich solid phase kit (SP-RIA-AUSRXA) available from
Abbott Laboratories (sec Part One, Section 2, chapter 3). The
initial version of the test (AHSBIA-l) utilined HB^Ab-coated tubes
and required a total incubation time of 21 hours. This was replaced
by a modified system (AUSRIA-2) in which the reactive surface area
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was increased and the amount of non-specific •background' isotope
binding decreased by using an HB Ab-coated bead, leading to a
slight improvement in both sensitivity ana specificity. Kinetic
studies based on the A03RXA test (rrinee and Jass, 1i?74^ revealed
a marked effect of incubation temperature and time upon sensitivity,
o
being enhanced at incubation temperatures up to fjO C, but declined
if kept beyond eight hours at this temperature. Buch findings
may be explained by (1) the increasing speed of diffusion of HB Ag
towards bound HE Ab attached to the solid phase, {?.) reduction in
the background count, and (3) partial denaturation of HB Ag ats
higher temperatures leading to the exposure of additional antigenio
sites.
To achieve an acceptable compromise providing good sensitivity
in a reasonable time, instructions with the AUSklA-2 kit suggest that
o
serum samples be incubated by floating on a 43 C w&terbath initially
for 2-4 hours, followed by a 1 hour incubation with labelled antibody.
For those laboratories with facilities for liquid scintillation
but not direct gamma counting, Jordan, Spiehler, Haendiges and
Helman (l:?74) have described a method of aolubilising the tube-bound
radiolabelled (AU34IA) complex with glacial acetic acid suitable for
subsequent liquid scintillation counting. It is claiinea the method
avoids high background, chemiluuinesconce and quench.
Duimel and rurnmelhuis (1373) have used voluminous m-diazo-
benzyloxymethylene cellulose a3 a carrier of HB Ab in a competitive3
125
SP-RLA also requiring highly purified I-labelled HE^Ag. The
presence of either HB Ag or HB Ab in the test sample results in a3 3
decrease in the amount °f bound tracer (separated by centrifugation)
compared with a negative oontrol 3erum. Differentiation between
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HB^Ag and HB^Ab necessitated a sandwich SP-RIA, although they point
out that this may be accomplished by a single competitive 3F-RIA
test if a mixture of iia xinoadsorbants (insolubilised HB Ag ands
HB Ab) are used,
s
Hollinger, i»erch and Melnick (1&74) compared the effectiveness
of SP-RIA (AU0RL-1) with that of double antibody radioimifjunoassey
(DA-RIAJ as screening tests for reducing the incidence of post¬
transfusion hepatitis B. Oeven out of eight susceptible recipients
who received DA-MA positive blood subsequently cieve oped clinical
hepatitis B or showed serologic evidence of exposure to HB Ag. In
contrast, SP-aIA failed to implicate a positive donor in five of
these, including two in whom clinical hepatitis B developed. Since
both tests were of comparable sensitivity for HBgAg detection, it is
interesting to postulate that DA-RIA was recognising additional
antigenic determinants (HB AgV) which were not identified by SP-RIA.
w
This situation could result from the U3e of low pH (pH 2,4) to
dissociate antigen-antibody complexes in the preparation of purified
HB Ag for raising 103 Ab for use in the DA-RIA. It is known that3 3
such treatment may disrupt the outer coat of the Dane particle,
exposing the inner core (hoilinger etjal., 1974). Antiserum
produced in this way could contain HBQAb in addition to HBflAb and
provide the capability for uetecting an additional set of antigen-
antibody reactions. At the time of writing DA-RIA kits ore not
commercially available.
The alternative to RIA is some form of haeraagglutination.
The best APHA reagents achieve a sensitivity similar to AlA, are
simple to use since they require no special equipment, ana are
considerably cheaper to purchase (Part One, section 2, chapter 2).
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Hepatest (Wellcome keagents) appears to be the JkPHA of choice in the
U.K., while 'Hepanosticon* (Qrganon) is attracting cons id ex-able
interest on the continent (heesink et al., 1973 i Schuurs and Kacaki,
1974i Hadziyarmis, 1974) ana Abbott Laboratories are supplying
'AusceJf mainly in the U.S.*. (Germain, Scux-divant and Eightael,
1973)* Hepatest has been evaluated by a number of blood transfusion
centres in Britain (Cayzer et al.. 1 974i Barbara, Penning, Cleghem,
Lane and Briggs, 1573) and is currently being used by many centres
in England and Wales.
It is to be expected that extx-emely sensitive tests will be
prone to occasional false positive reactions. However, recent data
suggests that HPHA tests, particularly using animal erythrocytes as
antibody 'carriers', may be subject to a higher than expected
incidence of false reactions in certain racial groups (Chrystie,
Islam and Banatvala, 1974# Wilcox, 1973)» Shattock and Smith (1975)
compered Hepatest and liepanosticon with l.D. using heterogenous
serum samples derived mainly from patients. While concluding that
both BPIiA tests satisfied most of the requirements for mass screening
they did point out that batch variation in sensitivity does occur.
Another BPHA test (iaphadex E) has recently been described by Prince,
Ikram, Chicot, Wright, Vnek, Neurath, Lippin and Swis3 (l975)• This
uses immunochemically purified chimpanzee KB Ab bound to stabilised
0
human erythrocytes. The test has equivalent sensitivity to EIA
(AUSR1A-1) and detected a similar number of HE Ag-containing specimens
during screening of volunteer blood donors. Unfortunately, there
appear to be differences in sensitivity between different reagent
batehes (Prince, 1979, personal communication).
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In parts Two anc Four of this thesis, evidence has been
presented that the iul test described possesses both the sensitivity
and specificity required of a third generation HB Ag technique.
Reagent stability combined with the relative ease of large scale
preparation results in a highly standardised test system which may
be readily introduced into raost blood transfusion centres at a cost
considerably below that of any comparable commercial reagent.
An interesting new development has recently come to light
regarding a haemagglutination procedure with very high sensitivity
for the detection of WWig (Pert and Verch, 1975). Fresh human
erythrocytes were coated with HB Ab and used to test for the presence
of HBsAg. Treatment of the reagent with cobra venom factor resulted
in inhibition, and there was a marked loss of sensitivity with cells
pretreated with formalin or chromic chloride, suggesting that Cj> and
some type of reactive sites on the cells are required. Sensitivity
is claimed to be several orders of magnitude higher than other
related tests, and the authors go as far as to suggest that this may
be sufficient to detect HB Ag if present in virtually aiy blood
sample. Reproducible discrimination between positive and negative
settling patterns is often difficult for the untrained observer, but
it is hoped to overcome this problem by partially automating the
technique (Pert, 1975, personal communication)•
Beteotion of circulating antibody to the core of the Bane
particle (HBcAb) msy provide a further means of identifying blood
donors capable of transmitting hepatitis type B, since most
individuals who axe chronic carriers of HB8Ag have circulating
HB Ab (Puree11, Herin, Almeida and Holland, 197VO* Development of
c
serological techniques for the detection of HBgAb have been
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hindered by the limited availability of the antigen. Free HB^Ag
has not yet been found in the serum of either acutely or chronically
Infected individuals (probably because it becomes heavily coated
with antibody)• Chronic HlWvg carriers could theoretically provide
a source of HB Ag, particularly if only those whose aero, was rich
in Bane particles viere chosen. Unfortunately, this would involve
processing large quantities of potentially infectious material
(Fauval, Babiuk, -heaff and Spenee, 1975)» a prospect which would
not appeal to rsany laboratories even if they possessed the necessary
equipment. Alternatively, HBcAg may often be extracted from the
nuclei of infected liver tissue (Barker et al., 1974; Maupas,
Werner, Barouze, Millman, Ixmdon, 0*Connell and Bluaberg, 1975) care
being taken to reroove free antibody before HB Ag is exposed.
Despite the application of MA to detection of HBoAg and HiWib
(Purcell et^aJL., 1973/4; Grcenroan, Robinson and Vyas, 1975) comple¬
ment fixation (C.F.) has been used extensively to characterise the
HB Ab response in patients with hepatitis B (Hoofnagle, Gerety andc
Barker, 19?4). KB Ab is frequently detectable while the surface
v
antigen is still present during acute infection. The titre of
HB Ab generally falls to low levels after recovery, but high HBcAb
titres are routinely found in persistent HB Ag carriers. Pre-
liminary investigation of the possibility that i©cAb might serve as
a marker of chronic infection with hepatitis B virus in some
individuals without etectable HB Ag has revealed a high prevalence
of HBoAb in donors (without HBflAg) who were implicated in cases of
hepatitis following blood transfusion.
The DNA polymerase reaction can be used to radiolabel Dane
particle cores for a specific and sensitive DA-hia for HBcAb
(Robinson, 1975)* DNA polymerase activity appears early in the
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period of KB Ag reactivity (corresponding to peak viral replication)
and disappears at about the same tiiae as KB «g (io-ugman, Koofnagle,s
Gerety, Kaplan and Gerin, 1974). Quantitation of DNA polymerase
may provide a useful approach in distinguishing the degree of
infect!vity of HB Ag positive sera.
o
The ability to subtype a weakly reacting test sample provides
important confirmation of the specificity of the original HB Ags
positive reaction. As detailed in Part rJhree(chapter 1), determinants
a, d, y, w and r are readily definable by HAI. As 'new* IB Ags
(virus-coded) reactivities are discovered the value of a sensitive
but simple subtyping test will become even more apparent. Since
the information in Part Une (Section 1, chapter 1, 11) was compiled*
some new HB Ag determinants have been reported or rumoured, for
example 'g*, 'n', *q* and 't* (Le Bouvier and iftilli&ms, 1975). It
must be shown that each new postulant antigen is distinct, associated
with the surface of HB Ag particles, and coded for by the HB-Ag
viral genome. Among the newly postulated determinants most data is
available regarding *t*, a peculiar feature of which is its variable
physical behaviour, being overt in association with the adw phenotype,
cryptic in association with ayw, and apparently absent from ayr.
Though apparently not attached to the HB Ag panicle surface,
the e antigen, first described by Magniua and 15spmark (1972), has
generated considerable interest in recent months as a possible
indicator of liver damage in I®sAg carriers. e-antigen or specific
e-antibody can be detected in the three-to-five-times concentrated
serum of most HB Ag carriers by I.D. Most investigators agree that3
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e-antigen is associated with active and usually continuing liver
disease and may prove a particularly useful prognostic aid, while
e-antibody appears to be significantly associated with normal or
only mildly abnormal liver function (El Sheikh, aoolf, Galbraith,
Eodleston, Dymock and illiaas, 1975* Kleftheriou, Thomas,
Heathcote and Sherlock, 1975# Feinman et al,, 1975)* My own
investigations (as yet unpublished) agree with these findings, since
the majority of apparently healthy HIS Ag (blood donor) carriers
in the South-East of Scotland are typable for the e-system by l.D.
provided test serum is concentrated three to five times with lyphogel.
To date the only carriers to exhibit e-antigen are those with
persistently elevated transaminase values, representing about
10 percent of carriers tested for the e-system. Since both
e-antigen and DNA polymerase appear to be associated with viral
replication, infectiviiy, abnormal liver function and the presence
of Dane particles, it is testing to hypothesise that they may
represent the same product.
III. Immunisation against Hepatitis B
Although HBgAg is distributed throughout the world, there are
certain 'high risk* groups who would benefit from some form of active
or passive protection. These include patients receiving blood
transfusions, drug abusers and health-care personnel such a3 surgeons,
physicians, dentists, nurses, laboratory technicians and blood bank
workers. Haemodialysis patients and staff, children of IIB#Ag
positive mothers, institutionalised patients and persons visiting or
living in certain tropical areas where sanitation is poor are also
considered to be at risk.
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Pi-ogress toward® the development of a vaccine against
hepatitis B has been hampered by the very limited success obtained
in growing the virus in culture and the difficulty of obtaining
a suitable animal model* Diluted and heat-treated whole serum
(Krugman et al., 1971) may be regarded as an inactivated 'vaccine',
but it is a very crude way of inducing immunity and it is
improbable that such -material will be licensed for general use.
isolated coat protein challenges the body's immune raeohanism in the
same way as the whole infectious agent and the possibility of using
purified HB ag free of nucleic acid, and therefore not Infective,
appears attractive. However, such an approach may be precluded
by contaminating ost protein which may induce various pie-existing
structures of the liver cell and may thus induce undesirable
immunological reactions (Popper and Mackay, 1972). Subunits of
HB#Ag, in the form of small polypeptides, ere considered by some
(buckerman and Howard, 1979) to possess a greater potential as
possible imraonogens. In a recent report by Lreesman, Chaires,
Suarea, Hollinger, Courtney and Melnick (1973)» five purified poly¬
peptides were isolated from HB Ag types adw and ayw and injected
into guinea pigs. Antibody to each HB Ag type was measured bys
Alii. Although not all the five elicited detectable antibody
response, it was concluded that subunlts free of ontigcnically cross-
reacting host components and which do not contain infectious viral
nucleic acid may yield an effective hepatitis B vaccine. Another
approach could be the development of a synthetic peptide, which,
when coupled to a raacromolecular carrier, could serve as a suitable
iiis&unogen. Successful transmission of hepatitis B virus to
ohinipanseea (Barker et al«, 1973) raav provide a means of monitoring
vaccines when they are developed.
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Results of studies on passive immunisation using pooled
human immunoglobulin have been inconsistent, probably because most
preparations contained little or no His^Ab, However, the evidence
in Part Four {chapter 4) suggests that immunoglobulin with a high
titre of KBaAb (HB-ig&) prepared from plasoia of selected donors
could offer protection in certain cases* Since the early work of
Prince et al« (1971)» Gocke (1971)» Conrad et al. (1971)» Rrugman
et al* (1971) and uoulier et al* (1972), the protective effect of
HB-Ig£ has been studied on a variety of 'high risk* groups*
Saauness et al, (1970 compared the protective effects of HB-IgG
and normal immune globulin (passive haemagglutination titre « 1/16)
on children ad Itted to three institutions and concluded that both
preparations were effective in preventing or modifying non-
parenterally transmitted hepatitis in an endemic setting during a
1.5 to two year follow-up period, Kohler, Dubois, Merrill and
Bowes (1974) found to be effective, compared to no treatment,
in preventing neonat.il hepatitis B infection in babies born to
HB Ag positive mothers, and Redeker, Mosley, Cocke, McKee and
Pollack (1975) obtained evidence that HB-Ig& appeared effective in
suppressing not only disease, but infection itself in spouses of
patients with acute type ii hepatitis, compared with normal immune
globulin*
The majority of reports concerning the effectiveness of
HB-IgC have been with regard to prevention of type B hepatitis in
dialysis units and in individuals accidentally exposed to HL^Ag
as a result of needle-stick-type accidents. Half as many cases of
hepatitis B developed among patients treated with HB-IgG as compared
with the group receiving normal globulin during a clinical trial
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in two haeraodialysis centres in New Jersey (dzmuness, Prince,
Hoofnagle, Kibot and Jacobs, 1975)* while in a double blind study
reported by foamyter, Bradbourne, Vemylen, J'aneels and Boelnert
(1975) HB-IgG significantly protected haemodialysis patients against
development of HB antigenaemia, oompared to control patients
receiving normal gamma globulin. Results of a large multicentre
study (Prince, Sz.nuness, Mann, Vyos, Grady, Shapiro, Suki, Freidman
and Stenzel, 1973) in which haemodialysis patients and staff were
given either high, intermediate or low titre HB-IgG suggest that
high tifcre material may be moat protective particularly among
patients.
Preliminary evaluation of patients who received proptylactic
HB-IgG following accidental needle-stick exposure to HB Indicated
that HB-lgG significantly reduced, the frequency of both clinical
and subclinical hepatitis during the first 3 to 4 months after
injection (Seeff, Zimmerman, Wright, Belcher, Binkelstein, Garcia-
Pont, Greenlee, l-ietz, Ha-idlton, Koff, -eevy, Kiernan, Taraburro,
Schiff, Vlahcevic, Zerael, Zioaan and hath, 1973). However, less than
10 percent of the recipients had detectable HB Ab at the sixth
month after injection, suggesting that !0i-IgG might need to be
given every 3 to 4 months to continually exposed individuals. This
i3 in agreement with ^y own findings reported in Part Four (chapter 4).
HB-IgG is administered to 'high risk' groups in the hope that
circulating Hb Ab will prevent the hepatitis B virus (should it
enter the blood) rrota reaching its target organ and replicating.
The logic of this seems to be borne out by the findings of
De la Concha, Ortiz, iiernandez-Guio and Hernanco (1973) who found
immunity to the disease to be direotly dependent on the titre of
circulating HB Ab.3
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Given that high titre HR-IgG appears to be .initially more
protective than normal gainma. globulin in certain circumstances,
the question of when and whore it should be used is not as clear-
cut as might be su posed. As follow-up is extended there are
indications that normal gamma globulin is more effective than HB-
IgG in inducing Ion, er-lasting passive-active immunity to lib Ag. Grady
O
and Lee v1975) fount that 12 months after injection more recipients
of normal gamma globulin possessed HB Ab than in a group receiving
0
high titre HB—Ig , suggesting that the latter treatment may inhibit
active stimulation. A similar finding was noted by Aeeff et al.
(1975) with over }0 percent of normal gamma globulin recipients
possessing KB Ab after six months, corspared with only 8 percent of
the HB-IgG group. This i3 an important point because the need to
stimulate active Immunity must be one of the consiterations in the
decision to use fffi-IgG or normal gamma globulin.
On the basis of available data, it is difficult to decide upon
specific guidelines for the use of either product, or indeed the
frequency of administration. Theoretically iamunoprophylaxis
need not be given to persons who already have circulating HB Ab.
0
The main requirement for HB-IgG would seem to be in cases of
accidental Hi Ag inoculation where one should aim for maximum3
immediate protection and be less concerned with long term immunity.
HB-IgG does not seem to be Indicated in the prophylaxis of
transfusion-associated hepatitis since approximately 90 percent of
such complications ore not now caused by hepatitis B virus (Prince
et al., 1974)• Posttransfusion (type B) hepatitis should oontinue
to be prevented mainly by using the least amount of blood possible,
using all-volunteer blood and screening donors by the moat sensitive
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assess available. Such preventative measures should have a much
greater potential impact than propjjylftctio gamma globulin.
It is difficult to know whether imm moprophylaxis sh uld be
given to persons who are repeatedly exposed to RB Ag, and if so,
whether it should be in the form of KB-lgG or normal gamma globulin.
Experimental hepatitis B vaccines are being prepared but several
years will be required before they are accepted as safe and
effective. In the interim, the use of HB-lgG or normal gamms
globulin will depend upon the availability of the former and upon
their relative ability to induce passive-active immunity.
IV. The bay Ahead (future research arising from work reported in
this thesis).
At the time of writing -he haemagglutination-inhibition test
for detection of f© .g, described in this thesis, is already proving
its worth in three Scottish Regional Blood Transfusion Centres and
the Iranian National Blood Transfusion Service, while laboratories
as far afield as South Africa and the U.S.A. are evaluating reagents
prepared in Edinburgh. However successful a teehnique may appear,
there is invariably room for improvement. Automation of HB AgQ
testing may be esirable in centres requij-ed to test very large
numbers of donations daily, and to this end I am pleased to report
that Mr. John Loekyer at the Blood Transfusion Centre in Bristol is
employing KB Ag-cooted, gluteraldehyde-fixed spherocytes prepared
in Edinburgh to develop a fully automated test procedure using the
Technicon autoanalyscr. Although many laboratories may not consider
automation of HB Ag testing worthwhile, the fact remains that thea —
main weakness of the present (manual) HAI test is its lack of
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objectivity. Automation at the point of reading, possibly in the
form of an optical scanning device in conjunction with a numerical
scale, would be desirable provided sensitivity did not aoffer.
The discovery that HB Ag-coated gluteraldehyde-fixed
spherocytes could be *overcceted' with specific antibody and
subsequently used for a direct IlPHA-type teat for HB^Ag has meant
that extremely stable BPHA reagents could be available to any
laboratory capable of preparing HB Ag-coated, gluteraldehyde-fixed
spherocytes. Not only do overcoated cells constitute a more stable
reagant than any of the commercial liPHA kits (which are extremely
unstable when reconstituted), but the fact that stabilised HB Ag-
coated 3pherocytes 'select' specific irBgAb from the environment
infers that specificity should also be improved. The >e are
features of the overcoated spherocytes which are in the process of
investigation.
The work of Puree11 et al. (1973/4) concerning the association
of HB Ab with HB Ag carriage and possible xnfectivity suggests thatO 3
a simple direct haemagglutlnation test for HB Ab could prove useful.c
To this end, one aim of current research is the extraction of HB Ag' o
from serum and/or -infected liver for subsequent 3pherocyte coating.
Preliminary experiments using a crude HB^g-HB^Ag preparation suggest
that it may be possible to coat HB Ag in the same way as HB Ag," C 3
although this may require de-purifying the 'purified* HB Ag withc
normal serum prior to coating.
Perhaps the most exciting prospect looming ahead of virologists
working in the hepatitis field is that of soon identifying other
posttransfusion hepatitis viruses. Their existence seems certain since with the
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introduction of 'third generation* MB Ag testing most posttransfusion3
(viral) hepatitis eases are negative for HB^Ag and subsequently show
no evidence of antibody response to either surface or core
components (Prince,et al., 1974, Feinstone, Kaplkian, Pureell,
Alter and Holland, 1975; Alter, Purcell, Holland, Feinstone, Morrow
and iori tsugu, 19751 Galbraith, Portmanrt, Sddleeton and Williams,
1975? Villare.jos, visona, Sduarte, Provost and Hilleman, 1975) •
In order to eliminate hepatitis A virus thA-Ag) as the causative
agent of non-B hepatitis, I have obtained antiserum to the M3-1
strain of HA-Ag fro© the 'national Institutes of Health (Bethesca,
U.S.A.) which I am currently using to attempt to identify the
causative agent of *epidemiological' hepatitis A outbreaks in
Edinburgh. when sufficient of the causative (virus) agent has
been isolated from pre md acute hase stool extracts, it is hoped
to attempt spherocyte coating. Meanwhile electron microscopy and
immune adherence hsema glutination appear to be identifying a virus¬




Phosphate Buffered Valine (t'.B.S.)
Stock Solutions*
1. Diaodium hydrogen orthophosph&te (.Na^PHO^, B.C.H., analar
grade, molecular weight = 177*99) ~ & 0.13 molar solution was
prepared by dissolving 53*3!?7 g«s. in 2000 ml, of sterile distilled
water. Two grass of sodium aside was also aoded to prevent
microbial growth,
2. Potassium dihydrogen orthophosphate (K K^PO,» o.I),H.,
analar grade, molecular' weight - I3o,09) - a 0,13 molar solution
was prepared ay dissolving 40,827 ga* in 2000 ml, sterile distilled
water. Two grama sodium aside was also added ^see above).
3. Sodium chloride (NaCl, 3,1.K., analar grade, molecular weight
= 30.44) - a 0.13 molar solution was prepared by dissolving
17.332 gas. in 2000 ml, sterile distilled water. Sodium azicie was
added as above.
o
Stock solutions were stored at 4 C or room temperature.
P.3.S. pH 6.4 was prepared by mixing the following volumes of stock
solutions:-
Nft HPO 280 ml.
2 **
K, PO^ 320 ml.
NaCl 800 ml.
tot al volume = i6C0 ml.
P.3.S. pH 7.2 was prepared by mixing the following volumes of
stock solutions:-
WaJiPQ. 713 ml.2 4
k HoP0 283 ml.2 4
itaOl 1 QUO ml,
total volume = 2000 ml.
o
forking solutions were kept at 4 0.
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llFAKLIA B
Preparation of from serum by extraction with polyethylene
O
trfrcol
Twenty-five rJL, KL Ag positive serum was centrifuged at
120,000 g. and the pellet resuapended to the original volume in
a.3,3, pH 6,4« -he pH was adjusted to 4*6, and 2 gut* P.A.&. 6000
were added. Alter stirring for 10 inmates, the mixtui© was
centrifuge! at 1pGQ g. for 10 uunutea, the supernatant discarded
and the precipitate resuspended in 2cj ml. of sterile distilled
water. The was subsequently removed by filtration through
Sephadex 0200. fractions possessmg lib Ag activity were pooled,s
concentrated ten times using an Amicon cell, dialyaed against
P.B.3. pH 6.4 and adjusted to contain 12b latex units of activity.
120.
iJ-PKNDlrt. 0
Preparation of serum by ueaaifa gradient centrifugation
HB Ag positive serum was ceatrifuged at 120,000 g« and the
pellet resuspended to 1/20 of its -rigrnal volume xn f.B.b. pH 6.4.
One ml. of this concentrate was layered onto a 4 ml. caesium
chloride (C3cl, h.B.H. analar grade, molecular weight - 10d. j,o;
density gradient ;2 gra. Csol dissolved in 4 ml. sterile distilled
water). Ihe gradient was then centrifuged at lj>0,0oQ g. for
o
04 hours at 4 C, after which 0.2 ml. fractions were collected
from the bottom of the tube. fhe refractive xndex of each
fraction was measured arid the density determined from tables.
fractions having a density between 1.1>40 - 1.2302 g./cm were
pooled, dialysed against f.B.b. pU 6.4 and re-gradiented. i'hose
fractions possessing most lid xg (as determined by immune eleotron
microscopy) were pooled, dialysed against i.B.b. pU 6.4 and




treatment of positive serum with betapropiolaptone lb.r.u.)
and ultra-violet light ( u.V.G.)
B.P.h.* was diluted. 1 in 10 in sterile uistilied water, ihis
10 percent solution was iurther uiluted 1 in 1U (to give final
u.P.l.. concentration of 17 percent; in saluie bicarbonate
o o v
solution'- *• (huovepproceaures should oe carried out at 0 0 to 4 C;.
one volume of 1 percent B.P.4. solution was mixed with two
• _ «_o
volumes of lis hg-positive serum xor 2 nours at j>7 0 and left
Q
^ . 0
overnight at 4 o.
the serum •#*"• • mixture was then decanted into plastic petri
dishes (just sufficient to cover ooctom of dish; and exposed to
U.7.L. xn a -.uckham chamber for 2 hours.
♦B.P.L. (Betaprone: i«'ellow3 and Testagar) should be stored at
minus 15°G to minus 20°G when not in use, and care should be taken
to avoid inhalation of fumes.
**Saline bicarbonate solution - The following reagents were dissolved
in 100 ml. sterile distilled water containing 1 rngm./al. sodium
aside;
1,6a ga. h'&HGO^ (b.D.H., analar grade, mol.wt.u4.01)
0.90 gnu NaCl ( " " " 56.44)




Phosphate Buffer pH 7.2
Stock solutions consisted of:
A. 0.2K Na^HPO (B.B.K., analar grade) .24 prepared by dissolving
B. 0.02M K H^PO^ (B.D.H., analar grade)
in sterile distilled water containing 0.1 percent (w/v) sodium
aside.
forking solutions were prepared by dissolving stock solutions




Sum-nary of I-B Ag testing data from five English Mood Transfusion
s
Centres.
SUI-'KARY OF RESULTS OP T: PTS FOR AUSTRALIA ANTIGEN AND ANTIBODY IN DONORf












































54,557 38 (1: 1462
1,222 1 (1s 1222
278 2 (1s 139
(November 1971 - April 1972$ second six months)
51,594 15 (1$ 3439)
50,005 13 (is 3846)
1,163 0
































(November 1971 - Kay 1972)
66,799 42 (1s 1590) 40
61,044 34 (1s 1801} 32
2,618 2 (1s 1309) 2
2,164 4 (1s 541) 5
973 2 (1s 486) 1
(January 1971 - February 1972)
23,390 16 (1 s 1462)
19,438 13 (1s 1494)
1,527 1 (1s 1527)
1,449 0
976 2 (1» /■—\00CO












































18 ((1» 2597) -
9 I(1s 4742) mm
3 (>1s 800) mm
6 ((1. 279) -
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Summary
The incidence of hepatitis B (surface) antigen and its
specific antibody among patients and staff of a burns
unit were investigated using a sensitive haemagglu-
tination test. Comparison with appropriate age- and
sex-matched controls showed a higher incidence of
specific antibody among both patients and staff within
the unit. No antigen was detected.
INTRODUCTION
Severe burns (in excess of 40 per cent total body
surface) are associated with profound alterations
in plasma volume during the first few hours
(Kukral and Shoemaker, 1970). Specific therapy
frequently employs the transfusion of plasma
during the initial resuscitation period (Muir and
Barcley, 1973), followed by whole blood for those
with more than 20 per cent full-thickness burns
(Sanders, 1974). Further transfusion may be
required during subsequent skin grafting.
Hepatitis B (serum hepatitis) has emerged as
a significant complication following the trans¬
fusion of blood and blood products, and it has
been estimated that 25-60 per cent of recipients
of hepatitis B (surface) antigen (HBS-Ag)-
positive blood develop antigenaemia, and in many
it is subsequently associated with hepatitis
(Gocke and Kavey, 1969). Each unit of dried
plasma is prepared from a pool of 10 donations,
and since a severely burned adult may receive
as many as 12 units of plasma during the initial
period of resuscitation, the maximum total
"Currently: Christine Kleiner Fellow in Hand Surgery,
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exposure might be as high as 120 blood donations
for plasma alone. The outcome of a challenge
with HBS-Ag in the burned patient may be
influenced by the transient immune deficiency
statewhich followsmajor thermal injury (Rapaporl
et ah, 1968; Munster et ah, 1970; Daniels et ah,
1971; Mahler and Batchelor, 1971) since a high
incidence of HBS-Ag has been found in associa¬
tion with conditions characterized by underlying
immune deficiency (Blumberg et ah, 1967).
The following article describes the results of
a study designed to detect HBS-Ag and FIBS-Ab
in the sera of 118 burned patients who received
plasma and whole blood prior to the introduction
of routine HBS-Ag blood-donation testing in
1971.
PATIENTS AND METHODS
Sera from 118 patients previously treated in the
burns unit and 26 staff (medical and nursing)
were collected and stored at —20°C until tested
for HBS-Ag and HBS-Ab. The controls con¬
sisted of 118 age- and sex-matched, healthy blood
donors being tested for the first time and with no
history of blood transfusion, and 25 members of
the medical and nursing staff from a general
surgical ward in the same hospital. A haem-
agglutination technique (Hopkins and Das, 1973)
was used to test the sera for the presence of
HBS-Ag and HBS-Ab. All specimens were coded
and their origin not revealed to the person
responsible for testing. Sera giving positive
reactions were confirmed and subtyped by a
modification of this technique (Hopkins and Das,
1974), Serum glutamic pyruvic transaminase
(SGPT) values were also determined on most
samples.
RESULTS
The overall results are summarized in Table / and
show that HB,-Ag was not detected in any of the
patients, appropriate matched controls, or mem¬
bers of the burn unit staff. HBS-Ab, however,
was present in 6-9 per cent of the patients but in
none of the control blood-donor population
Table I Incidence of HB.S-Ag and H8,-Ab




Patients 118 0 8 (6 9)t
Controls 118 0 0 (0)
Staff 26 0 2* (7-6)
Controls 23 0 1** (4-3)
t Figures in parentheses represent percentages
* Titres were 1 /80 and 1 /40; only anti-a was detec¬
table when subtyped
** Titre was 1/640 and subtyped as anti-ad
This difference was statistically significant at the
1 per cent level (McNamar test). In the staff of
the burns unit the incidence ofHB,-Ab was 7 6
per cent compared to 4-3 per cent in a similar
group working in a general surgical unit. The
difference between these two was not significant.
Further details of the HBs-Ab-positive patients
are summarized in Table II. With the exception
of 1 patient, the HBS-Ag titre was low. In 5
patients it was so low that it was not possible to
Burns Vol. 2/No. 1
subtype. One of these patients had a. slightly
abnormal elevation of SGPT.
DISCUSSION
Since February, 1974 all blood donations in the
South-east region of Scotland have been tested
for HB,-Ab and HBS-Ag by haemaggiutination
and haemagglutination-inhibition respectively
(Hopkins and Das, 1973). Current evidence,
using this technology on 41,053 donations, shows
an HB.-AB incidence of 0-7 per cent which com¬
pares with 0-04 per cent as determined by counter-
electrophoresis (CIEOP) in the same laboratory
during the previous 12 months (Hopkins et ah,
1975). If this frequency (0 7 per ceni) is taken as
a baseline for the regional population, then fhe
incidence of F1BS-Ab in burned patients, following
treatment, is 9-8 times greater. This difference
was highly significant. In a recent publication
Payne et al. (1974) found that ihe combined
incidence of HBS-Ab in patients admitted to medi¬
cal and surgical wards of a general hospital was
almost 3 times greater than that of the local blood
donor population. It seems iikely, therefore, that
burned patients are exposed to HB - Ag to a con¬
siderably greater extent than most other groups
of hospitalized patients This is hardly surprising
in view of the fact that resuscitation and subse¬
quent plastic surgery may expose a burned indivi¬
dual to more than 100 different blood donors and
that the immune status of these patients at the time
of exposure could be abnormal.
Within the group of HBs-Ab-positive patients
no correlation was found between the degree of
exposure (number transfusions given), the tirfie
elapsed since exposure, and the HBS-Ab litre, *In
all but one sample (patient no. 6) the amount of
antibody was too low to be detected by CIEQP,
a feature which may account for the fact that/in












6 22 15 4000 ay 3
7 31 2 10 a 2
15 25 2 10 a 10
33 18 2 80 a N.T.
90 22 5 40 a 6
104 30 10 40 a 7
106 20 16 160 ad 17
115 8 2 80 ad 1
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could be identified. SCiPT values were only
slightly elevated in one of the antibody-positive
patients.
The incidence of HBS-Ab among the surgical
and nursing staff of the burns unit was found to
be 10-8 times greater than in the regional blood-
donor population and almost twice that of com¬
parable staff in a general surgical ward of the same
hospital. Because the numbers in this part of the
study are small, it is not possible to come to firm
conclusions, but it does suggest that the high risk
seen in the burned patients is likely to be trans¬
ferred to the staff. Such a conclusion is supported
by the observation that in haemodialysis units
1 or 2 members of staff suffer some exposure for
every 2 patients (Editorial, British Medical
Journal, 1972).
CONCLUSION
The patients studied in this series were transfused
with blood and plasma prior to routine HBS-Ag
testing of blood donations, and thus the clinical
significance of the results so obtained should not
be interpreted in light of existing practices.
Further studies are in hand to ascertain the inci¬
dence of HBS-Ab in burned patients managed
with blood and plasma which has been HBS-Ag
tested. The data do suggest, however, that
burned patients may represent a population at
especially high risk and that this risk is transferred
to their attending staff. Burned patients may.
constitute a particularly sensitive hospital popu¬
lation on which the quality ot HBS-Ag testing by
the Blood Transfusion Service can be readily
assessed.
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cid and ay subtypes of hepatitis B antigen in a
case of hypogammaglobulinemia
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synopsis We describe the finding of d and y specificities of hepatitis B surface antigen (HBsAg) in
a case of hypogammaglobulinaemia of the 'common variable' type treated with fresh frozen plasma
infusions. Absorption studies show that the two specificities are on separate particles, suggesting
dual infection. It raises important questions regarding the relationship between HBaAg persistence
and the immune status of the carrier.
Levine and Blumberg (1969) first suggested that
HBsAg could be separated into subtypes with a
shared group specificity designated a. The principal
subtype specificities have since been defined and
designated d and y (le Bouvier, 1971) and w and r
(Bancroft et al, 1972). These pairs of specificities
seem to represent two allelomorphic systems, the
four phenotypes being adw (D), adr, ayw (Y), and
ayr. The last is exceedingly rare in a European
population. Increasingly, hepatitis reference labora¬
tories are able to test for d and y specificities using
monospecific antisera. As a rule, the two common
phenotypes, D and Y, are mutually exclusive. The
finding of d and y specificities in the same serum is.
rare. It is even less common to find both d and y on
separate particles, and the few reported cases were
all on long-term haemodialysis (van Kooten-Kok
Doorschodt etal, 1972; Soulier and Courouce-Pauty,
1973), In our present report immunoabsorption
studies indicate that the two specificities reside on
separate particles, suggesting dual infection.
To the best of our knowledge there are no previous
reports of this finding in hypogammaglobuiinaemia.
Such patients, if treated with fresh frozen plasma
infusions, may be at particular risk of becoming
hepatitis B virus (HBV) carriers.
Case Report
A 57-year-old Caucasian man had had recurrent
respiratory infections since adolescence. In 1957,
aged 39 years, he was investigated for recurrent
cough and purulent sputum. The bronchogram was
Received for publication 20 May 1975
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normal and a diagnosis of chronic suppurative
bronchitis was made. In 1962 he was admitted to
hospital with bilateral bronchopneumonia and found
to have a serum, y-globulm level of 0-2 g/1. Regular
therapy with pooled normal human y-globulin was
begun and he was much improved subsequently.
After four years he began to have anaphylactic
reactions to the y-globulin and treatment was
discontinued. Despite continuous prophylactic anti¬
biotic therapy he deteriorated and in 1969, after an
attempt at desensitization, y-globulin therapy was
resumed. Further anaphylactic reactions ensued and
in September 1971 he was started on infusions of
fresh frozen plasma, initially one per week and later
on every second week, along with continuous oral
ampicillin. In March 1972 he suffered an episode
of general malaise, anorexia, and upper abdominal
pain. He was not jaundiced and his serum bilirubin,
SGOT, SGPT, and LDH levels were normal, but
the serum alkaline phosphatase was raised at 263
IU/1. A liver biopsy was not done and serum was
not tested for HBsAg. Subsequently the alkaline
phosphatase returned to normal. In September
1973, plasma infusions were reduced to three-weekly
intervals and on this regimen he has since remained
reasonably well.
In June 1974 his immune status was fully investi¬
gated, with the following results:
Peripheral blood:
Absolute lymphocyte and granulocyte counts
were normal.
Serum immunoglobulins:
IgG 30 IU/ml, IgA 23 IU/ml, IgM 28 IU/ml (2|
weeks after plasma infusion).
Serum complement:
C3 and C4 levels normal.
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Red cell serology:
Direct and indirect antiglobulin tests and screen
for anti-erythrocyte antibodies negative
Iso-agglutinin litres.
Iso-agglutinins not detectable (red cells, "coup O)
Phagocyte function:
Phagocytosis and intracellular killing of Staphy¬
lococcus aureus by blood leucocytes, stimulated
NUT test,-and leucocyte chemotaxis (migration
through 3/a Miilipore filter), all normal
Lymphocyte function:
Stimulation of blood lymphocytes (incorporation
of 3H-ihymidine into DNA) by mitogens (pbyto-
haemagglutinin, coneonavolin A, and poke-weed
mitogen) and by pooled allogeneic cells, all normal
Blood lymphocyte subpopulations:
The T cell count (E rosettes) was normal; B cells
(EAC- rosettes) 6% (normal 10-20%)
Skin testing:
Positive delayed hypersensitivity response to
mumps antigen; no response to PPD and Candida
Antibody response to tetanus toxoid;
No antibody detected (passive haemagglutination
technique) before and 14 days after immunization
These results confirmed hypogammaglobulinemia
and demonstrated intact cell-mediated immunity,
both phagocytic and lymphoid.
In September 1974 routine testing in a diagnostic
laboratory (Regional Virus Laboratory, City) Hos¬
pital, Edinburgh) showed that the patient'siserum
was positive for HB.Ag (by counter-immunoefectro-
phoresis, CLEP). At this time the liver was not
enlarged and liver function tests (serum bilirubin,
GOT, GPT, and alkaline phosphatase) were normal.
• '
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HBsAg TESTING AND SUBTYPJNG
Methods used in our laboratory to confirm HBsAg
positivity were haemagglutination inhibition (MAI),
as previously described by Hopkins and Das (1973),
haemagglutination (turkey ceil HA kit, Welcome
Reagents Ltd), and radioimmunoassay (Austria I
RIA kit. Abbot Labs, Ltd). To identify and titre
d and y specificities, monospecific antisera -were
used in the HAI assay as previously described
(Hopkins and Das, 1974).
IMMUNOABSORPTION
In order to determine whether d and y were assoc¬
iated with the same or separate particles, 0-5 ml of
a 1 in 5 serum dilution was incubated with an equal
volume of monospecific anti-y serum1 at 37°C for
1 hour, and at 4°C for 16 hours. The mixture was
'Prepared by affinity chromatography. Antiserum containing
anti-ayw activity was processed on an activated Sepharose
4B column to which was coupled HBsAg of specificity adw,
removing anti-aw activity.
then centrifuged at 30 000 x g lor 60 minutes to
pci'vi immune complexes. The supernatant and
pellet were tested for a, d. and y antigeneic specifi¬
cities by HAl ant! the supernatant for the presence
of anti-y antibody by direct haemagglutination.
EI-EC T RON MICROSCOPY
Serum was centrifuged at 120 000 x g for 4 hours
and the pellet washed once in saline and recon¬
stituted to I/20th of the original volume. One drop
of this suspension was mixed with an equal volume
of 2° phosphotungstic acid (pH 6-S) and absorbed
o o a collodion coated copper grid (400 mesh) for





HBsAg positivity was confirmed in our laboratory
by HAI, HA, and RIA. Both d and y subspecificities
were detectable in the serum to tithes of 1 in 200
and 1 in 100 respectively (HAI method).
The results of immunoabsorption against mono¬
specific anti-y are summarized in the table. Anti-y
was present in the supernatant, shoeing that anti¬
body was present in excess. Therefore apparent
absence of y specificity in the pellet was presumably
because all y determinant combining sites were
occupied by anti-y. No y antigen was detectable in
the supernatant while d subspecificity remained at
the original titre (1:20, equivalent to 1:200 of the
undiluted serum), indicating that d bearing parficles
had not complexed with anti-y, that is, d and y
subspecificities were on separate .particles. The
reciprocal absorption (using monospecific anti-d)
was performed on a serum sample taken at a different
time; d subspecificity was removed, leaving y
undiminished in the supernatant at a titre of 1:1000.




Antigen Serum2 (1:10 Supernatant Pellet
Specificity Dilution) before after Absorption 6j-
Absorption
a 1/1600 1 /1000 1/200
a 1/20 1/20 Negative
y 1/10 Negative Negative
Table hmnunoabsorption with monospecific anti-y1
1Monospecific anti-y antiserum prepared by affinity chromatography
"litres performed on whole serum: figures corrected for 1:10 dilution
incurred during absorption
Reciprocal absorption of a separate serum sample using monospecific
anti-d antiserum removed d antigen leaving y antigen undiminished
(see text).
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Figure Electron micrograph (x 210 000) showing 20nm spherical and rod-like structures ofHBsAg and 42nm
Daneparticles
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presence of a in both the pellet arid supernatant
provided good supporting evidence that we were
dealing with two distinct populations of HBsAg
particles.
ELECT it ON MICROSCOPY
EM studies (figure) showed tiie characteristic
spherical and rod-like structures, 20 am in diameter,
as well as numerous 42 urn Dane particles, believed
to represent the complete infectious virion.
Review of Patient's Sera and Plasma Donors
Retrospective investigation of a serum sample of
7 February 1973 showed the presence of both
HB«Ag specificities (at the same titres as in 1974),
but a sample of 2 December 1970 was negative. We
were unable to locate any serum samples taken
between these dates. From the beginning of plasma
infusions on 7 September 1971 until 7 February 1973
he had received 72 donations of plasma. Screening
of all blood donations for HBsAg by the CIEP
method was begun in September 1971. Initially the
patient received four donations of plasma that had
not been tested. The remaining 68 donations were
HBsAg negative by the relatively insensitive C1EP
test. None of the 72 donors involved has subsequently
been found to be positive by CIEP or by the more
sensitive HAI technique which has been in routine
use since the beginning of J 974.
Review of Other Hypogannnaglobulinaeiiiic Patients
Recognizing the possibility that other similar
patients may have become HBsAg carriers, we
tested all the hypogammaglobulinaemic patients
known to us in the Edinburgh area. There were nine
such patients in all; seven had received y-globulin
therapy at some stage, and one had been receiving
fresh frozen plasma infusions for two and a half
years. All were negative for HBsAg by the HAI
method.
Discussion '
Generaiiy speaking the d and y specificities of
HBsAg are mutually exclusive, and it is exceptional
to find both specificities in the same serum. There
are three reports where d and y specificities may
have been present on separate particles in patients
on haemodialysis. Ling et ai (1973) reported two
such cases indicated by the results of radioimmuno¬
assay, but cross absorption studies were not done.
Van Kooten Kok-Docrschodt et til (1972) described
a case and Soulier and Courouce-Pauty (1973)
reported two further cases where d and y sub¬
specialties could be separated by absorption. The
absorption studieswhich we describe clearly indicate
that the «d and ay subtypes were present as distinct
populations. The simplest and most likely cx-
planalrn l is thai the patient underwent dual in¬
fection from two positive donors. Unfortunately,
serum samples were not available to show whether
the. two subtypes appeared sequentially. Therefore
there is the small possibility that he was infected by
one donor who carried both subtypes.
Tt i.-> now widely believed that the immune response
to HBV determines the nature and degree of tissue
damage and whether the subject develops the carrier
state. The HBV per se is probably not cytocidal to
hepatoeyte:: (Hand and Finlayson, 1973) but cell
damage results primarily from a cell-mediated
responseof the delayed hypersensitivity type (directed
against the virus or altered ceil components). This
is supported by several lines of evidence. If cellular
immune responses arc heightened by giving transfer
factor in chronic active hepatitis (HBsAg positive),
then there is a transient rise in serum transaminase
levels (Shulman et al, 1974). It has been repeatedly
shown, using leucocyte-migration inhibition and
lymphocyte transformation tests, that clinical
disease is associated with a positive in vitro response
to HBsAg, while in the chronic carrier there is a
negative response (Dudley et al, 1972; Laiwah et al,
1973).
Specific antibody alone is protective if present
before infection (Sutnick et al, 1972) or when given
prophylactically after accidental inoculation (Das
and Hopkins, 1974). Antibody may also mediate
cellular cytotoxicity to liver cells in chronic active
hepatitis (Eddieston and Williams, 1974). In estab¬
lished HBV infection the cell mediated immune
response would seem to act in conjunction with
circulating antibody to eliminate the virus; that is,
cytotoxic T or K cells cause lysis of infected hepato-
cytes, and the liberated viral particles are then
neutralized by circulating antibody. Thus it can be
postulated that both the cellular and humoral arms
of the immune response must be impaired (or
inadequate) to allow the development of the HBsAg
carrier state with little or no liver damage. In the
case we describe here, no deficiency in T cell function
could be detected; however, it is possible that a
specific defect existed which was not detectable by
the screening tests used, none of which was specific
for HBsAg.
There is ample epidemiological evidence indicating
that impaired immune function predisposes to the
carrier status. There is a relatively high incidence of
HBsAg carriers among institutionalized cases of
Down's syndrome (Sutnick et al, 1968), chronic
renai disease on haemodialysis (Turner and White,
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1969). transfused lymphocytic leukaemia (Sutnick
et al. 1970), and lepromatous leprosy (Blumberg and
Melartin, 1970); in all these conditions cellular
immune responses or both cellular and humoral
responses are impaired. Tolerance induction may be
important, and this is a plausible explanation for the
high incidence of carriers in infants exposed to the
HB virus in neonatal or prenatal life, reported by
Schweitzer et c// (5 972).
It is well recognized that generally there is no
increased susceptibility to viral infections in hypo-
gammaglobulinaemia, where cell mediated immunity
and interferon production are intact. However,
absence of specific antibody would increase the
susceptibility to any virus which gains entry via the
blood stream. This seems to be so in the case of
inoculated HBV (see above). Moreover, established
immunity to one subtype may confer immunity to
infection by the other subtype, by virtue of antibody
against common specificities, provided that the
challenge dose of virus is not overwhelming. From
these considerations we conclude that hypogamma-
globulinaemic patients are more susceptible to HBV
infection and to reinfection by the other subtype.
It is noteworthy that we failed to identify the
infective donor(s) despite retrospective checking of
every plasma donation against the records of HBsAg
positive donors. The majority of the people who
gave the original 72 donations of plasma would have
been tested by CIEP or HAI at subsequent donations
and none has proved positive. Nevertheless our
finding of both d and y subspecificities in this case of
hypogammaglobulinaemia indicates the strong
possibility of double infection from plasma infusions.
Patients with hypogammagiobuliriaemia who receive
only pooled human y-giobulin are exposed to a
negligible risk, but those who develop severe
reactions to y-globulin and require plasma infusions
may be at particular risk of becoming HBV carriers.
We recommend that all hypogarnrnagiobuiinaemic
patients having regular fresh frozen plasma should
be monitored closely for H8sAg.
We wish to thank Dr I. W. B. Grant, consultant
physician, Respiratory Unit, Northern General
Hospital, Edinburgh for kind permission to publish
this case. We also acknowledge the advice and
encouragement of Dr J. D. Cash, Director, South
East Scotland Regional Blood Transfusion Centre,
Edinburgh.
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Australia Antigen (HB-Ag) Subtyping by a Sensitive
Tanned Cell Haemagglutination-Inhibition Technique
R. Hopkins and P. C. Das
South-East Scotland Regional Blood Transfusion Service, Royal Infirmary, Edinburgh
(Received 11 December 1973 ; accepted for publication 2 January 1974)
Summary. The tanned cell haemagglutination-inhibition technique was used to
subtype Hepatitis B antigen (HB-Ag) sera according to their D (ad + , y—) and Y
(ay + , d—) specificity. The results were in agreementwith those obtained by workers
in the United States and Sweden using immunodiffusion. The majority (35 out of
39 tested) ofHB-Ag blood donors detected during the last 2 yr in South-East Scot¬
land were found to possess the D subtype. The Hepatitis B antibody subtype content
of two preparations of immunoglobulin prepared for clinical use has also been
studied.
Analysis of the surface antigens ofHepatitis B antigen (HB-Ag) have revealed one common
specificity 'a' and three additional determinants, 'd', 'y' and 'x' (Le Bouvier, 1971). Speci¬
ficities a, d and y appear to reflect the genotype of the antigen, while x may be a component
of the host which has become integrated into the particle or firmly attached to its surface
(Le Bouvier, 1972; Le Bouvier et al, 1972). It is now possible to divide HB-Ag positive
material into at least two subtypes, i.e. 'Set D' (ad+, y—) or 'Set Y' (ay+, d—). A third
subtype may be included within a miscellaneous collection ofHB-Ag samples which do not
fall into these categories and designated'Set A' (a + , dy—). Most, and perhaps all, of these
are more likely to reflect the inability of immunodiffusion to detect very low levels of d and
y. Two additional antigenic determinants designated 'w' and 'r' have recently been described
(Bancroft et al, 1972) in a study in which w predominated in the Western hemisphere, and
r characterized HB-Ag of Eastern origin. HB-Ag appears to breed true in the sense that a
given specificity gives rise to HB-Ag of the same specificity in the recipient (Krugman &
Giles, 1970). This makes it possible to trace the spread of both subtypes independently
through the community. Iwarson et al (1973) have reported evidence for a change in the
dominant subtype associated with HB-Ag positive clinical hepatitis in Sweden, from D to Y
over a period of 20 yr. A number of other recent publications suggest that subtype D is
often found in the chronic asymptomatic carrier (Holland et al, 1972; Wenzel et al, 1972).
The Y subtype has also been associated with outbreaks of serum hepatitis in renal dialysis
units, including the exceptionally severe outbreak in Edinburgh (Marmion & Tonkin, 1972).
Recently Nielsen & Le Bouvier (1973) have studied the relationship between HB-Ag subtypes
and the degree of liver damage in acute viral hepatitis. They too identified subtype Y in the
majority ofcases, but surprisingly found that when acute disease did occur in association with
Correspondence: Mr R. Hopkins, South-East Scotland Regional Blood Transfusion Service, Royal Infirmary,
Edinburgh.
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subtype D, it was usually more severe than that associated with Y. Immunodiffusion (ID)
was the first technique to be used for the detection ofHB-Ag (Blumberg, 1964) and remains
a useful means of subtyping (Gust, J971). Counter-electrophoresis (CIBOP) employing j
anttsera rendered, monospecific by absorption has also been applied to subtyping (Holland
el al, 1972), and solid phase radioimmunoassay (RIA) promises to provide a sensitive means
ofsubtyping HB-Ag not detectable by ID or CIEOP (Ginsberg ct a!, 1972).
Prince ct al (1972) were the first to apply haemagglutination inhibition (HAI) to die
subtyping ofHB-Ag, but the chromic chloride technique used (Vyas & Shulman, 1970)
has proved unsuitable tor mass donor screening. We report the application of a simple,
rapid and sensitive tanned cell HAI (Hopkins & Das, 1973) to the subtyping of HB-Ag
derived from local blood donors, dialysis patients and sera from standard panels supplied by
the. National Institute ofHealth and theAmerican Red Cross.
MATERIALS AND METHODS
A number of sera containing Hepatitis B antibody (HB-Ab) were tested by ID and CIEOP
against previously subtyped HB-Ag sera. It was apparent that one of the antisera reacted
strongly with antigen of subtype D, but weakly, if at all, with antigen of subtype Y, sug¬
gesting a predominance ofanti-a and anti-d. Anti-a was removed by absorption with HB-Ag
of subtype Y by concentrating the antiserum five times with lyphogel and incubating with
different concentrations ofY at room temperature for 1 hr, followed by overnight incuba¬
tion at 4°C. Immune complexes were removed by centrifug2tion at 20 000 rpm (Sorval
RC2B) for 1 hr and the supernatant tested for the presence of anti-d by direct haemagglu¬
tination (HA) with D-sensitized cells (Fig 1). Removal of anti-a activity was indicated by
agglutination ofD-sensitized cells, but not ofY-sensitized cells (Table I). Anti-y was prepared
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SsjS&tplus some unabsorbed anti -
Fig 1. Titration of HB-Ab (anti-ad) after absorption with different concentrations of HB-Ag of
specificity Y.
HB-Ag was subtyped by HAI (Hopkins & Das, 1973) using anti-d and D-sensitized cells.
Absence of agglutination was indicative of HB-Ag specificity d while the presence of
agglutination showed that anti-d had not been neutralized by the antigen, which may possess
specificity y. This was confirmed by retesting with anti-y antibody when a true Y antigen
would not allow agglutination of Y-sensitized cells.
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(prepared by absorption) + -
The reliability of the technique was tested by subtyping HB-Ag positive sera from three
different sources: five sera from a standard panel supplied by the National Institute ofHealth,
Bethesda, U.S.A., and five sera from a panel supplied by the American Red Cross. These
sera had previously been subtyped at source; three sera from healthy carriers detected during
routine donor screening by CIEOP at the Blood Transfusion Centre, Royal Infirmary,
Edinburgh, and two sera from dialysis patients involved in the Edinburgh outbreak of 1969-
70, which had already been subtyped (Dr G. Le Bouvier, Yale University Medical School,
Connecticut, U.S.A.) using ID. The sera from all three sources were double coded and an
equal number ofHB-Ag negative sera included, before being subtyped by HAI.
For the past 2 yr all blood donated in the South-East Region of Scotland has been tested
for HB-Ag by CIEOP. During this period 39 HB-Ag positive sera have been identified.
In order to determine the prevalence of each HB-Ag subtype in the local donor population
these sera were investigated by HAI using monospecific HB-Ab as described above. Most of
these sera had already been subtyped by Dr Le Bouvier (Yale University Medical School,
Connecticut, U.S.A.) or by Dr L. Magnuis (National Bacteriological Laboratory, Stockholm)
using ID. .
The technique has also been used to titrate the anti-ad and anti-ay specificity in the hyper¬
immune (HB-Ab) gammaglobulin (HB-Ab, IgG) prepared at the Protein Fractionation
Centre, Royal Infirmary, Edinburgh, and used prophylactically in cases of accidental ex¬
posure to FIB-Ag.
RESULTS
The results of subtyping HB-Ag positive sera by HAI and ID are given in Table II. Com¬
plete agreement was found between the two techniques. The prevalence ofD and Y amongst
HB-Ag positive blood donors in South-East Scotland is shown in Table III. The majority
appear to possess HB-Ag of subtype D. Table IV shows the differences in reactivity to two
batches of HB-Ab, IgG prepared at the Protein Fractionation Centre, Royal Infirmary,
Edinburgh.
C c-Tk c*. cji cUUj——- 1 C.<_9>c> o IM . q
DISCUSSION v . ' c^
At the present time most HB-Ag is subtyped by ID or CIEOP. Kim & Tillies (1971) were
first to note the greater negative charge associated with the Y subtype. This was subsequently
confirmed by P. E. Gibson & Y. E. Cossart (personal communication, 1973) who showed that
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'I aii; i: ]). Comparison of subtyping by MAI and II) of HB-Ag positive seta from three
different sources
Haemagglutiuation
Sample Origin Immunodiffusion inhibition
208 National Institutes ofHealth, Y Y




IOOI American Red Cross D D
1018 D D
1006 t; . i D D
2002. Y Y
2005 Y Y
BD-2-Edin Local HB-Ag positive Y Y
BD-7-Edin blood donors D D
BD-9-Edin D D
H226 HB-Ag positive dialysis Y Y
GC patients Y Y
Tabie lit. Prevalence of D and Y subtypes of
HB-A»g as determined by hacmagglutination-
inhibition amongst antigen positive blood donors
in South-East Scotland
No. of donors No. of donors
No. of with D subtype with Y subtype
carriers (%) (%)





Tabi.e IV. Haemagglutination titre of HB-Ab IgG prepared at the
Protein Fractionation Centre, Edinburgh
Batches of
gamma-globulin
Reciprocal titre of cells sensitized with
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HB-Ag of subtype Y migrated further than D in immunoelectrophoresis. Because of their
limited sensitivity, ID and CIEOP are wasteful of precious monospecific typing antisera and
are unable to subtype HB-Ag detected by more sensitive means (Shaffer et al, 1972; Ling &
Overby, 1972). Solid phase RIA offers a means by which such sera may be subtyped. Un¬
fortunately, this technique seems prone to give false positive results with certain sera (Sgouris,
1973; Prince ct al, 197*3) requires expensive counting equipment and specially trained per¬
sonnel to handle radioactive material. At the time of writing, solid phase RIA subtyping
kits are not commercially available. HAI (Hopkins & Das, 1973), on the other hand, is a
simple technique using human 'O' Rh negative erythrocytes sensitized with beta-propio-
lactone/UVL-treated HB-Ag. It has overcome many of the problems associated with the
chromic chloride technique. The application described here permits a rapid (within 2 hr)
differentiation ofD and Y subtypes ofHB-Ag with a sensitivity similar to that ofRIA. The
discovery of at least two subtypes of HB-Ag clearly implies that techniques and reagents
used for routine testing of blood donors and hepatitis patients should be capable of detecting
both subtypes. The apparent predominance of D amongst healthy HB-Ag positive blood
donors in South-East Scotland is in agreement with other Western European donor popu¬
lations (Iwarson ct al, 1973; Holland et al, 1972).
Subtyping ofHB-Ag is an important epidemiological tool in view of the possible relation¬
ship between subtype and disease. The prophylactic use of HB-Ab, IgG in 'accident' cir¬
cumstances may be effective, but as a therapeutic measure in the treatment of disease requires
further investigation. Its efficacy may be enhanced by using HB-Ab, IgG of the appropriate
subtype specificity.
Addendum A '
Since acceptance of this paper for publication the authors have received further confirma¬
tion of the subtypes relating to the antigen-positive blood donors detected locally. Results
obtained from Dr Overby (Abbott Laboratories) using radioimmunoassay show complete
agreement with those obtained by HAI. Dr Overby has also reported that each of the donor-
carriers tested possessed the antigenic determinant w by immunodiffusion.
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/ A Tanned Cell Haemagglutination Test for the Detection of
Hepatitis-Associated-Antigen (Au-Ag) and Antibody
(Anti-Au)
R. Hopkins and P. C. Das
South-East Scotland Regional Blood Transfusion Centre and Blood Products Unit,
Royal Infirmary, Edinburgh
(Received 22 March 1973; acceptedfor publication 2 May 1973)
Summary. A tanned cell haemagglutination technique using inactivated Au-Ag
to sensitize human 'O' Rh negative erythrocytes is described. The method may
be used to detect Au-Ag by haemagglutination inhibition (HI) and anti-Au by direct
haemagglutination (HA). Sensitivity and specificity are demonstrated and its applica¬
tion to mass donor screening is considered.
Although not all post-transfusion jaundice is caused by hepatitis B virus, transmission of
hepatitis B is one of the most serious complications of the use of blood and blood products.
This situation is likely to persist until all donated blood is screened for Australia antigen
(synonyms: Au-Ag, PIAA, HB-Ag) by a rapid, specific and sensitive test system. The tech¬
niques currently used in most Transfusion Services are counter electrophoresis (CIEOP)
(Prince & Burke, 1970), which lacks sensitivity, and latex agglutination (Leach & Ruck, 1971),
which is both rapid and sensitive, but lacks specificity (Plopkins &c Das, 1973; Ziegenfuss,
1972; Burrell et al, 1972). The radio-immuno techniques (Lander ct al, 1971; Ling & Overby,
1972) are extremely sensitive research tools, but are costly and not yet applicable to the rapid
mass screening demanded by the Blood Transfusion Service.
Most laboratories have experience of some form of haemagglutination, and many have
found it amenable to automation. Juji & Yokochi (1969) described a haemagglutination test
using formalinized erythrocytes coated with anti-Au (synonyms: anti-HAA, Hb-Ab). Un¬
fortunately they observed non-specific agglutination, and a tendency for sensitized cells
to lyse within a few days. Vyas & Shulman (1970) published details of a haemagglutination
technique using chromic chloride as a coupling agent. This very sensitive technique has
gained acceptance in many research laboratories since it compares favourably with CIEOP
(Shaffer et al, 1972). When considering the logistics of its application to routine donor
screening, limitations have arisen due to the highly purified antigen required (Vyas et al,
! 1972), and great variability observed between different batches of cells (Reesink & Duimel,
1972). Furthermore, it is desirable to use inactivated antigen for coating erythrocytes which
will subsequently be used as a routine test reagent. In our experience the outcome ofcoupling
inactivated Au-Ag to human erythrocytes by chromic chloride has proved very unpredictable.
Correspondence: Mr R. Hopkins, South-Erst Scotland Regional Blood Transfusion Centre and Blood Products
Unit, Royal Infirmary, Edinburgh EH3 9HB.
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This communication describes a tanned cell haemagglutiuation technique, incorporating
inactivated antigen, which we believe goes a long way towards filling flic An- Ag screening




Known Au-Ag positive sera, used as controls, were derived from panels obtained from the
N1H (Bethesda), American National Red. Cross, Blood Research Laboratory, and apparently
healthy carriers found locally. Sera from six healthy males (39-64 yr), repeatedly tested
serologically and electron microscopically, were used as negative controls. Known specific
anti-Au capable, of reacting with both acl+ and ay'f antigens (Lc Bouvier, 1972). were used
in the inhibition reaction to detect Au-Ag.
Test A'laterial
Samples were obtained from selected donors, known contacts of Au-Ag, renal dialysis
patients and a subject involved in an 'accident' with Au-Ag positive blood, who subsequently
received hyper-immune anti-Au IgG prepared by the Scottish National Plasma Fractionation
Centre, Edinburgh, Au-Ag positive and Au-Ag negative normal sera were coded and included
among the test samples.
Phosphate Buffered Saline (PBS)
This was prepared from 0.15 m Na2 HPQ4, 0.15 m KH2P04 and 0.15 m NaCl. Tv|o batches
were made, one adjusted to pH 6.4 and the other to pH 7.2. Cell diluent consisting ofPBS,
pH 7.2, containing 1% normal rabbit scrum (previously inactivated at 56°C fof 25 min
and absorbed with washed packed red cells from the batch being sensitized) was used to
suspend the sensitized cells. Diluting Fluid (D.F.) consisting of 50% normal human serum
in PBS 7.3 was used to make serial dilutions for end-point titrations. Diluting media




Au-Ag positive serum collected from apparently healthy carriers was inactivated using
/I-propiolactone and ultraviolet light according to Lo Grippo (Lo Grippo & Hartnian, 1958;
Lo Grippo et al, 1971). The inactivated material was pelleted by centrifugation at 120 000
g for 4 hr in a M.S.E. Superspeed 65 centrifuge, using an 8 x 25 ml angle head, washed twice
in sterile physiological saline and finally resuspended in a small volume of PBS 6.4 and
adjusted to give an end point titre of 1/256 by latex agglutination (Pfizer Ltd, Kent, Batch
No. Li3/4; Leach & Ruck, 1971), or a titre of 1/4 by CIEOP (Das ct al, 1971), against a
commercial anti-Au serum (Batch T2160C) supplied by Hoechst Pharmaceuticals (Hounslow).
Au-Ag, thus prepared and still containing some serum proteins was stored at — 20°C until
required, when it was thawed and heated at 6o"C for 30 min prior to sensitization.
Tanning and Sensitization Procedure
Human 'O' Rh negative blood was collected in heparin, washed three times in physiological
saline and packed by centrifuging at 800 g for 5 min. The packed cells were then resuspended
r
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in PBS, pH 7.2, to give a suspension of 6.6% (v/v) to which was added an equal volume
of 1 :io 000 tannic acid (w/v) freshly prepared in the same buffer. 'I'lic mixture was incubated
in a 37°C water bath for 15 min, shaking gently every 3 min. The tanned cells were washed
once in an equal volume of PBS, pH 6.4, and resuspended in the same buffer to a 4% cell
suspension, which was divided into two aliquots. Au-Ag was added to one aliquot in the
ratio of 1 volume Au-Ag to 4 volumes of cells, mixed and incubated for 1 hr at room
temperature (20°C) on a rotostat (Luckham Ltd, Sussex) to ensure thorough mixing. The
remaining aliquot of cells was sensitized in the same way, with 1/12$ dilution (in PBS,
pH 6.4) of pooled normal human plasma (Au-Ag and anti-Au negative) for use as a plasma
sensitized cell control. The sensitized cells were washed three times in equal volumes of
cell diluent then made up to a 1.5% suspension in the same diluent and left at 4°C overnight.
Next morning the supernatant was replaced with fresh cell diluent and the cells stored at
4°C in small aliquots.
Test Procedure
Two systems were employed. One used disposable U-bottomed microtitre plates (Flow
Laboratories, Irvine) into which reagents were dispensed as drops from a pastcur pipette—
referred to as the microtitre system (M.T.S.). In the other system Tcrasaki microtest tissue
culture trays with lids (Bio Cult Laboratories, Paisley) were used. Reagents were dispensed
in 5 /d volumes using an Eppendorf pipette with disposable tips (Alderman and Co. Ltd,
London). This wras designated the mini-microtitre system (M.M.T.S.). In M.T.S. 0.75%
sensitized cells were used, while a similar degree of sensitivity was obtained in M.M.T.S.
with 0.3% sensitized cells.
(i) Microtitre system. For detection of anti-Au by direct haemagglutination (HA), the
test scrum was diluted in PBS 7.2 and mixed with an equal volume of sensitized cells.
The plate was covered to diminish evaporation, and incubated at 37°C for 1 hr. Antibody-
containing wells showed positive agglutination characterized by a smooth 'mat' of cells,
while absence of antibody was characterized by a 'button' of cells at the bottom of the well
(Fig 1). Once confirmed, the test scrum was further diluted and the end point titre, the lowest
concentration of antiserum producing complete agglutination, was obtained and defined as
1 HA unit. Controls included (a) virus control = sensitized cells+ cell diluent, (b) positive
control = sensitized ccl!s+ known anti-Au and (c) negative control = sensitized cells+
normal serum.
Au-Ag was detected by a two-stage haemagglutination inhibition reaction (HI). The test
serum was diluted | in PBS 7.2 and mixed with an equal volume of standard anti-Au
i
gsg-
containing 4 HA units of antibody activity and the plate incubated at 37°C for 30 min.
Sensitized cells were then added, the plate mixed and reincubated at 37°C for a further hour.
Agglutination indicated that no antigen was present. Controls included (a) positive control =
anti-Au+ known Au-Ag+ sensitized cells, and (b) negative control = anti-Au+normal
scrum+ sensitized cells.
(ii) Mini-microtitre system. For detection of anti-Au, test serum was diluted 1/2 in PBS
7.2 and added to an equal volume of sensitized cells, mixed on a rotostat at room
temperature (20°C) for 15 min and then transferred to a 37°C incubator for a
further 15 min. The tray was then spun for 10-15 s at No. 1 speed (0-25 g) in a bench
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centrifuge equipped with a serological head (Griffin and George, Middlesex). Finally the
tray was inclined at an angle of 43-50 degrees, at room temperature and read against a light
background at 5 min intervals until control reactions were complete. Jf 110 agglutination
occurs the cells slide down to the lower part of the base of the wells (Fig 2).
For detection of Au-Ag, flu- test serum was diluted 1/2 in PBS 7.2 mixed with an equal
volume of anti-Au containing 4 > IA units and incubated for t hr at 37°C. Sensitized cells
(5 /d) were then added to each well, and the two-phase incubation procedure repeated. The
tray was centrifuged and read as described. Controls for HA and HI were the same as for
M.T.S.
Confirmation
Positive reactions for anti-Au were confirmed by (a) retesting the sample with plasma
sensitized cells and (b) using the test sera as anti-Au in an inhibition reaction with known
Au-Ag positive controls and normal sera.
Positive Au-Ag reactions were confirmed by the ability of the sample to inhibit the titre
of known anti-Au sera, when compared with normal serum.
Determination oj Sensitivity
The ability of HI to detect Au-Ag was compared with immuno diffusion (ID), electro¬
phoresis (Das et al, 1971; Hopkins & Das, 1973), latex agglutination (Leach & Ruck, 1971)
using two commercial reagents (Pfizer Ltd, and Floechst Pharmaceuticals), immune electron
microscopy (Kclen et al, 1971), radio-immunoassay (RIA) using reagents from Abbot
Laboratories (Kent), and radio-immuno precipitation (RIP) performed at the Bacteriology
Department, Edinburgh University Medical School.
The sensitivity of HA was measured by comparing Anti-Au titres with CIEOP and also
by its ability to detect circulating anti-Au after administration of hyperimmune gamma¬
globulin to 'accident cases'.
[ ; I
Specificity
This was investigated by coding known Au-Ag positive and Au-Ag negative sera and
distributing them randomly among the test samples. All positive results were repeated for
confirmation.
RESULTS
Fig 3 shows partially purified Au-Ag prior to sensitization, while Fig 4 shows a sensitized
cell with Au-Ag bound to its surface. No free Au-Ag can be seen in the supernatant surround¬
ing the cell.
Pooled Au-Ag containing both ad+ and ay+ subtypes was titred and compared with a
variety of other techniques (Fig 5). It is clear that the haemagglutination-inhibition method
has a similar degree of sensitivity to the radio-immuno methods, and is considerably more
sensitive than most of the techniques commonly used in routine laboratories for blood
j. /
donor or patient screening.
The direct haemagglutination test is capable of detecting very low levels of anti-Au as
compared with CIEOP (Fig 6). This was further evidenced by its successful application in
r
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Fic 2. Appearance of positive and negative haemagglutination patterns in mini-microtitre system,
including artist's impression.
Fig 3. Partially purified Au-Ag prior to sensitization (E.M. mag. = 50 000).
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Fig 4. Sensitized cell with Au-Ag bound to surface. No free Au-Ag visible in supernatant (E.M.
mag. = 28 000).
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monitoring the levels of passively administered hyperimmune anti-Au (details of dose and
inoculation schedule to be published elsewhere) in a number of cases where CIEOP has
consistently failed to detect any antibody. Fig 7 shows the levels ofanti-Au detected in one
such case. No antibody could be detected prior to administration of the gamma-globulin,
while circulating anti-Au could be detected within 48 hr after injection and persisted up
to 15 weeks later.
Fig 8 shows the results obtained when Au-Ag positive and negative sera were coded and
tested by a variety of techniques. The hacmagglutination-inhibition test detected all positive
samples as did CIEOP and RIA, and gave no false positive reaction, while one batch of latex,
ID and IEM failed to detect several of the positive (Au-Ag) sera, and latex agglutination from
both commercial sources gave false positive reactions.
Table I. Results obtained when sera from selected donors and dialysis patients were screened for
Au-Ag and anti-Au by haemagglutination-inhibition and CIEOP
CIEOP Tanned-cell haemagglntination
No. Anti-HAA HAA Anti-HAA HAA 'Plasma-cell'
tested positive positive positive positive agglutination
Donors 76 4 7 4 7 0
Dialysis
patients 14 2 0 2 0 2*
* Different samples from those possessing anti-HAA.
The results shown in Table I confirm the specificity of the hacmagglutination method,
showing complete agreement with CIEOP when sera from selected donors and dialysis
patients were tested for Au-Ag and anti-Au. In two of these patients low levels of antibody
capable of agglutinating antigen sensitized cells were, in fact, due to reactions against scrum
protein(s) as demonstrated by agglutination of plasma sensitized cells. This antibody did not
inhibit the reactivity of purified ad+ or ay+ antigens whereas a known anti-Au (diluted to
a similarly low level) did have an inhibitory effect under the same circumstances.
DISCUSSION
The technique described in this report provides a simple, rapid, economical and highly
sensitive test within the scope ofmost routine laboratories. Preparation of reagents is straight¬
forward, and the use of inactivated antigen reduces the risk from accidental exposure to
personnel involved in routine screening. The use of a 0.75% cell suspension (microtitre
system) allows a reasonable incubation time, removes the need to centrifuge plates and
facilitates interpretation of results by personnel receiving only a short period of instruction,
while retaining a sensitivity of the same order as that of the radio-immuno techniques.
The mini-microtitre system, on the other hand, reduces the volume of reagents consider¬
ably although it then becomes advisable to centrifuge the trays to obtain the best definition
between positive and negative results. The apparent absence of variation amongst different
batches of cells eliminates any dependence upon a select group of red cell donors and reflects
CN u»
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the stability of the technique. The extreme sensitivity suggests that antisera may he used at
least 100-1000 times more dilute than for immunodiffusion or counter-electrophoresis,
thereby alleviating problems arising from expense or shortage of reagents. A shelf life of
3 weeks is acceptable if routine sensitization is performed fornightly. Storage of fresh cells
in liquid nitrogen and the use of glutaralclchyde fixed cells arc at present under investigation
in this laboratory with a view to increasing the shelf life of the reagents. It remains to be seen
whether or not tanned cells sensitized with Au-Ag will prove suitable for application to an
autoanalyser.
Experience in a variety of other biological systems, including hormone estimation, where
the tanned cell haemagglutiuation system has been used extensively, has shown that non¬
specific inhibition can occur in the assay system despite the use of specific antibody (Stavisky
& Ingraham, 1964). However, the specificity of the present technique for detection of Au-
Ag seems good as no false positive inhibition reactions have occurred amongst the number
of samples so far tested. A prozone effect was noted in the. direct haemagglutination test when
testing hyperimmune sera containing high titre antibody; this was eliminated by using a
starting dilution of test sera of 1/2.
It is probable that a proportion of the normal, apparently healthy, population may show
positive reactions due to low levels of antibody against plasma proteins when screened by
this sensitive method. Brumelhuis et al (1971) found 13 such reactions in 30000 samples
tested by the Netherland Red Cross Transfusion Service using the less sensitive technique
of immunodiffusion. Patients, particularly multitransfused patients, arc likely to produce such
reactions due to the development of iso-precipitins (Blumberg, 1964; Langenhuysen, 1971).
One possible way of circumventing this problem is to use highly purified Au-Ag for coating
the cells. However, when 'purified' Au-Ag was used in the haemagglutination method of
Vyas& Shulman (1970), as modified by Prince et 11/(1971), the sensitized cellswere agglutinated
by commercial anti-whole human sera and an anti-human IgG (Prince, 1972). This
finding may indicate the presence of anti-Au in the commercial antisera, but is more
likely to represent contaminating serum protein(s) in the 'purified' antigen. Whether the
contaminant(s) is a part of the Au-Ag moiety (Millman et al, 1971), or plasma protein, is
not known. However, the practical conclusions from these observations are that any serum
giving a positive reaction, particularly for antibody, must be retested using plasma sensitized
cells, and further confirmed by the means outlined in this paper. Fig 9 represents the situation
which may arise in a multitransfused patient possessing antibodies to both HAA and certain
plasma proteins (Vierucci et al, 1970). Further investigation of this phenomenon is required,
but such results are of interest in the light of the high incidence of apparently low levels of
anti-Au in multi-transfused patients reported by Lander et al (1971) and Levy & Hawrisiak
(1972).
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direct haeinagglutination. Sera positive for HBsAg were confirmed by
subtyping (ad/ay) rising a modification of the test assay.'3
Other Assays.—C.E.P. was performed as previously described,*
and the piates were washed with 1% tannic acid before reading.
Radioimmunoassay (Austin, Abbott Laboratories) and haemagglu-
tination (Ausce!, Abbott Laboratories; Hep3nosticon, Organon;
and turkey ceils; Wellcome Reagents) were performed as recom¬
mended by the manufacturers.
Blood Donor Testing.—Three Scottish regional tram.lusion centres
have been evaluating E.H.A.I. for large-scale donor testing: the
North of Scotland Blood Transfusion Centre have tested 16 371
donations hv E.H.A.I. and C.fi.P. since August 1973; the Edinburgh
and South-East of Scotland Blood Transfusion Centre have tested
44 053 donations since February 1974; 4086 of which were also tested
with the turkey-ccli reagent; the East of Scotland Blood Transfusion
Centre have tested 9800 donations by E.H.A.I. Antigen suitable lor
cell sensitization was prepared centrajly at Edinburgh, but cell
sensitization and subsequent standardization were performed at
each centre independently.
Panel Studies.-—In addition to sera from the N.I.H. panel (no. 2),
which we have studied before, 11 the following antigen panels were
investigated: (a) Public Health Laboratory panel (A) supplied by the
Standards Laboratory for Serological Reagents and consisting of
25 antigen-positive sera of varying concentrations; (6) Canadian
Red Cross panel containing weakly antigen-positive sera (and . one
antibody specimen)—this has recently been used in a multicentre
C.E.P. study;'3 (c) American Red Cross panels (1) containing antigen-







Edinburgh 44 053 18 14
Inverness 16 371 4 2
Dundee 9800 4 3
Total 70 224 26 19
positive material of varying concentration, negative controls, and
which gave false-positive reactions by radioimmunoassay \vh
originally tested in the U.S.A., (2) containing 26 antigen-positivi
coded sera of different subtypes.
Comparative 'Titration Sensitivity.- Seven techniques were used to
assess relative sensitivity against a standard ad antigen and a standard
ay antigen.
Post-transfusion Hepatitis.—Since mid-1973 the South-Hast
region has stored 0-5-in! aliquots of serum at 20 C from all dona¬
tions, so we were able to retest the original donations given to eight
patients referred with suspected post-transfusion hepatitis by R.I.A.,
E.H.A.I., and C.E.P. E.H.A.I. was also used to assay two similar
specimens supplied by Manchester Regional Blood Transfusion
Centre. These sera were obtained at a return visit of the donors arid
were therefore not truly representative of the original donation.
They had all been rctested by C.E.P. and electron microscopy and
found to be antigen negative before their arrival in our laboratory.
Results and Comments
E.H.A.I. detected seven HBsAg-positive carriers (two previously
implicated in post-transfusion hepatitis and five donating blood for
the first time) which were missed by counterelectrophorests (table I),
each centre finding at least one additional positive. E.H.A.I. com¬
pares well in sensitivity to commercial haemaggiutination and radio¬
immunoassay kits (table II), a finding borne out by the results obtained
from the antigen panels studied (table III). All antigen-positive sera
were correctly identified by E.H.A.I. with no non-specific reactions.
Hepanosticon, however, missed two positive sera and the turkey cells
failed to detect the weakest antigen-positive sample in the American
Red Cross panel (I). Auscel gave three false-positive reactions in the
American Red Cross panel (1). During the screening of 4086 blood
donations with the turkey cells, C.E.P., and E.H.A.I. each method
detected the three positive sera, but there were 20 false-positive
reactions with turkey cells.
The retesting of more than 100 donations implicated in eight cases
of post-transfusion hepatitis in Edinburgh (cases 1-8, table IV; five
TABLE II—Comparison of Titration Sensitivity of Haemagglutinatwn Tests, C.E.P., and R.I.A. for HBsAg. Results are Reciprocals of Maximum Titres Recorded
C.E.P. Hepanosticon Turkey Cells Auscell E.H.A.I.* E.H.A.I.+ Ausria I Ausria II
ad .. .. ] 2 400 1000 64 000 2000 32 000 16 000 8000
ay .■ .. | 16 800 4000 32 000 8000 64 000 2000 4000
* With four units of antibody for inhibition.
t With three units of immune absorbed liigh affinity antibody for inhibition.
TABLE III—Results of Antigen Panel Studies
Public Health Laboratory Panel Canadian Red Cross Panel* American Red Cross Panel
(1) (2)
Positive Negative Positive Negative True Positive False Positive False Negative Positive Negative
C.E.P 20 5 3 6 6 0 4 23 3
Turkev cells 25 0 9 0 1
Ausria I 25 0
U.S.A 10 9 0
U.K. 10 0 0
HeDanosticon 23 2
10Auscell 3 0
E.H.A.I 25 0 9 0 10 0 0 26t 0
* This panel also contained another specimen with antibody (anti-HBsAg).
t 13 ad, 13 ay.
TABLE iv—Results of Reinvestigation of Donors implicated in 10 Cases of Post-transfusion Hepatitis. All Donations were Originally Found to be Negative
by C.E.P.
Case no.: 1 2 3 4 5 6 7 8 9 10
HBsAg + + _ 4- + + _ - + N.T.
No. of donations involved 8 14 18 18 32 14 3 10 4 17
No. of donations found to
be positive and method. . 1 by A.I., 1 by A.I., 1 by A.I., I bv
E.H.A.I., • E.H.A.I., and E.H.A.I.
and T.C. and T.C. E.H.A.I. and T.C.
A.I. = Ausria I. E.HJ\.I. = Economical haemaggiutination inhibition. T.C. = Turkey cells. N.T. =Not tested.
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Detection ofHepatitis B Surface Antigen among Scottish
Blood Donors: Evaluation of Sensitive Tanned-cell
Haemagglutination-^nhibition Test
R. HOPKINS, M. ROBERTSON, D. ROSS, W. M. TURNBULL, P. C. DAS
Summary
A total of 70 224 "blood donations were tested at three
Scottish blood transfusion centres for hepatitis B surface
antigen (IIBsAg) by an economical haemagglutination-
inhibition method (E.H.A.I.) and the results compared
with those of counterelectrophoresis (C.E.P.). A further
4088 donations were tested using the Wellcome turkey
cell haemagglutination test, C.E.P., and E.H.A.I. E.H.A.I.
was also compared with commercial haemagglutination
and radioimmunoassay reagents for sensitivity and
specificity against several established antigen panels
and used to reinvestigate counterelectrophoresis-negative
blood donations implicated in post-transfusion hepatitis.
E.H.A.I. combines the inherent specificity of an inhibi¬
tion reactionwith a sensitivity equal to that ofcommercial
radioimmunoassay and haemagglutinatson kits but at
a fraction of the cost. The assessment of 70 224 blood
donations in three regions showed that E.H.A.I. detected
more antigen-positive blood donations than C.E.P.
Results of retesting more than 100 blood donors impli¬
cated in 10 cases of post-transfusion hepatitis suggested
that the use of E.H.A.I. or a test of similar sensitivity
in place of C.E.P. may significantly reduce the incidence
of this complication.
Introduction
Despite the identification of the causal agent of type B post¬
transfusion (serum) hepatitis,1 and the subsequent removal of
blood identified as positive for HBsAg by counterelectro¬
phoresis (C.E.P.) hepatitis continues to complicate the thera¬
peutic use of blood and blood products.' More sensitive sero¬
logical tests for surface antigen might lead to a reduction in
the number of cases of post-transfusion hepatitis but are
unlikely to eliminate it completely because of the potential
infectivity of blood containing antibody to the Dane particle
core3 and the possible existence of a reputed hepatitis C virus4
—quite apart from other causes such as hepatitis virus A
(infectious hepatitis) and other microbial agents.5
The relatively insensitive technique of C.E.P.5 is most
commonly used in blood banks. Much more sensitive assays,
using principles of haemaggiutination or radioimmunoassay,
are now commercially available.'"10 Some reports suggest that
these kits can detect carriers of HBsAg too weak to be positive
on C.E.P.7"9 Unfortunately, their effective use in the blood
transfusion service will prove expensive and only time will tell
whether such expense is justified.
We report here the experience of three Scottish blood trans¬
fusion centres in evaluating a sensitive and economical tanned-
cell haemagglutination-inhibition test (E.H.A.I.).11 In addition
to a field assessment involving 70 224 blood donations the test
was compared with commercial haemagglutination and radio¬
immunoassay kits for specificity and sensitivity. We also present
data on the retesting of 138 blood donors' sera which were
HBsAg negative on initial screening by C.E.P. but were later
implicated in post-transfusion hepatitis in 10 patients.
Regional Transfusion Centre, Royal Infirmary, Edinburgh EH3 9HS
R. HOPKINS, B.sc., Scientific Officer
M. ROBERTSON, f.i.m.l.t., Senior Technician
P. C. DAS, m.b., ph.d., Medical Assistant
Regional Transfusion Centre, Raigmore Hospital, Inverness
D. ROSS, f.i.m.l.t., Senior Technician
Regional Transfusion Centre, Royal Infirmary, Dundee
W. M. TURNBULL, f.i.m.l.t., Chief Technician
Methods
Haemagglutination Inhibition.—The test used was the "mini-micro"
version of that described by Hopkins and Das11 in which washed,
p-propiolactone/ultra-violet light-treated antigen was used to sensi¬
tize human O Rh-negative erythrocytes. Test serum was diluted
1/10 or 1/5 in phosphate-buffered saline and the test conducted in
Terasaki trays using only 5 of reagent. Antibody was detected by
BMj/5/75 COPYRIGHT © ly/d. All mums or rltroduction of this reprint arr reserved in all countries of the world
410 BRITISH MEDICAL JOURNAL 24 MAY
direct haemag.jiutir ;,tiun. Sera'positive for HBsAg were confirr. ed by
subtyping (adjay) rising a modification of the test assay.12
Other Assays.-—C.E.P. was performed as previously described,*
and the plates were washed with 1% tannic acid before reading.
Radioimmunoassay (Ausria, Abbott Laboratories) and hacmagglu-
tination (Auscel, Abbott Laboratories; Hepanosticon, Orgarton;
and turkey cells; Wellcome Reagents) were performed as recom¬
mended by the manufacturers.
Blood Donor Testing.—Three Scottish regional tram.fusion centres
have been evaluating E.H.A.I. for large-scale donor testing: the
North of Scotland Blood Transfusion Centre have tested 16 371
donations by E.ILA.I. and C.E.P. since August 1973; the Edinburgh
and South-East of Scotland Blood Transfusion Centre have tested
44 053 donations since February 1974; 4086 of which were also tested
with the turkey-ccll reagent; the East of Scotland Blood Transfusion
Centre have tested 9800 donations by E.H.A.I. Antigen suitable lor
cell sensitization was prepared centrajly at Edinburgh, but cell
sensitization and subsequent standardization were performed at
each centre independently.
Panel Studies.—In addition to sera from the N.I.H. panel (no. 2),
which we have studied before, 12 the following antigen panels were
investigated: (a) Public Health Laboratory panel (A) supplied by the
Standards Laboratory for Serological Reagents and consisting of
25 antigen-positive sera of varying concentrations; (6) Canadian
Red Cross panel containing weakly antigen-positive sera (and , one
antibody specimen)—this has recently been used in a multicentre
C.E.P. study;13 (c) American Red Cross panels (1) containing antigen-







Edinburgh 44 053 18 14
Inverness 16 371 4 2
Dundee 9800 4 3
Total 70 224 26 19
positive material of varying concentration, negative controls, and :
which gave false-positive reactions by radioimmunoassay wh
originally tested in the U.S.A., (2) containing 26 ontigen-positivv
coded sera of different subtypes.
Comparative Titration Sensitivity.—-Seven techniques were used to
assess relative sensitivity against a standard ad antigen and a standard
ay antigen.
Post-transfusion Hepatitis.—Since mid-1973 the South-Hast
region has stored 0-5-ml aliquots of scrum at 20 C from all dona
tions, so we were able to retest the original donations given to eight
patients referred with suspected post-transfusion hepatitis by R.I.A.,
E.H.A.I., and C.E.P. E.H.A.I. was also used to assay two similar
specimens supplied by Manchester Regional Blood Transfusion
Centre. These sera were obtained at a return visit of the donors and
were therefore not truly representative of the original donation.
They had all been retested by C.E.P. and electron microscopy and
found to be antigen negative before their arrival in our laboratory.
Results and Comments
E.H.A.I. detected seven HBsAg-positive carriers (two previously
implicated in post-transfusion hepatitis and five donating blood for
the first time) which were missed by counterelectrophoresis (table I),
each centre- finding at least one additional positive. E.H.A.I. com¬
pares well in sensitivity to commercial haemagglutination and radio¬
immunoassay kits (table II), a finding borne out by the results obtained
from the antigen panels studied (table III). All antigen-positive sera
were correctly identified by E.H.A.I. with no non-specific reactions.
Hepanosticon, however, missed two positive sera and the turkey cells
failed to detect the weakest antigen-positive sample in the American
Red Cross panel (1). Auscel gave three false-positive reactions in the
American Red Cross panel (1). During the screening of 4086 blood
donations with the turkey cells, C.E.P., and E.H.A.I. each method
detected the three positive sera, but there were 20 false-positive
reactions with turkey cells.
The retesting of more than 100 donations implicated in eight cases
of post-transfusion hepatitis in Edinburgh (cases 1-8, table IV; five
■ n—Comparison of Titration Sensitivity of Haemagglutinatior. Tests, C.E.I'., and R.I.A. for HBsAg. Results are Reciprocals of Maximum. Tilres Recorded
* With four units of antibody for inhibition.
f With three units of immune absorbed high affinity antibody for inhibition.
.
C.E.P. Hepanosticon Turkey Cells Ausceli E.H.A.I.* E.H.A.I.t Ausria 1 Ausria II
ad 2 400 1000 64 000 2000 32 000 16 000 8000
ay 16 800 4000 32 000 8000 64 000 2000 4000
TABLE III—Results of Antigen Panel Studies
Public Health Laboratory Panel Canadian Red Cross Panel* American Red Cross Panel
(1) (2)
Positive Negative Positive Negative True Positive False Positive False Negative Positive Negative
C.E.P 20 5 3 6 6 0 4 23 3
Turkev cells 25 0 9 0 1
Ausria I 25 0
U.S.A 10 9 0
U.K. 10 0 0
Hepanosticon 23 o
10 3 0
E.H.A.I 25 0 9 0 10 0 0 26t 0
* This panef also contained another specimen with antibody (anti-HBsAg).
t 13 ad, 13 ay.
TABLE IV—Results of Reinvestigation of Donors implicated in 10 Cases of Post-transfusion Hepatitis. All Donations were Originally Found to be Negative
by C.E.P.
Case no.: 1 2 3 4 5 6 , 8 9 10
HBsAg
No. of donations involved
No. of donations found to



























A.I. = Ausria I. E.H-A.I. = Economical haemagglutination inhibition. T.C. = Turkey cells. N.T. =Not tested.
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patients were antigen positive) showed that in two cases an antigen-
positive unit of blood had been transfused which was undetectable by
the electrophoresis method during the initial screening as we'll as on
reinvestigation. In both cases antigen was detected only by the more
sensitive tests (table IV). On reinvestigation of the two cases from
Manchester (cases 9 and 10) a positive unit was detected in both cases,
though one was missed by turkey cells and the other by Ausria I.
The antigen-positive unit transfused in case 9 was subtyped as ad,
while that transfused in case 10 was found to be ay, confirming the
finding of the titration study (table II) in which Ausria I showed a
bias towards detection of the ad subtype, despite that all other tests
except Auscel found ad to be weaker. A similar bias in favour of the
ad subtype was recorded by Vandervveld et al.,u but this fault seems
to have been corrected to some extent in the newer Ausria II test
(table II).
Discussion
Recent reports have highlighted the inadequacies of C.E.P. in
detecting HBsAg in blood donations.2 7-10 The American Red
Cross seem to have opted for R.I.A., whiie regional transfusion
centres in the U.K. seem to favour haemagglutination. Three
commercial haeinagglutination assays, all using agglutination
of antibody-coated erythrocytes, are currently available. The
cheapest of these (about 1 Op per test ifordered in bulk) ismarketed
by Wellcome Reagents, and consists of fixed turkey erythrocytes
coated with affinity column purified antibody raised in horses.
In terms of speed and simplicity it is well suited to the large-
scale testing of blood donations,10 15 and its sensitivity is much
greater than that of C.E.P. but less than that of R.I.A. The
other two haemagglutination tests—Hepanosticon, which con¬
sists of fixed sheep erythrocytes coated with antibody raised in
sheep, and Auscel, which consists of fixed human erythrocytes
coated with antibody raised in guinea pigs—have been found
to be more sensitive than C.E.P.s 9 All three tests are susceptible
to a few false-positive reactions, the problem being solved by
absorption-titration experiments.
Our E.H.A.I, test is about as sensitive as R.I.A. and, being
an inhibition reaction, has an inherent specificity not found in
the haemagglutination tests. The use of monospecific antibody
(prepared by absorption or affinity chromatography) allows
E.H.A.I, to be used to subtype antigen-positive sera, which
provides an essential confirmatory step.12
The cost of E.H.A.I. is negligible owing to the availability
of raw material, the considerable expertise in haemagglutination
technology within the Blood Transfusion Service, and the sim¬
plicity of reagent preparation combined with the small quanti¬
ties (5 H) needed for testing. In one week 500 ml of high-titre
HBsAg-positive serum was processed to provide enough antigen
for the sensitization of sufficient cells to test 720 000 donations
for both antigen and antibody. Wc estimate that about 40 tests
can be done for lp.
The prime criterion in evaluating a new screening test must
be the number of additional antigen carriers detected in com¬
parison with current techniques. Our results indicate that
E.H.A.I. detects several donations possessing HBsAg in
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concentrations below the sensitivity of C.E.P. The importance
of these findings is emphasized by the results obtained from the
retesting of blood donations implicated in post-transfusion
hepatitis, which serves as a measure of the efficiency of HBsAg
testing within the Biood Transfusion Service. On the three
occasions in which a C.E.P. false-negative donation was detected
by R.I.A. it was also detected by E.H.A.I.; furthermore,
E.H.A.I. detected one out of 17 units transfused which re¬
mained R.I.A. negative (table IV). This tends to confirm the
findings of Koretz et al.,1* who reported that a positive haemag¬
glutination reaction was more closely related with hepatitis or
seroconversion than was a positive R.I.A. reaction.
E.H.A.I. may prove acceptable in large-scale blood donor
testing. The incidence of antibody, detected by direct haemag¬
glutination, is about 10-20 times greater than that detected by
C.E.P. (252/31 999 v. 13/31 999), thus not only providing valu¬
able materials for laboratory reagents but also increasing the
quantity of antibody for subsequent fractionation of hepatitis B
immunoglobulin for therapeutic use. It seems that with appro¬
priate training the technique may be readily introduced into
any regional transfusion centre, thereby keeping reagent costs
to a minimum. The basic technology has been adapted to a
rapid microcapiilary test for use in emergencies17 and is being
automated in Inverness and modified for the detection of anti¬
body to the Dane particle core in Edinburgh.
We thank Dr. J. D. Cash, Dr. I. A. Ccok, and Dr. C. Cameron,
regional directors of the South-F.ast, North, and East regions
respectively, for continued support and encouragement during this
project. We also thank Mr. R. Y. Dodd and Dr. T. J. Grecnwalt
(American National Red Cross), Dr. B. P. L. Moore (Canadian Red
Cross Society), and Dr. P. Bradstreet (Public Health Laboratory
Service) for kindly providing the antigen panels. We are grateful to
Dr. L. D. Wadsworth (Manchester Blood Transfusion Service) for
allowing us to report on two cases of post-transfusion hepatitis. Finally,
we thank Abbott Laboratories for the timely arrival of an Ausria II
evaluation kit.
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Bulk preparation of reagents for
hepatitis 8 testing
a. d. watt, m. robertson, and r. hopkins Sotltll-
East Scotland Regional Blood Transfusion Centre,
Royal Infirmary, Edinburgh, Scotland
Hepatitis B surface antigen (HBsAg) is a marker of
one of the causative agents of post-transfusion
(serum) hepatitis (Giles et at, 1969) and as such must
be identified in donor blood before transfusion. Over
the past few years, a number of techniques have been
applied to the detection of HBsAg, ranging in sensi¬
tivity and sophistication from agar-gel diffusion
(AGD, first generation test) to radioimmunoassay
(R1 A, third generation test). The experience ofmany
laboratories clearly indicates that third generation
methodology must be adopted if maximum efficiency
of blood donor testing is to be achieved (Ling and
Overby, 1972; Cayzer et al, 1974; Hopkins et at,
1975). Unfortunately, third generation reagents are
available to the majority of blood transfusion centres
only on a commercial basis, the cost ranging from 10
pence per test (Hepatest—Reverse Passive Haemag-
glutination (RPHA) Wellcome Reagents) to 50 pence
per test or more, apparently depending on geo¬
graphical location (AUSRIA-II, Radioimmunoassay
(RIA), Abbott Laboratories).
In 1973 details were published of a tanned-cell
haemagglutination inhibition (HAI) technique, uti¬
lizing Terasaki tissue culture trays, which achieved a
sensitivity similar to RIA but at a fraction of the cost
(Hopkins and Das, 1973). This technique has
recently been evaluated by three Scottish regional
transfusion centres testing over 70 000 blood dona¬
tions together with various well documented HBsAg
panels (Hopkins et al, 1975). The results indicated
that, with appropriate training, the technique could
be introduced into most regional transfusion centres,
thereby keeping reagent costs to a minimum. A valid
comparison between centres was possible only
because reagents were prepared in bulk at one centre
and were thus completely standardized.
This communication describes the bulk prepara¬
tion of HBsAg coated glutaraldehyde fixed sphero-
cytes in a quantity sufficient for approximately one
million tests.
Received for publication 25 November 1975
Preparation of Fixed Sphrrocyles
preparation of spherocytic
Reagent standardization should be enhanced if a
uniform cell population is used for HBsAg coating.
Uniformity is, in this case, achieved by selection of
the most robust cells using a controlled hypotonic
medium.
One unit (approximately 450 ml) of human group
O rhesus negative blood collected in anticoagulant
(citrate phosphate dextrose), and not more than three
weeks old, was obtained from the blood bank. It was
first necessary to determine the molarity of phos¬
phate buffer pH 7-2 required for the selection pro¬
cess. Isotonic (0-2 m) phosphate buffer containing 0 !
% sodium, azide was serially diluted in deionized
water, and 01 ml of fresh, well mixed blood was
added to 2 ml of each dilution of phosphate buffer in
a test tube, mixed thoroughly, and allowed to stand
for 60 minutes. That solution showing at least 50%
haemolysis was arbitrarily taken as optimum. The
molarity at this point was usually 0-045 m to 0-030 m.
The remainder of the unit of blood was then mixed
with phosphate buffer (adjusted lo 'optimum
molarity) in the ratio 1 volume of cells to 3- volumes
of buffer, and the bulk volume was split into 200 ml
aliquots for ease of subsequent washing* After 60
minutes at room temperature the aliquots Were spun
at 1000 rev/min for 15 minutes at 20°C or room tem¬
perature using an MSE 6L centrifuge, thelsupernat-
ant was removed, and fresh hypotonic buffer was
added. This procedure was repeated until only a
minimum of haemolysis was observed in |he super¬
natant, and the rema ining cellsaccounted fojrapproxi-
mately 50% of those originally present. Wet film
microscopy showed that ihe ceils had lost their con¬
ventional biconcave morphology and become
rounded. They were subsequently referred to as
'spherocytes'.
fixation of spherocytes
In a pilot experiment some spherocytes were divided
into aliquots to which glutaraldehyde (Koch Lights,
25%) was added to give the following concentra¬
tions: 1 in 100,1 in 200,1 in 400, i in 800, 1 in 1600, 1
in 3200, and 1 in 6400. After thorough mixing, the
cell aiiquots containing fixative were left at room
temperature overnight. The following morning cells
from each aliquot were examined microscopically
and subjected to a 'water-resistance' test, which
Technical method
involved adding 25 /xl of'settled' spherocytes to 2 nil
of deionized water, when properly fixed cells resisted
haemolysis. Dilutions of glutaraldehyde up to 1 in
1600 (0-06%) produced acceptable fixation, although
dilutions up to 1 in 400 (0-25%) tended to distort the
shape of the spherocytes, causing them to revert to
biconcave discs. The remaining spherocytes (from
the unit pack) were fixed in the appropriate concen¬
tration of glutaraldehyde (approximately 0-06%) as
above and stored at 4°C in phosphate buffer con¬
taining 0-1% sodium azide. All solutions contained
0-1% sodium azide.
TANNING, SENSITIZATION, AND
STABILIZATION OF FIXED SPHEROCYTES
(for onemillion HAI tests)
Sixteen ml of packed glutaraldehyde-fixed
spherocytes were washed twice with 500 ml volumes
of physiological saline (MRC bottle spun at 1000
rev/'min for 5 minutes in an MSE 6L centrifuge at
room temperature). The deposited cells were resus-
pended in 500 ml of tannic acid (M & B at a 1 in
60 000 dilution in phosphate buffer 015 m pH 7-2 con¬
taining 0-1% sodium azide and previously heated to
37°C) and left in a 37°C waterbath for 15 minutes
with occasional mixing. The tanned cells were spun
down as before, washed twice with 500 ml of phos¬
phate buffered saline (PBS) pH 6-4 containing 0-1%
sodium azide, and finally resuspended in 400 ml
PBS pH 6-4.
Twenty millilitres HBsAg, prepared as previously
described (Hopkins and Das, 1973) and containing
both'd' and 'y* antigenic determinants, was added,
and the spherocyte-antigen suspension was mixed
continuously at room temperature (see addendum).
After 20 hours a 1 ml aliquot was removed, stabilized
as previously described (Hopkins and Das, 1973),
and used to titrate a known standard HBsAb con¬
taining serum. Sampling was repeated at approxi¬
mately 20-hour intervals until a satisfactory sensi¬
tivity was achieved. The bulk reagent was removed
from the mixer and the cells were recovered by
centrifugation as before. The sensitized cells were then
stabliiizea by resuspension and mixing for 4 hours at
room temperature in 500 ml PBS pH 7-2 containing
2% normal human serum to give a cell suspension of
approximately 3-2% (or 10 times working concentra¬
tions).
Storage of these cells overnight at 4°C was followed
by a repetition of the stabilizing procedure. There¬
after, the 3-2% suspension of cells was dispersed into
50 ml aliquots and stored at 4°C ready for pasteuri¬
zation.
PASTEURIZATION AND STORAGE OF HBsAg
COATED SPHEROCYTES
Immediately before pasteurization the coated
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spherocytes were pelleted and resuspended to the
same volume with PBS pH 7-2 containing 0 05%
phenol. They were then left for 12-16 hours in a 60°C
waterbath, allowed to cool, divided into smaller
aliquots (for convenience), and stored at 4°C until
required when each aliquot would be diluted 10-fold
with PBS pH 7-2 to achieve working strength.
The coated cells could also be stored at — 20°C or
in the lyop'niiized state without appreciable loss of
sensitivity.
Comment
Recent reports have highlighted the inadequacies of
first and second generation methods of HBsAg test¬
ing (Ling and Overby, 1972; Cayzer et at, 1974;
Hopkins et a!, 1975). The American Red Cross
appear to have opted for RfA as a means of blood
donor screening, while transfusion centres in the
United Kingdom seem to favour haemagglutination.
It is the purpose of this communication to empha¬
size that third generation testing efficiency is avail¬
able at a fraction of the cost of purchasing commer¬
cial reagents. Preparation of sufficient HAI reagents
for approximately one million tests is described in
detail using a process which is readily reproducible
(we have recently prepared a second batch of
reagents sufficient for 3-5 million HAI tests) and
requires relatively unsophisticated laboratory equip¬
ment. The cost of onemillion RPHA tests is £80 000,
while a similar number of RIA tests bought commer¬
cially could cost £500 000.
Experience has shown that HAI reagents are
extremely stable in that they will survive 4°C for over
one year, repeated freezing and thawing, Iyophiliza-
tion and exposure to 2-5 mega rads of gamma irradia¬
tion from a cobalt source (Courtesy of Ethicon Ltd,
Edinburgh), neither does transport over thousands of
miles via air freight appear to have an adverse effect,
even when ceils are maintained in the liquid state.
The safety of laboratory staff handling hepatitis B
testing reagents is of paramount importance. Until it
is possible to evaluate the biological activity of HB-
Ag it is essential that every reasonable precaution
should be taken to ensure the safety of such reagents.
For this reason we have attempted to incorporate
into reagent preparation accepted methods of virus
inactivation, combining the principles of chemical
and physical inactivation, namely, (a) betapropiolac-
tone treatment and ultraviolet irradiation of raw
serum (LoGrippo et al, 1971), (6) pasteurization of
HBsAg coated glutaraldehyde fixed spherocytes, and,
if required, (c) gamma irradiation of the lyophilized
reagents.
We wish to express our sincere thanks to Drs J. D.
Cash and P. C. Das, of the South East of Scotland
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Regional Blood Transfusion Centre, for their sup¬
port and encouragement in the course of this pro¬
ject,
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Addendum
We observed that cell sensitization was successful
when prepared bv mixing in an MRC 500 ml bottle
by mechanical turntable but unsuccessful when per¬
formed in the same type of bottle using a magnetic
mixer with plastic-coated follower. Adsorption of
HBsAg onto the plastic follower has been eliminated
but the electrochemical or electrophysical possibili¬
ties for the failure have yet to be investigated.
British Journal ofHaematology, 1971, 2r, 673.
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Summary. A modification of the counter-immunoelectroosmophoresis method
is described which will allow rapid identification ofhepatitis associated antigen and
antibody within 2 hx. by producing a reaction of identity with known reference
materials. The specificity, of the reaction is established by the demonstration of
non-identity and partial identity by.this technique.
The exact relationship between Australia/SH antigen, presently known as hepatitis associated
antigen (HAA), and A or 13 hepatitis virus remains to be clearly defined. However, there is
little doubt that products containing KAA are capable-of transmitting the infection to sus¬
ceptible recipients. Amongst the various immunological techniques used for the detection of
HAA, the counter-immunoelectroosmophoresis (CIEOP) (Passendorfer et al, 1970) has
recently gained popularity for its sensitivity and the rapid formation ofprecipitin lines due to
an enhanced reaction between the antigen and antibody. Combining the principle of electro¬
phoresis and immunoprecipitation simultaneously, the basic technique involves two wells
per sample between which a precipitin line is observed when the antibody immunoglobulin
present in the anode well reacts with the material in the cathode well containing IIAA. When
a precipitin line does occur, it is necessary to confirm its specificity by demonstrating its
identity with known reference material. Occasionally, erroneous results may be obtained
because the antisera of human origin which are presently used for detection of HAA, are
mostly derived from mukitransfixsed patients and may contain, besides anti-lJAA, other
antibodies to plasma proteins (Blumberg, 1964). Zuckerman Taylor (1970) and Passendorfer
et al (1970) suggested that CIEOP is. unable to produce reaction of identity readily and recom¬
mended the Ouchterlony double diffusion method for this purpose. This has been a major-
drawback to the adoption ofCIEOP for identification ofEIAA and its antibody.
It was suggested (F. Reicht, personal communication 1970) that CIEOP could be used for
identification purposes if the precipitin bands are allowed to form sufficiently close between
the wells containing reference material such as known HAA and the test substance reacting
simultaneously against the complementary antibody present in a third well. This paper
describes such a modification and allows the identification of antigen and/or antibody within
an hour by showing reaction of identity, partial and non-identity between the reactants.
MATERIA!, AND METHOD
Materials
HAA. Plasma and serum containing HAA were obtained from a hepatitis patient; the
reference antigen was received from Dr Okochi, Tokyo.
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Fibrinogen. Normal plasma obtained from a Iiealthy blood donor was used as a source of
human fibrinogen and hooded rat plasma for rat fibrinogen.o £ c>
Anti-human fibrinogen (Bchringwerke AG, Germany) produced 111 the rabbit was used.
This antiserum reacts only with fibrinogen but not with other plasma proteins.
Anti-HAA was obtained from a multiply transfused haemophiliac and its reactivity had .




A 0.9%. agarose solution in 0.025"M veronal buffer (pH 8.6) was used. Aliquots of 25 ml . f
molten agarose were poured on to a 10 em square plastic petri dish (Sterilin) on a levelled
table and allowed to solidify. Circularwells 2 nun in diameter were cut in the agarose 3 mm
apart along the electrophoresis axis (rig 1). If HAA was suspected, the pair of wells 1 mm
apart were placed towards the cathode and vice versa. - yy,': I.
mmfiSSHpr
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Fig r. Position of wells in the agarose gel for the CIEOP technique. A: HAA control; B. suspected







The anode well(s) were filled with antiserum by means of a capillary tube. The petri dish
was then placed in the electrophoresis chamber (Shandon, Model U.177) and maintained at
30°C by means of a water jacket (Shandon) through which water was circulated at the rate
of 1 litre/2,5 min from a water bath using a peristaltic pump. Glass fibre paper (Whatman)
was used as connecting wicks with veronal buffer (pH 8.6, 0.05 m) in the electrophoresis
chamber and a current of 40 mA (about 200 volts) was passed for 5 min. The current was
then switched off and. the antiserum wellfs) 'topped' up. Antigen was added to the cathode
well(s) and and the current re-started. Under these conditions, the precipitin lines appear in
1 hr. If the reactants in the two vertical wells both contain HAA (or antibody) a line of
identity will be obtained. The specificity of the technique is further demonstrated by the
production of reactions of non and partial identity. . . *vr 1 ,
■■■; f&sii&MHKm
RESULTS
Fig 2(a) shows a complete reaction of identity1 by CIEOP using serum and plasma from the
same patient. Complete identity was also obtained when the test serum was compared with
the reference antigen (Fig 2b). This basic observation was not exclusive to the HAA and anti-
HAA system and couid be extended to plasma fibrinogen as shown in Fig 2(c). However,
Rapid Identification of Hepatitis Associated Antigen
Fig 2. Different types of immunological reaction obtained by the CIEOP. (a), (b) and (c) Reaction of
identity; (d) non-identity reaction; (e) reaction of partial identity.
(Facing p 674)
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when, the patient's plasma was allowed to react simultaneously against the anri-HAA and
aiiti-fibrinogen serum, a reaction., of non-identity showing the characteristic intersected
precipitin lines was obtained (Fig 2d). When human .and rat plasma were allowed to react,
against an anti-human fibrinogen by this method, the resultantprecipitin lines showed partial-
identity due to the known serological differences in rat and human fibrinogen. The size and
direction of the 'spur' indicate the degree of dissimilarities between the antigens (Fig ze).
DISCUSSION
In examining 158 transfused thalassaemic patients, Vierucci et al (1970) reported that 20%
of those showing anti-Ag (low density lipoprotein) also contained anti-HAA and. suggested
that use of such antisera in HAA detection might give rise to false positives. Establishment of
the nature of reaction by identifying the precipitin bands is therefore ofmajor importance
since much ofithe anti-HAA presently available is derived from multiply transfused, patients
in whom iso-precipitins, not related to HAAmay be present (Blumbcrg, 1.964).. During the
last year at least one such reaction has been demonstrated in this laboratory in a para-protein-
aemic patient's serum which- produced a precipitation line against anti-HAA, hut failed to
demonstrate virus like particles 011 electronmicroscopy.
In using the CIEOP technique, the size of the wells does not appear to be critical and some
workers preferred, to alter the well-diameter according to the concentration of the reagents
used. The optimal distance between the. anode and cathode wells seems to be 3 mm (Alter
et al, 1971), For accurate identification one must ensure that the margins of the wells are
intact (Ouchterlony, 1964). We have found that layering the gel with 1% freshly made
tannic acid solution at room, temperature for 10-15 rain significantly increases the
sensitivity of the system by sharpening the weak precipitation bands (Alport et al, 1970),
and has the added advantages of time and simplicity over the conventional staining
methods.
Despite the increasing use ofCIEOP for the detection ofHAA many laboratories still base,
their final conclusion on a reaction of identity produced by the technique of Ouchterlony.
A major disadvantage of this method is that it is relatively time consuming requiring 1-7
days (Prince & Burke, 1970) before a definite answer is available. It is therefore ill suited for
blood transfusion, purposes, particularly in making available fresh whole-blood and platelet
concentrates which may be required for transfusion within a few hours of withdrawal. The
technique,we describe seeks to reduce substantially this delay, so that in less than 2 hr initial
screening and identification is possible. Besides the HAA system, this method could also be
applied in other antigen-antibody systems such as plasma fibrinogen and alpha~feto~protein
(Kohn, 1970).
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electrophoresis method by tannic
acid for detection of Australia
antigen
R. HOPKINS ANi> P. C. DAS
From the Regional Transfusion Service, Royal Infirm¬
ary, Edinburgh
For detection of Australia antigen (Au-Ag) by
counter-immuaoelectroosmophoresis (CIEOPj stain¬
ing the agarose gel plates with certain dyes has been
claimed to improve the sensitivity (Combridge and
Shaw, 1971). In our experience, however, a simpler
and less time-consuming procedure is that of layering
the gel plates with 1 % freshly made tannic for 10
minutes (Alpert, Monroe, and Schur, 1970) after the
routine CIEOP procedure (Das, Hopkins, Cash, and
Gumming, 1971). This has resulted in a significantly
increased sensitivity by improving visualization of
precipitin lines.
Serial dilutions of Au-Ag containing serum and
anti-Au (human origin) were set up in the test
system using a 'chessboard' design. After the electro¬
phoresis 'run' the gel plates were observed at an angle
under direct light over a dark background. The
results were scored as + for sharp precipitin line,
± for weak precipitation, and — for no reaction.
Table I shows that the litre of Au-Ag against the
neat antiserum was 1/4, and no significant improve¬
ment was noticed when the same plate was reviewed
after overnight incubation. Tannic acid was now
added and the plate read after 10 minutes: the titre
was now 1/16. This improvement reflects an in¬
creased sensitivity of the system as a whole; thus,
before tannic acid treatment, the total number of
Received for publication 11 May 1972.
fechtu'cal •••<•.
jositives in t'.v 'chessboard' was 14, and after tannic
i treatmen i they were 21. 'f Ins was further
;onfirmed over a perioJ oj two weeks during vvhicn
212 selected specimens from patients, including drug
addicts, with cloUiog disorders and hepatitis, as
well as blood donors, some of them already known
to he carriers of Au-Ag, v. ere subjected to the pro¬
cedure described above. Results show (Table lit
that the number of positive samples were eight before
and 12 after tannic acid treatment; the additional
.Vo. ofSamples Tested
JJioc-J fallen: Laboratory Total
Donor Staff Positive
178 27 7
Before tannic acid 3 5 0 8
After tannic acid 4 8 0 12
Table II A'umber ofpositive specimens amongst 212
selected samples before and after tannic acid treatment
of CIEOP plates
positive results consisted of three from the patient
group and one from the blood donors. In view of these
results the above procedure was extended to the
'routine' laboratory where every unit of blood
donated was screened for the presence of Au-A.g.
During a per-oc) -of.five mn-vhs ,*t total of 19 423
donors were tested, 10 were found to be positive
by routine procedure en.-; no additional positive
appeared, however, after tannic acid treatment of the
O.COP plates.
The mechanism by which tannic acid increases
the sensitivity of the system is not clear, but from a
practical point of view there is no doubt that it is
capable of bringing out Aw-Ag-antibody precipitin
lines, especially amongst the patient's sera. The
present procedure in this laboratory is to score the
results immediately after the routine CIEOP 'run',
the plates are washed, then treated with tannic
acid, re-read and photographed immediately. All
positive samples are re-investigated for identity
reaction, if necessary, after concentration.
We are grateful to Dr R. A. Cumming and Dr J. D.
Cash of this Department for constant encourage¬
ment, support, and reading the typescript.
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Latex agglutination test for detection of Australia
antigen (HB-Ag) among blood donors and patients
R. HOPKINS AND P. C. DAS
From the South-East Regional Blood Transfusion Service, Royal Infirmary, Edinburgh
summary The application of the latex test for the detection of Australia antigen (Au-Ag) was
investigated. Reagents from two commercial sources were compared with the electrophoresis method
with regard to sensitivity and specificity using samples from blood donors, hospital patients, and
plasma fractions. Discordant results were further investigated by electron microscopy and radio¬
immunoassay.
Differences were noted in the results between these reagents and the significance of the findings
together with suggestions for minimizing false positive results are discussed.
The introduction of a latex agglutination test for the
detection of Au-Ag (HAA/HB-Ag) by Leach and
Ruck (1971), which can be read in minutes and is
claimed to be as sensitive as the generally recognized
counter immunoelectroosmophoresis technique, may
be regarded as an important advance. This report
describes our experience with this technique ap¬
plied to blood donors and patients and compares
it with the counter immunoelectroosmophoresis
method. Electron microscopy and radioimmuno¬
assay were performed on those specimens showing
consistent discrepancy between the*—results by
counter immunoelectroosmophoresis and latex ag¬
glutination.




Test samples were obtained from several sources:
from plasmapheresis donors, from known contacts
to Au-Ag, from miscellaneous patients including
s"ome with rheumatoid arthritis, and from coagu¬
lation factor concentrates prepared by the Scottish
National Plasma Fractionation Centre. Also, 10
known Au-Ag positive sera were derived from the
screening, by counter immunoelectroosmophoresis,
of 15 000 donors. Of these 10 Au-Ag positive sera,
four were subtyped as ad+ and a further four as ay+
by Le Bouvier (1971) at Yale University; all 10
were coded and randomly dispersed among the other
test samples.
STANDARD SERA
Known Au-Ag positive serum and plasma samples
from our reference panel were collected either locally
or from abroad including the reference panel no. 2
of the Department of Biologies Standard, NIH
(Bethesda, Maryland), and the American Red Cross
(Washington). Serum and plasma taken into different
anticoagulants (citrate, oxalate, heparin, and EDTA)
from nine healthy males (39-64 years) were tested
both serologically including radioimmunoassay,
and by electron microscopy for use as negative
controls. Further, a group of sera selected from the
panel that had been tested by different laboratories
(by multiple methods) and giving concordant results,
LATEX AGGLUTINATION TEST
Two separate batches (PF1, PF2) of latex particles
coated with anti-Au-Ag, prepared in guinea-pigs
and supplied by Pfizer Ltd,1 were tested according
to the method of Leach and Ruck (1971). A further
set of reagents (anti-Au-Ag prepared in rabbits) was
also supplied by Hoechst Pharmaceuticals Ltd,3 and
the tests were performed as recommended by the
manufacturers. By the same procedure further tests
were carried out using latex tagged with normal
rabbit IgG and with guinea-pig immunoglobulin
(obtained commercially from Wellcome Reagents3
Received for publication 23 October 1973. 'Kent, UK. 'Brentford, UK. 3Beckenham, UK.
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Samples with (*) or
Without (°) Au-Ag







•B f -F +
°C — —
— .
*D + 4- 4- 4- +
*E -1- 4- -b 4- -r
°F — —
—,




— — — ' . —
*K 4- + 4- 4- +
*L 4- •F 4- — -F
"M — — — — —
°N — — — — —
*o + 4- 4- 4-
°P — — — — - —
*Q 4* 4- 4- 4- -F
°R — — — — —
Table I Coded reference panel samples tested by radioimmunoassay, two different preparations of latex, and other
methods
and Pfizer Ltd). The results were scored as + for
strong, ± for weak, and — for no agglutination.
OTHER METHODS
Counter immunoelectroosmophoresis was performed
by the modification of Das, Hopkins, Cash, and
Cumming (1971) and read after tannic acid treatment
(Hopkins and Das, 1972).
Basic electron microscopy and immune electron
microscopy were performed as described by Kelen,
Hathaway, and McLeod (1S71). Solid phase radio¬
immunoassay using radioiodinated marker, anti-
Australia antigen 125.1(Austria-125), obtained from
the Abbott Laboratories1, was used in accordance
with the manufacturer's directions.
Results
Preliminary studies on the various latex preparations
set up against known standard Au-Ag positive sera
demonstrated that although all apparently reacted
satisfactorily, differences in sensitivity could be
shown between the reagents (table II). Further, the




osmophoresis Pfizer Butch 1 Pfizer Batch 2 Hoechst
1:16 1:4 1:256 (1:512)1 1:4 (J)
Table II Comparative antigen titration with different
batches of latex and by counter immuno¬
electroosmophoresis
'Figures in parenthesis are before addition of normal animal serum.
15 000 blood donors, when tested with one batch of
laiex (PF1), all reacted strongly; four of these which
were subtyped ad+ had a mean reaction time of
T9 minutes (range 0-8-2-5 minutes) and four which
were subtyped ay+ had a mean reaction time of
2-8 minutes (range 1-5-4-5 minutes).
Based on these findings 100 selected test samples
were set up against the PF2 and Hoechst latex
preparations. The results are summarized in table III;
all samples shown to be positive by counter immuno-
electrophoresis were also strongly positive with
the PF2 latex preparation. However, the Hoechst
material failed to detect one out of six of the Au-Ag-
positive samples, and both the latex preparations
produced five false positives.
As the one false negative reaction occurred in a
serum from a patient, a further 10 patients' sera
were tested. These sera were kindly supplied by the
Edinburgh University Department of Bacteriology's
diagnostic service and were tested against the PF2
and Hoechst reagents. The results are summarized
in table IVwhich shows that the PF2 reagent detected
ail six Au-Ag positive sera. However, the Hoechst
latex preparation reacted to only two of these sera.
Both reagents gave false positive reactions all of
which were also negative to electron microscopic
and immune electron microscopic examination.
Prior heat treatment of these sera (56CC for 30
minutes) did not influence the non-specific latex
agglutinin titre, except in one sample out of the six
so treated, and the addition of normal guinea-pig
serum to the test as recommended by one manu¬
facturer produced false negative result in a haemo¬
philiac (table IV), probably due to physical dilution.
However, in all of these sera the presence of non-
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Source No. of Samples Number ofPositives
Tested
Counter Immuno- Latex Latex
electroosmophoresis Pfizer IJ Hoechst
Plasmapheresis subjects 65 0 0 3
Coagulation disorders 9{s Io 1 01
Plasma fraction (DEF-IX) 4 0 2 1
Carrier (Au-Ag) blood donor 5 5 5 5
Contacts and staff 11 0 0 0
Transplant donors 2 0 1 0
Alcoholic liver 1 0 0 0
Myeloma 1 0 1 0
Normal sera 2 0 0 0
Total 100 6 11 10










J6703 Diabetis — + + —
J 5821 Serum jaundice + + + —
J6566 Chronic myeloid leukaemia — — — —
J6477 Haemophilia + + — +
J6508 Haemophilia + + + —
J6655 Aplastic anaemia -f -f + —
J6046 Obstructive jaundice + + + +
J6018 After bypass — — — —
J5979 Haemophilia + + -i. —
J5983 Obstructive jaundice — — — +
Table IV Results obtained on patients'' sera using Pfizer and Hoechst latex agglutination test
specific latex agglutinins could be readily demon¬
strated by latex-coated normal rabbit or guinea-pig
immunoglobulins.
In order to ascertain whether this latter observa¬
tion could be used in monitoring false positive
results, sera from 19 patients with rheumatoid
arthritis (seven of whom were positive for rheuma¬
toid factor) were tested with rabbit anti-Au-Ag
coated latex (Hoechst) and with normal rabbit
immunoglobulin sensitized latex (Wellcome Re¬
agents). Table V shows that nine samples were
negative to both preparations, one serum showed
a weak positive reaction to anti-Au-Ag coated
latex only, but a further nine samples reacted to
both specific and non-specific latex reagents; the
agglutination titres against the specific anti-Au-Ag
coated latex (mean 24 ± 23) and non-specific
gamma globulin-coated latex (13 ± 11) showed
highly significant correlation (r = 0-91, p < 0 001)
in the later group of nine sera. All 19 samples were
negative by counter immunoelectrophoresis.
Attempts to reduce further the time required for
the latex technique by using plasma instead of serum
Number of Anti-Au- Normal Rabbit Counter-
Samples coated Gamma Globulin- immuno-
Latex coated Latex electro-
osmophoresis
9
9 + + —
1 ±
Table V Sera from rheumatoid arthritis patients
tested by normal rabbit gamma globulin-coated latex
and anti-Au-sensitized latex (Hoechst)
proved disappointing. Fresh normal plasma, irre¬
spective of the anticoagulant used, produced weak
but definite latex agglutination and heat treatment
(56°C for 30 minutes) did not modify this reaction.
Sera from the same donors (tested after two hours
at 37°C) were negative.
In a further investigation, radioimmunoassay was
used in parallel with both preparations of anti-
Au-Ag-coated latex (Hoechst and Pfizer). Positive
and negative specimens from the Reference Panel
were coded and tested by a variety of other methods.
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Table i shows that all the eight known positive
samples were correctly identified by radioimmuno¬
assay, counter immunoelectroosmophoresis, and
Pfi/er latex (PF2). However, one remained negative
with the 1-loechst reagent and tliree with electron
microscopy. No false positive results were obtained
by radioimmunoassay, counter immunoelectro¬
osmophoresis, and electron microscopy, but one
occurred with both specific latex reagents. This was
confirmed by negative results obtained by these
three techniques.
Discussion
The surprising feature of this study was the good
agreement between both the latex preparations and
the counter immunoelectroosmophoresis technique
when applied to sera obtained from known Au-Ag-
positive blood donors. On the other hand undoubted
false negatives occurred in sera obtained fromAu-Ag-
positive patients with the Hoecbst and PF1 prepara¬
tions. This may have been due to a limited specificity
of the coating antibody, for preliminary studies in
this laboratory have suggested that the antigen
typed as ay+ may not react as effectively as those
designated ad+ with the latex reagents we used. It
seems more likely, however, that the problem, which
is of some clinical importance, may be more closely
related to the low sensitivity of these reagents. This
conclusion is supported by the absence of false
negatives with the PF2 preparation.
False positive reactions to both the latex reagents
used in this study have been reported previously
(Banatvala, Best, Almeida, and Dane, 1971;
Cossart, Field, March, and Porter, 1972; Burreil,
Dickson, Gerber, McCormick, and Marmion, 1972)
and our results confirm these observations. In
investigating the proficiency of anti-Au-Ag coated
latex, Perkins, Perkins, Chen, and Vyas (1972)
noted about 2-5 times higher false positivity amongst
hospital samples compared with those from normal
volunteer donors, and while using basically a similar
latex agglutination principle for the detection of
rheumatoid factor, Caplan, (1963) noted a very high
degree of reactivity amongst the non-rheumatoid
patients compared with blood donors. The increased
reactivity in patients' sera may reflect the presence of
substances such as rheumatoid factor, heterophil
antibody, or species specific substances, whose
diverse properties may affect comparisons between
normal individuals and patients (Hoq, Cash. Das,
and Cumming, 1971). In addition Langenhuysen
(1971) demonstrated the presence of antibodies
against gamma globulin causing agglutination in the
latex fixation test in patients following transfusions
and cytomegalovirus infection. One factor respons¬
ible for these non-specific reactions in some sera
seems to be associated with the IgM fraction (Zalan,
Wilson, and Lub/.ofFsky, 1972), for three out of five
rheumatoid sera which agglutinated both specific
and non-specific latex reagents became negative
following mercaptoethanol treatment (table V).
With regard to the false positive results, none of
the preparations tested appeared to have any ad¬
vantage over the others. The fact that different latex
preparations react falsely with different Au-Ag-
negative sera may reflect differences in animal
species from which the immunoglobulins were
derived, and in the methods of coating the latex, all
of which may influence the primary structure of the
immunoglobulin molecule (Stanworth and Pardoe,
1967).
To eliminate this problem heating at 56°C for
30 minutes has been claimed to be effective
(Ziegenfuss, 1972), but this was not confirmed by our
experience. However, our findings do suggest that
latex coated with appropriate normal immuno¬
globulin introduced as 'control' would help to iden¬
tify spurious positive results, although simultaneous
presence of Au-Ag and non-specific agglufinin(s)
could cause agglutination of both 'test' and 'control'
reagents. Since the positive Au-Ag sera gave 85%
agreement between the two manufacturers' reagents
tested, this approach might be useful for emergency
screening, provided that the reagents are of high
quality and sensitivity; the result, however, is
available in about five minutes and repeating the
test after an absorption procedure with appropriate
normal gamma globulin-coated latex could augment
the specificity of this reaction. The simplicity and
short length of time involved in the latex test for
detecting Au-Ag appear to make it an ideal, reagent
for rapid monitoring of purification stages of Au-Ag
containing materials, and this approach has been
successfully employed as one of the methods for
standardization of the antigen for sensitizing human
red cells employed in a passive haemagglulination
test (Hopkins and Das, 1973) for detection of
Au-Ag and its antibody.
We are grateful to Drs R. A. Cumming and J. D.
Cash for constant help and encouragement, to
Dr George L. Le Bouvier of the Department of
Epidemiology and Public Health, Yale University
School of Medicine, for the subtyping study, to
Professor B. P. Marmion of the Department of
Bacteriology, Edinburgh University, for electron
microscopy, to Mr J. M. Leach of Pfizer Ltd, and
to Mr D. Evans of Hoechst Pharmaceuticals, for a
generous supply of latex agglutination kits. Tests for
rheumatoid factor were carried out by Dr M. S.
Hoq.
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A rapid micro-capiliary haemagglutination method for
detection of Australia antigen (HB-Ag) and its antibody
M. LESLIE, R. HOPKINS AND P. C. DAS
Regional Transfusion Service, Royal Infirmary,
Edinburgh EH3 9HB, Scotland
(Received September 1974, and in revised form November 1974)
A rapid and a simple micro-capillary haemagglutination test is described for screening and
identification of HB-Ag and its antibody in sera. While retaining the specificity and very small
volume of reagents required it has a similar degree of sensitivity to the microtitre plate method.
The reagents are glutaraldehyde pre-fixed human KBCs coupled to beta propiolactone-
inactivated HB-Ag, which retain their reactivity for at least 6 months after storage.
Introduction
With the demonstration of the association between Australia antigen (HB-Ag) and Hepatitis
B, blood has been screened for its presence by a variety of immunologic methods, including
haemagglutination (HA) which requires 1-2 nr for completion of the test and has a similar
degree of sensitivity to radioimmune assay (Hopkins & Das, 1973). This communication
describes a modification of the conventional HA plate procedure to a micro-capillary system
which, while retaining the sensitivity and specificity of the former, has the primary
advantage that the tests can be read within 20 min, and also requires smaller amounts of the
reagents. Other advantages are that the antigen-coated human erythrocytes may be stored
for at least 6 months, and the presence of both HB-Ag and HB-Ab can be detected and
confirmed by the same technique. A similar technique has been described for the detection
of serum fibrin degradation products by Israels, Rayner, Israels & Zipursky (1968).
Materials and Methods
Human erythrocytes (group O) were fixed with glutaraldehyde and treated with tannic acid
according to the procedure of Hoq & Das (1971). Partially purified HB-Ag, treated with
bcta-propiolactone was coupled to the tanned cells by following the method of Hopkins &
Das (1973). A 4% (v/v) suspension of these cells in phosphate buffered saline (PBS) at
pH 7.2, containing 1% normal absorbed rabbit serum and Na-azide (1 mg/cm , PBS) was
prepared and stored at 4 C in aliquots sufficient for one day's expected requirements. PBS
was used as diluent in all experiments and the supernatant of the stored cells replaced with
fresh PBS at monthly intervals. Under these conditions the cells retain their reactivity for at
least six months for both the capillary and microtitre plate tests. Fixed cells similarly coated
with normal pooled plasma, and uncoated cells, were used as controls. In the preliminary
experiments 38 samples containing either HB-Ag or HB-Ab were obtained from previously
screened blood donors. Of these, 19 were coded and dispersed at random among 18 normal
sera (Table 1).
The tests were performed with appropriate laboratory precautionary measures as
described in a report by a scientific group of the WHO (1973). Capillary tubes with blunt
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Test Results
Nat ure of sample Number IIB-Ag Hit Ab Negative
UB-Ab 25 0 25
HB An 1 3 1 3 0
Norma! sera 18 0 0
ends, 90 mm in length and 0.5 mm internal diameter were selected. The details of the
methodological procedures are shown in Fig. 1. During the entire performance of the test
the capillary tube was held (while wearing surgical gloves) only at the upper end (U) which
remains uncontamtnated throughout the procedure.. By capillary action test: sera, reagents,
( d ) ( e )
Rig. 1. Stages of microcapillary method. Capillary was held only at the upper end (U) throughout the
test procedure. Reagents and tests enter by capillary action through the lower end (L). (a) Sera containing
HB-Ab. (b) IIB-Ag coated RBC. (c)-(d) Known antibody plus test expelled our of capillary, mixed and
refilled via L. (e)—(f) Inversion and embedding of capillary (note RBC now positioned at the top), (f) RBC
gravitating down to form negative or positive reaction pattern.
and control sera enter the capillary tube through the lower end (L). The index finger of the
performer rests gently on the upper end of the tube, releasing the capillary lumen at
appropriate times, thereby allowing the reactants to reach the desired levels inside the
capillary.
The capillaries were marked at intervals of 5 5 and 60 mm from the lower end. For HB-Ab
detection serial dilutions of the test serum were drawn by capillary action to the 55 mm




METHOD FOR DETECTION OF AUSTRALIA ANTIGEN 123
detection of HB-Ag, the antiserum was selected by determining the titration end point of a
given serum and using a ten-fold concentration for the test (e.g. the working dilution of an
antibody with a titre of 1 in 10 000 would be 1 in 1000). By capillary action the antiserum
was drawn to the 55 mm mark (Fig. l(a)| followed by test serum to the 60 mm mark, then
a rubber teat was fitted at the upper end of the capillarv and the contents gently expelled to
the bottom of a well of a microtitre (Flow Laboratory, Irvine) plastic plate [Fig. 1(c)]. The
teat was removed and with the capillary held at the upper end, the index finger resting over
the capillary lumen (U), the contents were mixed inside the well wirh the tip of the lower
end of the capillary (L) for 10 sec. The finger was removed and the mixture was re-drawn by
capillary action to the 55 mm mark [Fig. 1(d)] , followed by coated cells to the 60 mm mark
[Fig. 1(b)]. After filling the tubes an air gap (30 mm) remained between the column of
reagent (inside the capillary tube) and the upper end of the capillary [Fig. 1(b)] . The
capillaries were inverted thus the red cells were positioned at the top of the liquid
[Fig. 1 (e)|, and the ends (U) embedded in plasticine fixed to a sheet of translucent glass,
tilted to produce an angle of 55 and mounted in a metal viewing box illuminated by a
fluorescent lamp [Fig. 1(f)). Observations were made at intervals of 2-3 min over a period
of 10-20 min, after which the results were recorded. As the red cells gravitate down from
the top and through the liquid in the capillary, they form their characteristic pattern in
approximately 5 min. In the absence of agglutination this takes the form of a well-defined
line tapering to a pencil point [Fig. 1(f)]. In the presence of haemagglutination the
characteristic 'fir tree' is first formed followed eventually by frank agglutinates [Fig. 1(f)] .
Reactions were recorded as + (agglutination), — (no agglutination) and ± (intermediate). For
antibody titrations reactions were designated +++, ++ and +.
The presence of HB-Ag was confirmed by further tests using two specific antibodies.
Samples showing direct agglutination (antibody) were retested using red cells coated with
normal plasma and the specificity confirmed by utilizing the test serum as anti-HB-Ag in an
inhibition reaction with HB-Ag positive controls and normal serum. The following controls
were incorporated in each batch of tests:
Positive: Anti-HB-Ag with PBS and normal serum
Negative: Anti-HB-Ag with known HB-Ag positive serum
Test control: PBS with test samples
Cell control: PBS with sensitized cells
Results and Discussion
Table 1 shows that all 38 samples in the preliminary experiments were correctly identified.
Titration of Hb-Ab material showed that, when undiluted, some immune sera of animal
origin (chimpanzee and rabbit) produced an unusual reaction pattern suggestive of a prozone
effect. The cells remained on the surface of the column even after standing for 3 hr, in
contrast to the expected negative (non-agglutination) pattern. Human serum containing
HB-Ab has not so far shown this phenomenon (Table 2). Comparative titrations of IIB-Ab
TABLE 2
Capillary HB-Ab titration showing prozone effect in some immune animal sera* but not in human sera
HB-Ab Neat 1/10 1/100 1/1000 1/10 000
Chimpanzee — + ++ +++ ++
Rabbit ± ++ ++ + +
Human (1) + + + ± —
Human (2) ++ ++ + + —
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containing materials so far suggest that the capillary method as described has 'one tube* of
advantage over the plate procedure, bui by comparison with doubling dilutions of known
HB-Ag the capillary method is shown to be slightly less sensitive (] tube difference). This is
consistent with our experience in the determination of scrum fibrin degradation products
(Hoc; & Das, 1971) and is probahh related to the larger volumes and to the higher
concentrations of antiserum relative to the test sample (55 mm/5 mm), used in the capillary
method. The sensitivity of the micro capillar)' rest for the detection of antigen could be
increased by preincubation of equal volumes of test serum and antibody, drawing the
mixture to the 55 mm mark followed by cells to the 60 mm mark, or by reducing the
concentration of antibody, f or antigen screening however, larger volumes of antiscra were
used to improve definition. The test does not require costly equipment and even some of the
items described above could be simplified. Its simplicity, rapidity, and sensitivity render it
superior to the rapid, but problematic latex test (Hopkins & Das, 1974/?) for emergency
requirements involving a limited number of samples. The red cells are capable of 1113-Ag
subtyping into ad and ay varieties and can be used for this purpose in the analysis of the
specific antibody content of HB-IgG preparations (Hopkins & Das, 1 974a).
We are grateful to Dr R. A. Gumming for bis encouragement and for reading the
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